Processing 00000000.tx.1: In Vitro Characterization of Conditions for Amyloid- Peptide Oligomerization and Fibrillogenesis* W. 

Phrase: "In Vitro Characterization of Conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "for Amyloid- Peptide Oligomerization"

Phrase: "and"

Phrase: "Fibrillogenesis"

Phrase: "* W."
Processing 00000000.tx.2: Blaine Stine Jr., Karie N. 

Phrase: "Blaine Stine Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Karie N."
Processing 00000000.tx.3: Dahlgren, Grant A. 

Phrase: "Dahlgren,"

Phrase: "Grant A."
Processing 00000000.tx.4: Krafft, and Mary Jo LaDu** From the Department of Medicine, Division of Geriatrics, Evanston Northwestern Healthcare Research Institute, Evanston, Illinois 60201and Departments of Molecular Pharmacology and Neurobiology and Physiology and **Alzheimer's Disease Core Center, Northwestern University, Chicago, Illinois 60611 Received for publication, October 4,2002, and in revised form, December 18,2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Extensive research causally links amyloid- peptide (A) to Alzheimer's disease, although the pathologically relevant A conformation remains unclear. 

Phrase: "Krafft,"

Phrase: "and"

Phrase: "Mary Jo LaDu"

Phrase: "*"

Phrase: "*"

Phrase: "From the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "Division of Geriatrics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "Evanston Northwestern Healthcare Research Institute,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0035172:Research Institute [Organization]
   804   C0021622:institute [Organization]
   804   C1272753:Institute [Idea or Concept]

Phrase: "Evanston,"

Phrase: "Illinois 60201and Departments of Molecular Pharmacology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Neurobiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027817:Neurobiology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "and **"

Phrase: "Alzheimer's Disease Core Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "Northwestern University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C1709274:Northwestern [Spatial Concept]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois 60611"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020898:Illinois [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 4,"

Phrase: "2002,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "December 18,"

Phrase: "2002  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Extensive research causally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A) to Alzheimer's disease,"

Phrase: "although"

Phrase: "the pathologically relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "A conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.5: A spontaneously aggregates into the fibrils that deposit in senile plaques. 

Phrase: "A spontaneously"

Phrase: "aggregates into the fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205418:Aggregate [Qualitative Concept]
   770   C0225328:fibrils [Cell Component]
   737 E C1948066:Fibril [Physical Object]

Phrase: "that deposit in senile plaques."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposit [Functional Concept]
Processing 00000000.tx.6: However, recent in vivo and in vitro reports describe a potent biological activity for oligomeric assemblies of A. 

Phrase: "However,"

Phrase: "recent in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro reports"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0684224:Reports [Intellectual Product]
   827   C0700287:reports [Health Care Activity]
   793 E C3273238:Report [Intellectual Product]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "describe"

Phrase: "a potent biological activity for oligomeric assemblies of A."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0005532:Biological [Biomedical Occupation or Discipline]
   742   C0205177:Activity [Functional Concept]
   742   C0205460:biological [Qualitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.7: To consistently prepare in vitro oligomeric and fibrillar forms of A1-42, a detailed knowledge of how solution parameters influence structure is required. 

Phrase: "To consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "in vitro oligomeric"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "fibrillar forms of A1-42,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "a detailed knowledge of how solution parameters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0376554:Knowledge [Intellectual Product]

Phrase: "influence"

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.8: This manuscript represents the first study using a single chemically and structurally homogeneous unaggregated starting material to demonstrate that the formation of oligomers, fibrils, and fibrillar aggregates is determined by time, concentration, temperature, pH, ionic strength, and A species. 

Phrase: "This manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the first study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a single chemically"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037179:Single [Population Group]
   861   C0087136:single [Finding]
   861   C0205171:Single [Quantitative Concept]
   861   C0220806:Chemically [Chemical]

Phrase: "and"

Phrase: "structurally homogeneous unaggregated starting material to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Material [Substance]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the formation of oligomers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "fibrils,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "is"

Phrase: "determined by time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "ionic strength,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0086486:Ionic Strength [Quantitative Concept]
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789   C0022023:Ion [Element, Ion, or Isotope]
   789 E C0442821:Strong [Qualitative Concept]
   789   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "A species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.9: We recently reported that oligomers inhibit neuronal viability 10-fold more than fibrils and ~40-fold more than unaggregated peptide, with oligomeric A1-42-induced neurotoxicity significant at 10nM. 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that oligomers"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "neuronal viability 10-fold more than fibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443348:viability [Qualitative Concept]

Phrase: "and ~"

Phrase: "40-fold more than unaggregated peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0332462:Fold [Spatial Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "with oligomeric A1-42-induced neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "significant at 10nM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237881:significant [Quantitative Concept]
   790   C0750502:Significant [Idea or Concept]
   790   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.10: In addition, we were able to differentiate by structure and neurotoxic activity wild-type A1-42 from isoforms containing familial mutations (Dahlgren, K.N., Manelli, A.M., Stine, W.B., Jr., Baker, L.K., Krafft, G.A., and LaDu, M.J.(2002) J.Biol. Chem. 277,32046-32053). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "differentiate by structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205615:differentiate [Qualitative Concept]
   790   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "neurotoxic activity wild-type A1-42 from isoforms"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0205177:Activity [Functional Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0445392:Wild [Intellectual Product]
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   744   C1547052:*Type [Quantitative Concept]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "familial mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Dahlgren,"

Phrase: "K.N., Manelli,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stine,"

Phrase: "W.B.,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "L.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "and"

Phrase: "LaDu,"

Phrase: "M."

Phrase: "J.(2002"

Phrase: ")"

Phrase: "J.Biol. Chem. 277,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: "32046-32053"

Phrase: ")."
Processing 00000000.tx.11: Understanding the biological role of specific A conformations may define the link between A and Alzheimer's disease, re-focusing therapeutic approaches by identifying the pernicious species of A ultimately responsible for the cognitive dysfunction that defines the disease.  

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the biological role of specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "A conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0026377:Conformation [Spatial Concept]

Phrase: "may"

Phrase: "define"

Phrase: "the link between A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "re-focusing"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0000936:focusing [Clinical Attribute]
   861   C2981153:Focusing [Finding]
   861   C2986904:RE [Idea or Concept]
   827 E C0205234:Focus [Spatial Concept]
   827 E C1285542:focus [Functional Concept]

Phrase: "therapeutic approaches by identifying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449445:Approaches [Spatial Concept]
   770   C1292724:Approaches [Functional Concept]

Phrase: "the pernicious species of A ultimately responsible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "for the cognitive dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "that"

Phrase: "defines"

Phrase: "the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Amyloid plaques are one of the pathological hallmarks of Alzheimer's disease (AD).1 Genetic findings over the past decade have further supported the pivotal and likely causal role that amyloid- peptide (A) plays in the etiology of AD (1-4). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "one of the pathological hallmarks of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "(AD).1 Genetic findings over the past decade"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   754   C0730319:Genetic finding [Laboratory or Test Result]
   744   C2607943:findings [Functional Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   726 E C0559563:Birth finding [Finding]
   712 E C0577203:Genital finding [Finding]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0243095:Finding [Finding]
   711 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "the pivotal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C1709557:Pivot [Medical Device]
   928   C2947019:Pivot [Food]

Phrase: "and"

Phrase: "likely causal role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]

Phrase: "that amyloid- peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A)"

Phrase: "plays in the etiology of AD (1-4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0015127:aetiology [Functional Concept]
   744   C0032214:Play [Daily or Recreational Activity]
   744   C0600138:Plays [Finding]
   744   C1314792:Aetiology [Functional Concept]
   744   C1524003:Etiology [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.13: This research demonstrates that autosomal dominant mutations affecting the total amount or relative amount of the 42-versus 40-residue form of A are sufficient to cause the disease (for review, see Ref. 5). 

Phrase: "This research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "demonstrates"

Phrase: "that autosomal dominant mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the total amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "or"

Phrase: "relative amount of the 42-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "versus"

Phrase: "40-residue form of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "("

Phrase: "for review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.14: However, a direct causal relationship between amyloid plaques and cognitive impairment remains unclear (6, 7). 

Phrase: "However,"

Phrase: "a direct causal relationship between amyloid plaques"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "cognitive impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "remains"

Phrase: "unclear"

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.15: This apparent disconnect between plaque burden and neuronal dysfunction and loss has also been described in transgenic mouse models of AD (8, 9). 

Phrase: "This apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]

Phrase: "disconnect between plaque burden"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0011389:Plaque [Disease or Syndrome]
   770   C0332461:Plaque [Finding]
   770   C0333463:plaque [Acquired Abnormality]
   770   C1880354:DISCONNECT [Phenomenon or Process]
   770   C2828008:Burden [Idea or Concept]

Phrase: "and"

Phrase: "neuronal dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "described in transgenic mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mouse, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1552738:described [Idea or Concept]

Phrase: "models of AD (8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.16: Recent theories that reconcile these findings point to small soluble oligomeric or protofibrillar assemblies of A that would likely escape the immunostaining and histopathological staining used to detect both diffuse amyloid deposits and senile plaques (10-13). 

Phrase: "Recent theories"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871935:theories [Idea or Concept]

Phrase: "that"

Phrase: "reconcile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1960278:RECONCILE [Organic Chemical,Pharmacologic Substance]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "point to small soluble oligomeric"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0700321:Small [Quantitative Concept]
   760   C1552961:Point [Quantitative Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   760   C2347617:point [Quantitative Concept]

Phrase: "or"

Phrase: "protofibrillar assemblies of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1706853:Assembly [Activity]
   737   C1879748:Assembly [Manufactured Object]

Phrase: "that"

Phrase: "would"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "escape"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870509:escape [Mental Process]
  1000   C1880554:ESCAPE [Event]

Phrase: "the immunostaining"

Phrase: "and"

Phrase: "histopathological staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "both diffuse amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936349:Amyloid Deposits [Acquired Abnormality]
   827   C0333562:Deposits [Functional Concept]

Phrase: "and"

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "(10-13"

Phrase: ")."
Processing 00000000.tx.17: Soluble oligomers of A have been isolated from brain, plasma, cerebrospinal fluid (14, 15), transfected cells (16), and cells derived from human brain (11, 17). 

Phrase: "Soluble oligomers of A"

Phrase: "have"

Phrase: "been"

Phrase: "isolated from brain,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C0205409:Isolated [Functional Concept]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "plasma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "(14,"

Phrase: "15"

Phrase: ")"

Phrase: ","

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "derived from human brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0086418:Human [Human]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "(11,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.18: In vitro, oligomeric and protofibrillar forms of A have been shown to be directly neurotoxic and inhibit electrophysiologic activity that may be necessary for the formation and maintenance of memory (15, 17-21). 

Phrase: "In vitro, oligomeric"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "protofibrillar forms of A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "directly neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "electrophysiologic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "necessary for the formation"

Phrase: "and"

Phrase: "maintenance of memory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024501:Maintenance [Activity]

Phrase: "(15,"

Phrase: "17-21"

Phrase: ")."
Processing 00000000.tx.19: Experimental in vivo and in vitro evidence linking oligomeric assemblies to neurodegeneration is reflected in a recent revision to the amyloid hypothesis of AD (22) and other diseases involving amyloidogenic proteins (for review, see Ref. 23). 

Phrase: "Experimental in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro evidence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332120:Evidence [Functional Concept]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "oligomeric assemblies to neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1706853:Assembly [Activity]
   737   C1879748:Assembly [Manufactured Object]

Phrase: "is"

Phrase: "reflected in a recent revision"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332185:Recent [Temporal Concept]
   760   C0439617:Revision [Temporal Concept]
   760   C0558058:reflected [Mental Process]
   760   C0558347:Revision [Therapeutic or Preventive Procedure]
   760   C1527075:Revision [Therapeutic or Preventive Procedure]

Phrase: "to the amyloid hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "of AD (22"

Phrase: ")"

Phrase: "and"

Phrase: "other diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "amyloidogenic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloidogenic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "for review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450348:23 [Quantitative Concept]
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.20: A complete study of A, either in vivo or in vitro, requires an understanding of the conditions that drive peptide assembly toward one conformational state or another. 

Phrase: "A complete study of A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "either in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "or"

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "requires"

Phrase: "an understanding of the conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "that"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "peptide assembly toward one conformational state"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]

Phrase: "or"

Phrase: "another."
Processing 00000000.tx.21: Any change that affects the conformation of A likely affects its biological activity. 

Phrase: "Any"

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the conformation of A likely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026377:Conformation [Spatial Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "its biological activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205177:Activity [Functional Concept]
   861   C0205460:biological [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.22: In light of genetic and in vivo evidence, we have chosen to specifically focus on the longer, more hydrophobic A1-42 species. 

Phrase: "In light of genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "in vivo evidence,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332120:Evidence [Functional Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "to specifically focus on the longer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205234:Focus [Spatial Concept]
   753   C1285542:focus [Functional Concept]

Phrase: "more hydrophobic A1-42 species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.23: We have determined that the critical initial step in the controlled assembly of A1-42 is to remove preexisting structure. 

Phrase: "We"

Phrase: "have"

Phrase: "determined"

Phrase: "that"

Phrase: "the critical initial step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1261552:Step [Conceptual Entity]
   812   C1704379:Step [Functional Concept]
   812   C1705117:Step [Quantitative Concept]
   812   C2825408:Step [Manufactured Object]

Phrase: "the controlled assembly of A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "preexisting structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.24: Using this chemically and structurally uniform unaggregated starting material, we demonstrate that changes in incubation time, concentration, temperature, ionic strength, and pH result in distinct structural species including soluble oligomers, protofibrils and short fibrils, extended fibrils, and insoluble fibrillar aggregates. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this chemically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220806:Chemically [Chemical]

Phrase: "and"

Phrase: "structurally uniform unaggregated starting material,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Material [Substance]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that changes in incubation time,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "ionic strength,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0086486:Ionic Strength [Quantitative Concept]
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789   C0022023:Ion [Element, Ion, or Isotope]
   789 E C0442821:Strong [Qualitative Concept]
   789   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "pH result in distinct structural species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "soluble oligomers,"

Phrase: "protofibrils"

Phrase: "and"

Phrase: "short fibrils,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "extended fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0752265:extended fibrils [Cell Component]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "insoluble fibrillar aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.25: We have reported recently (24) that oligomers formed using these methods inhibit neuronal viability 10-fold more than fibrils and ~40-fold more than unaggregated peptide, with oligomeric A1-42-induced inhibition significant at 10nM. 

Phrase: "We"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(24"

Phrase: ")"

Phrase: "that oligomers"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "neuronal viability 10-fold more than fibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443348:viability [Qualitative Concept]

Phrase: "and ~"

Phrase: "40-fold more than unaggregated peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0332462:Fold [Spatial Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "with oligomeric A1-42-induced inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0021467:Inhibition [Mental Process]
   804   C0021469:Inhibition [Molecular Function]
   804   C1628982:% inhibition [Quantitative Concept]
   804   C3463820:Inhibition [Activity]
   733 E C0311403:Inhibited [Qualitative Concept]

Phrase: "significant at 10nM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237881:significant [Quantitative Concept]
   790   C0750502:Significant [Idea or Concept]
   790   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.26: In addition, we were able to differentiate by structure and neurotoxic activity wild-type A1-42 from isoforms containing known familial mutations (24). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "differentiate by structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205615:differentiate [Qualitative Concept]
   790   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "neurotoxic activity wild-type A1-42 from isoforms"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0205177:Activity [Functional Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0445392:Wild [Intellectual Product]
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   744   C1547052:*Type [Quantitative Concept]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "known familial mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.27: Considering the difficulties in detecting unaggregated and oligomeric A using traditional light and electron microscopy, atomic force microscopy (AFM) was chosen for this study as the primary means of characterizing A assembly state. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the difficulties in detecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1299586:difficulties [Finding]

Phrase: "unaggregated"

Phrase: "and"

Phrase: "oligomeric A"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "traditional light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "electron microscopy,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "atomic force microscopy (AFM)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "was"

Phrase: "chosen for this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1707391:Chosen [Activity]
   770   C2603343:Study [Research Activity]

Phrase: "as the primary means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704970:Means [Conceptual Entity]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]

Phrase: "of characterizing"

Phrase: "A assembly state."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]
Processing 00000000.tx.28: AFM has proven uniquely well suited to the study of A (15, 18, 25-28) and other amyloidogenic proteins (29-31), because it generates detailed three-dimensional information at a nanometer scale. 

Phrase: "AFM"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "has"

Phrase: "proven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456369:Proven [Qualitative Concept]

Phrase: "uniquely well suited to the study of A (15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205170:Well [Qualitative Concept]
   742   C3146287:Well [Manufactured Object]

Phrase: "18,"

Phrase: "25-28"

Phrase: ")"

Phrase: "and"

Phrase: "other amyloidogenic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1456454:Amyloidogenic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(29-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "it"

Phrase: "generates"

Phrase: "detailed three-dimensional information at a nanometer scale."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1533716:Information [Idea or Concept]
Processing 00000000.tx.29: This technique is capable of characterizing the wide range of structures present in aggregated A mixtures with sufficient resolution to detect individual 0.9-nm structures in unaggregated preparations that appear monomeric up to multi-micron dense fibrillar aggregates. 

Phrase: "This technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "is"

Phrase: "capable of characterizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "the wide range of structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "present in aggregated"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0150312:Present [Quantitative Concept]
   790   C0332621:Aggregated [Functional Concept]
   790   C0449450:Present [Idea or Concept]
   756 E C0205418:Aggregate [Qualitative Concept]

Phrase: "A mixtures with sufficient resolution to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:mixtures [Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "individual 0.9-nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "structures in unaggregated preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678594:Structure [Spatial Concept]
   737   C0455052:Preparation [Health Care Activity]
   737   C1521827:Preparation [Functional Concept]

Phrase: "that"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "monomeric up to multi-micron dense fibrillar aggregates."
Processing 00000000.tx.30: For the present study, samples were also characterized by Western blot analysis of SDS-PAGE, a technique used in previous publications to identify SDS-stable A assemblies (11, 16, 17, 19, 24, 32). 

Phrase: "For the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "characterized by Western blot analysis of SDS-PAGE,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1704732:Page [Intellectual Product]
   744   C1705493:Western [Spatial Concept]
   744   C1880022:Characterized [Activity]

Phrase: "a technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "used in previous publications to"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0034036:Publications [Intellectual Product,Manufactured Object]
   760   C0205156:Previous [Temporal Concept]
   760   C1273517:used [Finding]
   760   C1552607:previous [Temporal Concept]
   726 E C0034037:Publication [Occupational Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1704324:Publication [Intellectual Product]
   726 E C1947944:Use [Intellectual Product]

Phrase: "identify"

Phrase: "SDS-"

Phrase: "stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]

Phrase: "A assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706853:Assembly [Activity]
   966   C1879748:Assembly [Manufactured Object]

Phrase: "(11,"

Phrase: "16,"

Phrase: "17,"

Phrase: "19,"

Phrase: "24,"

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.31: These techniques were used to characterize the structural heterogeneity present in lyophilized stocks of commercial A peptide and define conditions that eliminate any preformed peptide assemblies. 

Phrase: "These techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the structural heterogeneity present in lyophilized stocks of commercial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "define"

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that"

Phrase: "eliminate"

Phrase: "any preformed peptide assemblies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1706853:Assembly [Activity]
   793   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.32: Using this common homogeneous unaggregated starting material we characterized how concentration, time, temperature, pH, and ionic strength influence A1-42 assembly. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this common homogeneous unaggregated starting material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Material [Substance]

Phrase: "we"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "how concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "ionic strength influence A1-42 assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1706853:Assembly [Activity]
   799   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.33: In addition, the solubility of these A142 preparations was estimated by centrifugation. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the solubility of these A142 preparations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0037628:Solubility [Qualitative Concept]

Phrase: "was"

Phrase: "estimated by centrifugation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0750572:Estimated [Quantitative Concept]
Processing 00000000.tx.34: Finally, solution conditions that favored oligomer and fibril formation for A1-42 were applied to A1-40. 

Phrase: "Finally,"

Phrase: "solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that favored oligomer"

Phrase: "and"

Phrase: "fibril formation for A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "were"

Phrase: "applied to A1-40."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C0439509:/40 [Temporal Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.35: These results demonstrate the importance of a common homogeneous starting material and how specific conditions determine the formation of distinct conformations of A, thus providing the necessary foundation for controlling their assembly. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "the importance of a common homogeneous starting material"

Phrase: "and"

Phrase: "how specific conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "determine"

Phrase: "the formation of distinct conformations of A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "thus"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "the necessary foundation for controlling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016617:Foundation [Organization]

Phrase: "their assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.36: Understanding the biological roles that specific conformations of A play in the pathogenesis of AD may define the link between A and AD, re-focusing therapeutic approaches by identifying the pernicious species of A ultimately responsible for the cognitive dysfunction that is the primary symptom of the disease.  

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the biological roles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]

Phrase: "that specific conformations of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0026377:Conformation [Spatial Concept]

Phrase: "play in the pathogenesis of AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0032214:Play [Daily or Recreational Activity]
   753   C0543483:pathogenesis [Functional Concept]
   753   C0600138:play [Finding]
   753   C0699748:Pathogenesis [Pathologic Function]

Phrase: "may"

Phrase: "define"

Phrase: "the link between A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "AD,"

Phrase: "re-focusing"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0000936:focusing [Clinical Attribute]
   861   C2981153:Focusing [Finding]
   861   C2986904:RE [Idea or Concept]
   827 E C0205234:Focus [Spatial Concept]
   827 E C1285542:focus [Functional Concept]

Phrase: "therapeutic approaches by identifying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449445:Approaches [Spatial Concept]
   770   C1292724:Approaches [Functional Concept]

Phrase: "the pernicious species of A ultimately responsible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705920:Species [Conceptual Entity]

Phrase: "for the cognitive dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "that"

Phrase: "is"

Phrase: "the primary symptom of the disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1457887:Symptom, NOS [Sign or Symptom]
Processing 00000000.tx.37: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Initial Solubilization of A Peptide-- The peptide used in these studies was produced either by chemical synthesis (American Peptide, Sunnyvale, CA) or recombinant expression (Recombinant Peptide Technologies, Athens, GA). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Initial Solubilization of A Peptide"

Phrase: "-"

Phrase: "-"

Phrase: "The peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "used in these studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "produced"

Phrase: "either by chemical synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007987:chemical synthesis [Natural Phenomenon or Process]
   770   C0220781:synthesis [Biologic Function]
   770   C0220806:Chemical [Chemical]
   770   C1883254:Synthesis [Activity]
   770   C3272558:Chemical [Intellectual Product]

Phrase: "(American Peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "Sunnyvale,"

Phrase: "CA)"

Phrase: "or"

Phrase: "recombinant expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Recombinant Peptide Technologies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:technologies [Occupation or Discipline]
   734   C0599286:recombinant peptide [Amino Acid, Peptide, or Protein]

Phrase: "Athens,"

Phrase: "GA"

Phrase: ")."
Processing 00000000.tx.38: Both sources yielded peptide of greater than 95% purity by reverse-phase high performance liquid chromatography and demonstrated the correct molecular mass by mass spectrometry analysis. 

Phrase: "Both sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449416:sources [Finding]
   966 E C1705919:Source [Idea or Concept]

Phrase: "yielded"

Phrase: "peptide of greater"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "than 95% purity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1882508:Purity [Quantitative Concept]
   789 E C2247561:PurE [Molecular Function]

Phrase: "by reverse-phase high performance liquid chromatography"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   913   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   904   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   901   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   901   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   901   C1579831:High performance liquid chromatography [Functional Concept]
   827   C0008565:Liquid Chromatography [Laboratory Procedure]
   799   C0008550:Chromatography [Laboratory Procedure]
   799   C0205250:High [Qualitative Concept]
   799   C0205390:Phase [Temporal Concept]
   799   C0302908:Liquid [Substance]
   799   C0597198:Performance [Individual Behavior]
   799   C1299351:High [Qualitative Concept]
   799   C1304698:Liquid [Finding]
   799   C1546699:Liquid NOS [Intellectual Product]
   799   C1555029:Reverse [Idea or Concept]
   799   C1561501:Liquid NOS [Substance]
   799   C1882330:Performance [Activity]
   799   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "demonstrated"

Phrase: "the correct molecular mass by mass spectrometry analysis."
Processing 00000000.tx.39: Lyophilized peptide was stored in sealed glass vials in desiccated containers at 80 C. 

Phrase: "Lyophilized peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "stored in sealed glass vials"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C1708244:Glass Vial [Manufactured Object]
   760   C0017596:Glass [Manufactured Object]
   760   C0184301:vials [Medical Device]
   760   C1533199:Vials [Quantitative Concept]
   760   C1947936:Glass [Medical Device]
   726   C0036492:Seal [Mammal]
   726   C0325125:seal [Mammal]
   726   C1698986:Store [Functional Concept]
   726   C1704637:Seal [Manufactured Object]
   726 E C1706497:VIAL [Medical Device]

Phrase: "in desiccated containers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0180098:Containers [Manufactured Object]

Phrase: "at 80 C."
Processing 00000000.tx.40: Prior to resuspension, each vial was allowed to equilibrate to room temperature for 30min to avoid condensation upon opening the vial. 

Phrase: "Prior to resuspension,"

Phrase: "each vial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184301:Phial [Medical Device]
  1000   C1533199:Vial [Quantitative Concept]
  1000   C1706497:VIAL [Medical Device]

Phrase: "was"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "equilibrate to room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]

Phrase: "for 30min to"

Phrase: "avoid"

Phrase: "condensation upon opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0233656:Condensation [Mental or Behavioral Dysfunction]
   790   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "the vial."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184301:Phial [Medical Device]
  1000   C1533199:Vial [Quantitative Concept]
  1000   C1706497:VIAL [Medical Device]
Processing 00000000.tx.41: The first step in resuspending the lyophilized peptide was treatment in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP; catalog number H8508; Sigma). 

Phrase: "The first step in resuspending"

Phrase: "the lyophilized peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "treatment in 1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3-hexafluoro-2-propanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0062622:hexafluoro-2-propanol [Organic Chemical]
   812   C0001964:Propanol [Organic Chemical,Pharmacologic Substance]
   812   C0175804:Propanol [Organic Chemical]

Phrase: "(HFIP"

Phrase: "; catalog number H8508"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C3274660:Catalog Number [Intellectual Product]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: All work with HFIP was done in a chemical fume hood with adequate protection. 

Phrase: "All work with HFIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "done in a chemical fume hood"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0303748:Chemical fume [Chemical Viewed Structurally]
   753   C0220806:Chemical [Chemical]
   753   C0457553:Fume [Chemical Viewed Structurally]
   753   C1272695:Done [Qualitative Concept]
   753   C2720748:hood [Medical Device]
   753   C2746065:Done [Temporal Concept]
   753   C3272558:Chemical [Intellectual Product]

Phrase: "with adequate protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]
Processing 00000000.tx.43: Each vial of peptide was diluted in 100% HFIP to 1mM using a glass gas-tight Hamilton syringe with a Teflon plunger. 

Phrase: "Each vial of peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0184301:Phial [Medical Device]
   770   C1533199:Vial [Quantitative Concept]
   770   C1706497:VIAL [Medical Device]

Phrase: "was"

Phrase: "diluted in 100% HFIP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "to 1mM"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a glass gas-tight Hamilton syringe with a Teflon plunger."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1708243:Glass Syringe [Manufactured Object]
   739   C0039142:Syringe [Medical Device]
   739   C1706072:Syringe [Manufactured Object]
Processing 00000000.tx.44: The clear solution containing the dissolved peptide was then aliquoted in microcentrifuge tubes (VWR, 20170-293) using a positive displacement repeat pipette (Multipette; Eppendorf). 

Phrase: "The clear solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the dissolved peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "aliquoted in microcentrifuge tubes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0175730:tubes [Medical Device]
   770   C1547937:Tubes [Intellectual Product]
   770   C1704474:Tubes [Quantitative Concept]
   737   C1510844:Aliquot [Quantitative Concept]
   737 E C1561954:tube [Conceptual Entity]
   737 E C1704730:TUBE [Medical Device]

Phrase: "(VWR,"

Phrase: "20170-293"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a positive displacement repeat pipette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0182301:Pipette [Medical Device]
   812   C1706407:Pipette [Medical Device]

Phrase: "(Multipette"

Phrase: "; Eppendorf"

Phrase: ")."
Processing 00000000.tx.45: The HFIP was allowed to evaporate in the fume hood, and the resulting clear peptide films were dried under vacuum (6.7mtorr) in a SpeedVac (Savant Instruments) and stored desiccated at 20C. 

Phrase: "The HFIP"

Phrase: "was"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaporate in the fume hood,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0457553:Fume [Chemical Viewed Structurally]
   760   C2720748:hood [Medical Device]

Phrase: "and"

Phrase: "the resulting clear peptide films"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086296:Films [Manufactured Object]
   779 E C1561571:film [Biomedical or Dental Material]
   779 E C1561572:film [Substance]

Phrase: "were"

Phrase: "dried under vacuum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0042221:Vacuum [Natural Phenomenon or Process]
   790   C1512080:Dried [Qualitative Concept]
   790   C2827485:Dried [Body Substance]
   756 E C0011682:Dry [Natural Phenomenon or Process]
   756 E C0205222:Dry [Qualitative Concept]

Phrase: "(6.7mtorr"

Phrase: ")"

Phrase: "in a SpeedVac"

Phrase: "(Savant Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "desiccated at 20C."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205240:Desiccated [Qualitative Concept]
   756 E C0011682:Desiccate [Natural Phenomenon or Process]
Processing 00000000.tx.46: The HFIP-treated peptide aliquots were re-checked for chemical purity by reverse-phase high performance liquid chromatography and mass spectrometry. 

Phrase: "The HFIP-treated peptide aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "re-checked for chemical purity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220806:Chemical [Chemical]
   760   C1283174:Checked [Activity]
   760   C1882508:Purity [Quantitative Concept]
   760   C2986904:RE [Idea or Concept]
   760   C3272558:Chemical [Intellectual Product]

Phrase: "by reverse-phase high performance liquid chromatography"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   913   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   904   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   901   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
   901   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
   901   C1579831:High performance liquid chromatography [Functional Concept]
   827   C0008565:Liquid Chromatography [Laboratory Procedure]
   799   C0008550:Chromatography [Laboratory Procedure]
   799   C0205250:High [Qualitative Concept]
   799   C0205390:Phase [Temporal Concept]
   799   C0302908:Liquid [Substance]
   799   C0597198:Performance [Individual Behavior]
   799   C1299351:High [Qualitative Concept]
   799   C1304698:Liquid [Finding]
   799   C1546699:Liquid NOS [Intellectual Product]
   799   C1555029:Reverse [Idea or Concept]
   799   C1561501:Liquid NOS [Substance]
   799   C1882330:Performance [Activity]
   799   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.47: Immediately prior to use, the HFIP-treated aliquots were carefully and completely resuspended to 5mM in anhydrous dimethyl sulfoxide (D2650; catalog number D-2650; Sigma) by pipette mixing followed by bath sonication for 10min (model 2120; Branson). 

Phrase: "Immediately prior to use,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0042153:use [Functional Concept]
   770   C0205548:Immediately [Temporal Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
   770   C2826257:PRIOR [Event]

Phrase: "the HFIP-treated aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "carefully"

Phrase: "and"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "resuspended to 5mM"

Phrase: "in anhydrous dimethyl sulfoxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   827   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0038771:sulfoxide [Organic Chemical]
   827   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(D2650"

Phrase: "; catalog number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3274660:Catalog Number [Intellectual Product]
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "D-"

Phrase: "2650"

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "by pipette mixing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205430:mixing [Functional Concept]
   827 E C1421951:MIX [Gene or Genome]
   827 E C1720722:Mix [Qualitative Concept]

Phrase: "followed by bath sonication"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0037680:Sonication [Research Activity]
   770   C0150141:Bath [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "for 10min"

Phrase: "(model 2120"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "; Branson"

Phrase: ")."
Processing 00000000.tx.48: A1-42 Oligomer- and Fibril-forming Conditions-- A1-42 oligomers were prepared by diluting 5mM A1-42 in Me2SO to 100M in ice-cold cell culture medium (phenol red-free Ham's F-12; BioSource), immediately vortexing for 30s, and incubating at 4C for 24h (19). 

Phrase: "A1-42 Oligomer-"

Phrase: "and"

Phrase: "Fibril-forming Conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "--"

Phrase: "A1-42 oligomers"

Phrase: "were"

Phrase: "prepared by diluting 5mM A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1521827:Prepare [Functional Concept]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "in Me2SO"

Phrase: "to 100M"

Phrase: "in ice-cold cell culture medium"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   875   C0456913:Cold medium [Finding]
   840   C0007585:Cell Culture [Laboratory Procedure]
   840   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   804   C0007634:Cell [Cell]
   804   C0009458:Medium [Intellectual Product]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C0439536:Medium [Quantitative Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1705217:Medium [Substance]
   804   C1948049:Cell [Spatial Concept]
   804   C2242979:Culture [Laboratory Procedure]
   804   C3244283:medium [Intellectual Product]

Phrase: "(phenol red-free Ham's F-12"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   827   C0031430:Phenol Red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   827   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   827   C1541709:Red free [Qualitative Concept]
   799   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   799   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   799   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   799   C0332296:free [Functional Concept]
   799   C0332575:Red [Finding]
   799   C0439133:(f) [Intellectual Product]
   799   C1260956:Red [Qualitative Concept]
   799   C1553038:[f] [Quantitative Concept]
   799   C1880497:Free [Qualitative Concept]
   799   C1996904:Free [Qualitative Concept]
   727 E C0359916:phenolic [Organic Chemical,Pharmacologic Substance]

Phrase: "; BioSource"

Phrase: ")"

Phrase: ","

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "vortexing for 30s,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0227073:30S [Body Part, Organ, or Organ Component]
   790   C0439648:vortexing [Spatial Concept]
   790   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   756 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "and"

Phrase: "incubating at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:incubating [Laboratory Procedure]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.49: A1-42 fibrils were prepared by diluting 5mM A1-42 in Me2SO to 100M in 10mM HCl, immediately vortexing for 30s, and incubating at 37C for 24h. 

Phrase: "A1-42 fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "prepared by diluting 5mM A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1521827:Prepare [Functional Concept]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "in Me2SO"

Phrase: "to 100M"

Phrase: "in 10mM HCl,"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "vortexing for 30s,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0227073:30S [Body Part, Organ, or Organ Component]
   790   C0439648:vortexing [Spatial Concept]
   790   C0724378:vortexing [Organic Chemical,Pharmacologic Substance]
   756 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "and"

Phrase: "incubating at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:incubating [Laboratory Procedure]

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.50: CD Spectroscopy-- HFIP-treated A (1-40 and 1-42) samples prepared using the methods described above were diluted to 50M with HFIP. 

Phrase: "CD Spectroscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "--"

Phrase: "HFIP-"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "A (1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "were"

Phrase: "diluted to 50M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "with HFIP."
Processing 00000000.tx.51: CD spectra were collected on a Jasco J-715 spectropolarimeter. 

Phrase: "CD spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "collected on a Jasco J-715 spectropolarimeter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
Processing 00000000.tx.52: Spectra were obtained from 190to 260nm (1-nm steps, 1-nm bandwidth, 20-millidegree sensitivity) in a 0.1-cm path length quartz cell fitted with a Teflon stopper to control for evaporation. 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from 190to 260nm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(1-nm steps,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261552:steps [Conceptual Entity]
   793 E C1704379:Step [Functional Concept]
   793 E C1705117:Step [Quantitative Concept]
   793 E C2825408:Step [Manufactured Object]

Phrase: "1-nm bandwidth,"

Phrase: "20-millidegree sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]

Phrase: ")"

Phrase: "in a 0.1-cm path length quartz cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0007634:Cell [Cell]
   795   C1269647:Cell [Cell]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: "fitted with a Teflon stopper to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0032611:Teflon [Biomedical or Dental Material,Organic Chemical]
   753   C0036572:Fit [Sign or Symptom]
   753   C0424576:Fit [Finding]
   753   C0699518:Teflon [Biomedical or Dental Material,Organic Chemical]
   753   C2349186:Fit [Activity]
   753   C3272593:Stopper [Manufactured Object]

Phrase: "control for evaporation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C0596539:evaporation [Natural Phenomenon or Process]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.53: All spectra were solvent-subtracted and smoothed with the Savitzky-Golay algorithm according to the manufacturer's instructions provided by Jasco. 

Phrase: "All spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "solvent-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "subtracted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719767:Subtract [Intellectual Product]
   966   C2348589:Subtract [Phenomenon or Process]

Phrase: "and"

Phrase: "smoothed with the Savitzky-Golay algorithm"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0002045:algorithm [Intellectual Product]
   753   C1553907:algorithm [Laboratory Procedure]
   753   C1948044:Smoothed [Research Activity]
   719 E C0205357:Smooth [Qualitative Concept]

Phrase: "according to the manufacturer's instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "provided by Jasco."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.54: Spectra were then converted to mean residue ellipticity and fitted by using a linear least squares method with the program CDFIT for Jasco data (JFIT; written by Bernhard Rupp, 1997.This software was provided by Lawrence Livermore National Laboratory, and more information can be found at www-structure.llnl.gov/cd/cdtutorial.htm#Program%20CDFIT). 

Phrase: "Spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1883073:Spectrum [Quantitative Concept]
   966   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "converted to mean residue ellipticity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0444504:Mean [Quantitative Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "and"

Phrase: "fitted by"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0036572:Fit [Sign or Symptom]
   833   C0424576:Fit [Finding]
   833   C2349186:Fit [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a linear least squares method with the program CDFIT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "for Jasco data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "(JFIT"

Phrase: ";"

Phrase: "written by Bernhard Rupp,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0043266:write [Occupation or Discipline]
   737   C1576875:Write [Finding]
   737   C2584304:Write [Mental Process]

Phrase: "1997."

Phrase: "This software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "was"

Phrase: "provided by Lawrence Livermore National Laboratory,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C1999230:Provided [Activity]
   753   C3244292:laboratory [Functional Concept]
   753   C3245503:national [Intellectual Product]

Phrase: "and"

Phrase: "more information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "at www-structure.llnl.gov/cd/cdtutorial.htm#Program%20CDFIT"

Phrase: ")."
Processing 00000000.tx.55: AFM-- Peptide solutions were characterized using a NanoScope IIIa scanning probe work station equipped with a MultiMode head using an E-series piezoceramic scanner (Digital Instruments, Santa Barbara, CA). 

Phrase: "AFM"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "--"

Phrase: "Peptide solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a NanoScope IIIa scanning probe work station"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0043227:Work [Occupational Activity]
   799   C1883167:Station [Manufactured Object]
   727 E C0439835:Stationary [Qualitative Concept]

Phrase: "equipped with a MultiMode head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0018670:Head [Body Location or Region]
   760   C1281590:Head [Body Part, Organ, or Organ Component]
   760   C1706305:Head [Manufactured Object]
   704 E C0205096:Cephalic [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an E-series piezoceramic scanner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0183115:scanner [Medical Device]
   812   C1710020:Scanner [Medical Device]

Phrase: "(Digital Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Santa Barbara,"

Phrase: "CA)."
Processing 00000000.tx.56: AFM probes were single-crystal silicon microcantilevers with 300-kHz resonant frequency and 42Newton/meter spring constant model OMCL-AC160TS-W2 (Olympus). 

Phrase: "AFM probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]
   756   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "were"

Phrase: "single-crystal silicon microcantilevers with 300-kHz resonant frequency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0037107:Silicon [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "42Newton/meter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475209:Meter [Quantitative Concept]
   861   C1706378:METER [Manufactured Object]

Phrase: "spring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0241232:Spring [Temporal Concept]
  1000   C1705204:Spring [Manufactured Object]

Phrase: "constant model OMCL-AC160TS-W2"

Phrase: "(Olympus"

Phrase: ")."
Processing 00000000.tx.57: Samples were imaged under dry helium. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "imaged under dry helium."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0011682:Dry [Natural Phenomenon or Process]
   770   C0018880:Helium [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0205222:Dry [Qualitative Concept]
   770   C1512080:Dry [Qualitative Concept]
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]
Processing 00000000.tx.58: 10-50 l of sample solution was spotted on freshly cleaved mica, incubated at room temperature for 5min, rinsed with 0.02m of filtered (Whatman Anotop 10) deionized NANOpure water (Barnstad Thermoline), and blown dry with tetrafluoroethane (CleanTex MicroDuster III). 

Phrase: "10-50 l of sample solution"

Phrase: "was"

Phrase: "spotted on freshly cleaved mica,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0066503:Mica [Inorganic Chemical,Pharmacologic Substance]
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C1417162:MICA [Gene or Genome]
   726   C0329155:Spot [Fish]
   726   C1427618:SPOT [Gene or Genome]
   726   C1705203:Spot [Conceptual Entity]

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "for 5min,"

Phrase: "rinsed with 0.02m of filtered"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   719   C0180860:Filter [Manufactured Object]
   719   C0581406:Filter [Medical Device]
   719   C1522664:Filter [Intellectual Product]
   719   C1701810:Rinse [Functional Concept]
   719   C1704449:Filter [Conceptual Entity]
   719   C1704684:Filter [Medical Device]
   719   C1875155:FILTER [Medical Device]
   719   C1882955:Rinse [Activity]

Phrase: "(Whatman Anotop 10"

Phrase: ")"

Phrase: "deionized NANOpure water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0599638:WATER [Substance]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "(Barnstad Thermoline"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "blown"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0009170:Blow [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   966   C0413399:Blow NOS [Injury or Poisoning]

Phrase: "dry with tetrafluoroethane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011682:Dry [Natural Phenomenon or Process]
   790   C0205222:Dry [Qualitative Concept]
   790   C1330625:TETRAFLUOROETHANE [Organic Chemical,Pharmacologic Substance]
   790   C1512080:Dry [Qualitative Concept]

Phrase: "(CleanTex MicroDuster III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.59: Image data were acquired at scan rates between 1and 2Hz with drive amplitude and contact force kept to a minimum. 

Phrase: "Image data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "acquired at scan rates"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0034606:Scan [Diagnostic Procedure]
   770   C0439661:Acquired [Temporal Concept]
   770   C0441633:Scan [Diagnostic Procedure]
   770   C2826292:SCAN [Finding]
   770   C3245488:acquired [Intellectual Product]
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]
   737 E C1706701:Acquire [Activity]

Phrase: "between 1and 2Hz"

Phrase: "with drive amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "contact force"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0441722:Force [Phenomenon or Process]
   861   C0563538:Force [Phenomenon or Process]
   805 E C0729333:Dynamic [Functional Concept]

Phrase: "kept to a minimum."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524031:Minimum [Qualitative Concept]
   770   C1552614:minimum [Idea or Concept]
   770   C2826545:MINIMUM [Quantitative Concept]
   737   C0333118:Keep [Functional Concept]
Processing 00000000.tx.60: Western Blot Analysis of SDS-PAGE-- Gel electrophoresis and Western blot analysis were performed according to the manufacturer's protocols (Invitrogen) as described previously (24). 

Phrase: "Western Blot Analysis of SDS-PAGE-- Gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "performed according to the manufacturer's protocols"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   753   C0442711:Protocols [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1705426:Manufacturer [Population Group]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719 E C2348563:Protocol [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.61: Briefly, unheated samples in lithium dodecyl sulfate sample buffer were applied to 12% bis-Tris NuPAGE gels were electrophoresed using MES running buffer and transferred to 0.45-m polyvinylidene difluoride membrane (Invitrogen). 

Phrase: "Briefly,"

Phrase: "unheated samples in lithium dodecyl sulfate sample buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "applied to 12% bis-Tris NuPAGE gels"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0053809:Bis-Tris [Organic Chemical]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0185125:Applied [Health Care Activity]
   748   C0556985:BIS [Temporal Concept]
   748   C0814229:TRI [Intellectual Product]
   748   C2247301:BIS [Molecular Function]
   748   C3540495:BIS [Intellectual Product]
   714 E C1382104:Gel [Substance]
   714 E C1632850:Apply [Functional Concept]
   714 E C1879355:Apply [Functional Concept]

Phrase: "were"

Phrase: "electrophoresed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013855:electrophorese [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "MES running buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "transferred to 0.45-m polyvinylidene difluoride membrane"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0071710:polyvinylidene difluoride [Organic Chemical]
   744   C0025255:Membrane [Tissue]
   744   C0348011:transferred [Functional Concept]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0596901:Membrane [Cell Component]
   744   C1706182:Membrane [Manufactured Object]
   711 E C0040671:Transfer [Mental Process]
   711 E C1705822:Transfer [Activity]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.62: Membranes were blocked in 5% non-fat dry milk in Tris-buffered saline containing 0.0625% Tween 20.Blots were incubated in the primary antibody 6E10 (mouse monoclonal against A residues 1-16; Signet, Dedham, MA) or 4G8 (mouse monoclonal against A residues 17-24; Signet, Dedham, MA). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked in 5% non-fat dry milk"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   774   C0991850:MILK FAT [Lipid,Pharmacologic Substance]
   748   C0011682:Dry [Natural Phenomenon or Process]
   748   C0026131:Milk [Body Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0205222:Dry [Qualitative Concept]
   748   C0332206:Blocked [Functional Concept]
   748   C0349374:Milk [Food]
   748   C0424612:FAT [Organism Attribute]
   748   C0444318:Milk [Substance]
   748   C1512080:Dry [Qualitative Concept]
   748   C1518422:Non [Functional Concept]
   748   C2825079:Milk [Food]
   748   C2983591:BLOCKED [Research Activity]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "in Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.0625% Tween 20.Blots"

Phrase: "were"

Phrase: "incubated in the primary antibody 6E10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "monoclonal against A residues 1-16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0746619:monoclonal [Finding]

Phrase: "; Signet,"

Phrase: "Dedham,"

Phrase: "MA)"

Phrase: "or"

Phrase: "4G8"

Phrase: "(mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "monoclonal against A residues 17-24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0746619:monoclonal [Finding]

Phrase: "; Signet,"

Phrase: "Dedham,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.63: Immunoreactivity was detected using enhanced chemiluminescence (ECL; Amersham Biosciences) and imaged on an Eastman Kodak Co. 

Phrase: "Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   861   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   861   C2349975:Enhanced [Activity]
   789 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "(ECL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "; Amersham Biosciences"

Phrase: ")"

Phrase: "and"

Phrase: "imaged on an Eastman Kodak Co."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]
Processing 00000000.tx.64: Image Station 440CF. 

Phrase: "Image Station 440CF."
Processing 00000000.tx.65: Molecular weight values were estimated using rainbow pre-stained molecular weight markers (Amersham Biosciences). 

Phrase: "Molecular weight values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "were"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rainbow"

Phrase: "pre-stained"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]
   861   C2986582:Stained [Qualitative Concept]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "molecular weight markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.66: Solubility Analysis-- A1-42 preparations were centrifuged for 30min at 4C at either 16,000g in an Eppendorf 5415D microcentrifuge (Brinkmann Instruments) or at 100,000g in a Beckman Optima MAX ultracentrifuge using a TLA 120.1rotor in 834-mm polycarbonate ultracentrifuge tubes (Beckman Coulter Instruments). 

Phrase: "Solubility Analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "A1-42 preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "centrifuged for 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "at either 16,"

Phrase: "000g in an Eppendorf 5415D microcentrifuge"

Phrase: "(Brinkmann Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")"

Phrase: "or at 100,"

Phrase: "000g in a Beckman Optima MAX ultracentrifuge"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a TLA 120.1rotor in 834-mm polycarbonate ultracentrifuge tubes"

Phrase: "(Beckman Coulter Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0348000:instruments [Medical Device]

Phrase: ")."
Processing 00000000.tx.67: A supernatant and pellet fractions were extracted by dilution to 70% formic acid (EM Science), bath sonicated (model 2120; Branson) for 5min, and incubated for 1h at room temperature. 

Phrase: "A supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "extracted by dilution"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0079240:Dilution [Laboratory Procedure]
   790   C0185115:Extracted [Therapeutic or Preventive Procedure]
   790   C1948037:Dilution [Functional Concept]
   790   C3541890:EXTRACTED [Finding]
   756 E C2828366:Extract [Substance]

Phrase: "to 70% formic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   901   C0885348:formic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "(EM Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "bath"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150141:Bath [Therapeutic or Preventive Procedure]

Phrase: "sonicated"

Phrase: "(model 2120"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "; Branson"

Phrase: ")"

Phrase: "for 5min,"

Phrase: "and"

Phrase: "incubated for 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442450:1H [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.68: Control samples were prepared in an identical manner using the same tubes and solutions in the absence of centrifugation. 

Phrase: "Control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared in an identical manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205280:Identical [Qualitative Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]

Phrase: "and"

Phrase: "solutions in the absence of centrifugation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0037633:Solutions [Substance]
   719 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.69: Values from these control samples were used to determine non-sedimenting background and were subtracted from test samples. 

Phrase: "Values from these control samples"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "non-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Non [Functional Concept]

Phrase: "sedimenting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550099:Sediment [Body Substance]

Phrase: "background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "and"

Phrase: "were"

Phrase: "subtracted from test samples."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   737   C0370003:Sample [Substance]
   737   C1719767:Subtract [Intellectual Product]
   737   C2347026:Sample [Conceptual Entity]
   737   C2348589:Subtract [Phenomenon or Process]
Processing 00000000.tx.70: For dot blot analysis, A supernatant and pellet fractions were diluted to 23.3% formic acid in deionized water. 

Phrase: "For dot blot analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0013064:dot blot [Laboratory Procedure]

Phrase: "A supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "diluted to 23.3% formic acid"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0885348:formic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0450348:23 [Quantitative Concept]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "in deionized water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.71: Quantitative dot blot analysis was performed using a series 105596-well vacuum dot blot apparatus (Invitrogen) fitted with a 0.45-m Immobilon-P membrane (Millipore). 

Phrase: "Quantitative dot blot analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a series 105596-well vacuum dot blot apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0243111:apparatus [Manufactured Object]
   795   C1947951:Apparatus [Anatomical Structure]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "fitted with a 0.45-m Immobilon-P membrane"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0123400:Immobilon P [Organic Chemical]
   742   C0025255:Membrane [Tissue]
   742   C0036572:Fit [Sign or Symptom]
   742   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0424576:Fit [Finding]
   742   C0441923:M+ [Intellectual Product]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]
   742   C2349186:Fit [Activity]

Phrase: "(Millipore"

Phrase: ")."
Processing 00000000.tx.72: 40l of each diluted fraction was applied to the membrane and developed using the same methods described for Western blot analysis. 

Phrase: "40l of each diluted fraction"

Phrase: "was"

Phrase: "applied to the membrane"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0025255:Membrane [Tissue]
   770   C0185125:Applied [Health Care Activity]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "developed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "described for Western blot analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1552738:described [Idea or Concept]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.73: Quantitation of immunoreactivity was determined using Kodak one-dimensional image analysis software (version 3.5.4).  

Phrase: "Quantitation of immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Kodak one-dimensional image analysis software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(version 3.5.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0333052:Version [Functional Concept]
   812   C2607870:Version [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.74: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES In vitro studies necessary to define the structure and activity differences between small oligomeric and fibrillar assemblies of A need to be based on procedures that consistently produce fully characterized, homogeneous structural populations. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "In vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "necessary to"

Phrase: "define"

Phrase: "the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "activity differences between small oligomeric"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "fibrillar assemblies of A need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1706853:Assembly [Activity]
   719   C1879748:Assembly [Manufactured Object]

Phrase: "be"

Phrase: "based on procedures"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   790   C0025664:procedures [Intellectual Product]
   790   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   790   C2700391:procedures [Activity]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756 E C1880279:Base [Biomedical or Dental Material]
   756 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   756 E C3274430:PROCEDURE [Health Care Activity]
   756 E C3538935:Procedure [Idea or Concept]
   756 E C3539779:Procedure [Intellectual Product]

Phrase: "that consistently"

Phrase: "produce"

Phrase: "fully"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: ","

Phrase: "homogeneous structural populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.75: To achieve this goal, the first point to address is the intrinsic structural variability between different lots of A peptide. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "this goal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018017:Goal [Intellectual Product]
  1000   C1571704:Goal [Idea or Concept]

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "is"

Phrase: "the intrinsic structural variability between different lots of A peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2827666:Variability [Conceptual Entity]
Processing 00000000.tx.76: This variability can exist between chemically identical peptide lots and often results in changes in biological activity in vitro (33, 34). 

Phrase: "This variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2827666:Variability [Conceptual Entity]
   928 E C0439828:Variable [Qualitative Concept]

Phrase: "can"

Phrase: "exist between chemically identical peptide lots"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0205280:Identical [Qualitative Concept]
   753   C0220806:Chemically [Chemical]
   753   C2987476:Exist [Conceptual Entity]
   719   C1115660:LOT [Intellectual Product]
   719   C1518000:Lot [Qualitative Concept]
   719   C1710198:Lot [Idea or Concept]

Phrase: "and"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "results in changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in biological activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205177:Activity [Functional Concept]
   861   C0205460:biological [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(33,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.77: HFIP Pretreatment Produces Uniform, Unaggregated Fields of A1-42-- Removal of any preexisting structures in lyophilized stocks of A142 peptide is required for controlled aggregation studies. 

Phrase: "HFIP Pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "Produces"

Phrase: "Uniform,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205375:Uniform [Qualitative Concept]
  1000   C1608508:uniform [Quantitative Concept]

Phrase: "Unaggregated Fields of A1-42"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   726   C1521738:Field [Conceptual Entity]
   726   C2346620:Field [Conceptual Entity]
   726   C2349184:Field [Conceptual Entity]
   726   C3539073:FIELD [Spatial Concept]

Phrase: "--"

Phrase: "Removal of any preexisting structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "in lyophilized stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710198:Stock [Idea or Concept]

Phrase: "of A142 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "required for controlled aggregation studies."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   781   C0681867:Controlled Study [Research Activity]
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1514873:Required [Functional Concept]
   760   C2587213:Controlled [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.78: In this study, lyophilized A directly dissolved to 5mM in 100% HFIP was characterized by AFM. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "lyophilized"

Phrase: "A directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "dissolved to 5mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1549535:Dissolve [Functional Concept]

Phrase: "in 100% HFIP"

Phrase: "was"

Phrase: "characterized by AFM."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   760   C1880022:Characterized [Activity]
   704 E C0729333:Dynamic [Functional Concept]
Processing 00000000.tx.79: This treatment resulted in a dense, homogeneous field of unaggregated peptide immediately after resuspension (Fig. 1A). 

Phrase: "This treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in a dense, homogeneous field of unaggregated peptide immediately"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0205548:Immediately [Temporal Concept]
   739   C0439794:Dense [Qualitative Concept]
   739   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   739   C1521738:Field [Conceptual Entity]
   739   C1881065:Homogeneous [Qualitative Concept]
   739   C2346620:Field [Conceptual Entity]
   739   C2349184:Field [Conceptual Entity]
   739   C3539073:FIELD [Spatial Concept]
   706   C1274040:Result [Functional Concept]
   706   C1546471:Result [Idea or Concept]
   706   C2825142:Result [Finding]

Phrase: "after"

Phrase: "resuspension"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.80: After a 24-h incubation at room temperature, no aggregates, fibrils, or protofibrils were detected in these HFIP A solutions. 

Phrase: "After a 24-h incubation"

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "no aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "fibrils,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "or"

Phrase: "protofibrils"

Phrase: "were"

Phrase: "detected in these HFIP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "A solutions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.81: The z-height value for the individual peptide structures as measured by AFM was 1.0(0.3) nm, which agrees the expected size of a single A monomer. 

Phrase: "The z-height value for the individual peptide structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1522609:Value [Quantitative Concept]

Phrase: "as"

Phrase: "measured by AFM"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0444706:Measured [Qualitative Concept]
   760   C0563538:Force [Phenomenon or Process]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "was"

Phrase: "1.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(0.3"

Phrase: ")"

Phrase: "nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0312860:NM [Cell Function]

Phrase: "which"

Phrase: "agrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641827:Agree [Intellectual Product]

Phrase: "the expected size of a single"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "A monomer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.82: However this technique is not capable of absolute molecular weight determination and therefore does not provide proof that these structures are monomeric. 

Phrase: "However"

Phrase: "this technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "is"

Phrase: "not capable of absolute molecular weight determination"

Phrase: "and"

Phrase: "therefore"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "proof"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0556981:% proof [Quantitative Concept]

Phrase: "that"

Phrase: "these structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "monomeric."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.83: HFIP is a corrosive alcohol and is not compatible with in vitro and cell-based assays. 

Phrase: "HFIP"

Phrase: "is"

Phrase: "a corrosive alcohol"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0001962:ALCOHOL [Organic Chemical]
   861   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   789 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "and"

Phrase: "is"

Phrase: "not compatible with in vitro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:compatible [Idea or Concept]
   760   C1524057:Compatible [Qualitative Concept]

Phrase: "and"

Phrase: "cell-based assays."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1527178:Based [Functional Concept]
   827   C1704653:Cell [Medical Device]
   827   C1705938:Based [Idea or Concept]
   827   C1948049:Cell [Spatial Concept]
   793 E C0002055:base [Inorganic Chemical]
   793   C0005507:Assay [Laboratory Procedure]
   793 E C0178499:Base [Chemical Viewed Functionally]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   793 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.84: For this reason, it was removed by evaporation in a fume hood followed by incubation in a 6.7-mtorr vacuum, and samples were stored as peptide films. 

Phrase: "For this reason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "it"

Phrase: "was"

Phrase: "removed by evaporation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0596539:evaporation [Natural Phenomenon or Process]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "in a fume hood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2720748:hood [Medical Device]

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in a 6.7-mtorr vacuum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0042221:Vacuum [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "stored as peptide films."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   770   C0086296:Films [Manufactured Object]
   737 E C1561571:film [Biomedical or Dental Material]
   737 E C1561572:film [Substance]
   737   C1698986:Store [Functional Concept]
Processing 00000000.tx.85: View larger version (104K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(104K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.86: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.87: AFM analysis of A1-42 solubilized in HFIP, Me2SO, and H2O. 

Phrase: "AFM analysis of A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "solubilized in HFIP,"

Phrase: "Me2SO,"

Phrase: "and"

Phrase: "H2O."
Processing 00000000.tx.88: A, lyophilized synthetic A1-42 was solubilized to 5mM in 100% HFIP, Me2SO, or deionized H2O. 

Phrase: "A,"

Phrase: "lyophilized synthetic A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1883254:synthetic [Activity]

Phrase: "was"

Phrase: "solubilized to 5mM"

Phrase: "in 100% HFIP,"

Phrase: "Me2SO,"

Phrase: "or"

Phrase: "deionized H2O."
Processing 00000000.tx.89: 5mM stock solutions were incubated for 24h at room temperature. 

Phrase: "5mM stock solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.90: Samples before (0-h) and after incubation (24-h) were mounted for AFM analysis at 10M. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "before"

Phrase: "(0-h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and after incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(24-h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "mounted for AFM analysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0026018:Microscopy [Laboratory Procedure]
   753   C0441722:Force [Phenomenon or Process]
   753   C0449878:mounted [Finding]
   753   C0563538:Force [Phenomenon or Process]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   719 E C0181909:Mount [Medical Device]

Phrase: "at 10M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]
Processing 00000000.tx.91: Representative 11-m x-y, 5-nm total z-range AFM images are shown. 

Phrase: "Representative 11-m x-y,"

Phrase: "5-nm total z-range AFM images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1704254:Image [Intellectual Product]
   758   C1704922:Image [Entity]
   758   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.92: Inset image, 390390nm x-y, 5-nm total z-range. 

Phrase: "Inset image,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "390390nm x-y,"

Phrase: "5-nm total z-range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]
Processing 00000000.tx.93: B, HFIP-treated lyophilized peptide stocks were resuspended to 5mM in Me2SO and diluted to 10M for AFM analysis. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "HFIP-treated lyophilized peptide stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1710198:Stock [Idea or Concept]

Phrase: "were"

Phrase: "resuspended to 5mM"

Phrase: "in Me2SO"

Phrase: "and"

Phrase: "diluted to 10M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1442446:10M [Temporal Concept]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "for AFM analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   756   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
Processing 00000000.tx.94: Representative 22-m x-y, 5-nm total z-range AFM image is shown. 

Phrase: "Representative 22-m x-y,"

Phrase: "5-nm total z-range AFM image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C1704254:Image [Intellectual Product]
   791   C1704922:Image [Entity]
   791   C3542466:Image [Intellectual Product]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.95: Inset image, 200200-nm x-y, 5-nm total z-range. 

Phrase: "Inset image,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "200200-nm x-y,"

Phrase: "5-nm total z-range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]
Processing 00000000.tx.96: Fluorinated alcohols including HFIP and trifluoroethanol have been shown to break down -sheet structure, disrupt hydrophobic forces in aggregated amyloid preparations, and promote -helical secondary structure (35-37). 

Phrase: "Fluorinated alcohols"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0001975:Alcohols [Organic Chemical,Pharmacologic Substance]
   827 E C0001962:ALCOHOL [Organic Chemical]
   777 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "HFIP"

Phrase: "and"

Phrase: "trifluoroethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040983:Trifluoroethanol [Organic Chemical]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to break down -sheet structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0678594:Structure [Spatial Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "hydrophobic forces in aggregated amyloid preparations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441722:forces [Phenomenon or Process]
   719 E C0563538:Force [Phenomenon or Process]

Phrase: "and"

Phrase: "promote -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "helical secondary structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162807:Secondary Structure [Spatial Concept]
   827   C0027627:secondary [Neoplastic Process]
   827   C0175668:Secondary [Temporal Concept]
   827   C0205436:Secondary [Quantitative Concept]
   827   C0678594:Structure [Spatial Concept]

Phrase: "(35-37"

Phrase: ")."
Processing 00000000.tx.97: CD is commonly used to determine changes in secondary structure averaged for a given sample solution. 

Phrase: "CD"

Phrase: "is"

Phrase: "commonly"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "changes in secondary structure"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "averaged for a given sample solution."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0037633:Solution [Substance]
   753   C0370003:Sample [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C2347026:Sample [Conceptual Entity]
   719   C1510992:Average [Quantitative Concept]
   719   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.98: Thus, CD spectroscopy is a bulk solution technique that might not detect small quantities of fibrillar seeds that differ in secondary structure. 

Phrase: "Thus,"

Phrase: "CD spectroscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "is"

Phrase: "a bulk solution technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449851:Technique [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]

Phrase: "that"

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "small quantities of fibrillar seeds"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1265611:QUANTITIES [Quantitative Concept]
   726 E C1554108:Quantity [Intellectual Product]
   726 E C1561573:Quantity [Intellectual Product]

Phrase: "that"

Phrase: "differ in secondary structure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0162807:Secondary Structure [Spatial Concept]
   770   C0027627:secondary [Neoplastic Process]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]
   770   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.99: A preparations containing primarily fibrillar peptide as determined by electron microscopy produce a CD spectra consistent with a predominately -sheet conformation (38). 

Phrase: "A preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "primarily fibrillar peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "as"

Phrase: "determined by electron microscopy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0026019:Electron Microscopy [Laboratory Procedure]
   833   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   770   C0013852:Electron [Quantitative Concept]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C3463986:Electron [Bird]

Phrase: "produce"

Phrase: "a CD spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "consistent with a predominately -sheet conformation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.100: However, despite random coil CD spectra, aggregates can be detected by AFM in A1-40 directly resuspended in dH2O (39). 

Phrase: "However,"

Phrase: "despite random coil CD spectra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1883073:Spectrum [Quantitative Concept]
   779   C2827424:Spectrum [Conceptual Entity]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "detected by AFM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "in A1-40 directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439509:/40 [Temporal Concept]
   827   C1947931:Directly [Qualitative Concept]

Phrase: "resuspended in dH2O"

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.101: In the present study, using 100% HFIP to remove structural history resulted in CD spectra for A1-42 and A1-40 solutions indicating a secondary structure almost entirely -helical (~50-70%) and random coil (~30-50%), with little -sheet (<1%) (Table I). 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "100% HFIP to"

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "structural history"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "resulted in CD spectra"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C1883073:Spectrum [Quantitative Concept]
   737   C2825142:Result [Finding]
   737   C2827424:Spectrum [Conceptual Entity]

Phrase: "for A1-42"

Phrase: "and"

Phrase: "A1-40 solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "indicating"

Phrase: "a secondary structure almost entirely -helical"

Phrase: "(~50-70%"

Phrase: ")"

Phrase: "and"

Phrase: "random coil"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0034656:RANDOM [Research Activity]
   861   C0439605:Random [Qualitative Concept]
   861   C0444764:coil [Spatial Concept]
   861   C1413568:COIL [Gene or Genome]
   861   C1705946:Coil [Medical Device]

Phrase: "(~30-50%"

Phrase: ")"

Phrase: ","

Phrase: "with little -sheet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349187:Sheet [Quantitative Concept]

Phrase: "("

Phrase: "<1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.102: These data are in agreement with previous CD results using either HFIP or trifluoroethanol to induce -helical structure (36, 40). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with previous CD results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either HFIP"

Phrase: "or"

Phrase: "trifluoroethanol to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040983:Trifluoroethanol [Organic Chemical]

Phrase: "induce -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "helical structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "(36,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.103: Taken together, these CD studies indicate that dissolving A1-42 in 100% HFIP removes any preexisting -sheet secondary structure, yielding predominately -helix and random coil. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these CD studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "dissolving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549535:Dissolve [Functional Concept]

Phrase: "A1-42 in 100% HFIP"

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "any preexisting -sheet secondary structure,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0162807:Secondary Structure [Spatial Concept]
   812   C0027627:secondary [Neoplastic Process]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]

Phrase: "yielding"

Phrase: "predominately -helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "and"

Phrase: "random coil."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0034656:RANDOM [Research Activity]
   861   C0439605:Random [Qualitative Concept]
   861   C0444764:coil [Spatial Concept]
   861   C1413568:COIL [Gene or Genome]
   861   C1705946:Coil [Medical Device]
Processing 00000000.tx.104: These results are also in agreement with the AFM analysis of A1-42 solutions in HFIP that demonstrate the peptide assumes a uniform, unaggregated conformation that shows no signs of aggregation after incubation for 24h (Fig. 1A).  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "also in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with the AFM analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   756   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "of A1-42 solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "in HFIP"

Phrase: "that"

Phrase: "demonstrate"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "assumes"

Phrase: "a uniform,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205375:Uniform [Qualitative Concept]
  1000   C1608508:uniform [Quantitative Concept]

Phrase: "unaggregated conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "that"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no signs of aggregation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0220912:signs [Functional Concept]
   770   C0220913:signs [Manufactured Object]
   770   C0311392:SIGNS [Finding]
   737 E C1547188:Sign [Idea or Concept]

Phrase: "after incubation"

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.105: View this table: [in this window] [in a new window]  Table I CD spectroscopy of A1-40 and A1-42 in HFIP CD spectrum of 50M, A1-40 and A1-42 were acquired in 100% HFIP at room temperature. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I CD spectroscopy of A1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037812:spectroscopy [Laboratory Procedure]
   748   C2713504:Spectroscopy [Occupation or Discipline]
   748   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "and"

Phrase: "A1-42 in HFIP CD spectrum of 50M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1883073:Spectrum [Quantitative Concept]
   744   C2827424:Spectrum [Conceptual Entity]

Phrase: "A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "A1-42"

Phrase: "were"

Phrase: "acquired in 100% HFIP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439661:Acquired [Temporal Concept]
   770   C3245488:acquired [Intellectual Product]
   737 E C1706701:Acquire [Activity]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.106: Secondary structure values were estimated by spectral deconvolution as described under "Experimental Procedures." 

Phrase: "Secondary structure values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
   734   C0162807:Secondary Structure [Spatial Concept]

Phrase: "were"

Phrase: "estimated by spectral deconvolution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0750572:Estimated [Quantitative Concept]
   770   C1707643:Deconvolution [Machine Activity]
   770   C1883073:Spectral [Quantitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.107: Detection of A1-42 Fibrils after Direct Resuspension in Me2SO-- Me2SO is a highly polar, water-soluble organic solvent commonly used to solubilize hydrophobic peptides, including A (41), and is recommended by commercial suppliers (Bachem). 

Phrase: "Detection of A1-42 Fibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "after Direct Resuspension"

Phrase: "in Me2SO"

Phrase: "--"

Phrase: "Me2SO"

Phrase: "is"

Phrase: "a highly polar, water-soluble organic solvent commonly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   818   C0360100:Organic solvent [Organic Chemical]
   795   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "solubilize"

Phrase: "hydrophobic peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "A (41"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "recommended by commercial suppliers"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0034866:Recommended [Idea or Concept]
   770   C0470689:Suppliers [Health Care Related Organization]
   770   C0680536:commercial [Intellectual Product]
   770   C3272563:Commercial [Intellectual Product]
   737 E C0470690:supplier [Health Care Related Organization]

Phrase: "(Bachem"

Phrase: ")."
Processing 00000000.tx.108: Analytical ultracentrifugation studies have demonstrated that A1-40 and A1-42 are primarily monomeric in 100% anhydrous Me2SO (42, 43). 

Phrase: "Analytical ultracentrifugation studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0596085:analytical ultracentrifugation [Laboratory Procedure]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "A1-42"

Phrase: "are"

Phrase: "primarily monomeric in 100% anhydrous Me2SO"

Phrase: "(42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.109: In the current study, AFM analysis of different commercial lots of synthetic and recombinant A1-42 directly resuspended to 5mM in 100% anhydrous Me2SO without HFIP pretreatment demonstrated that the peptide appears primarily unaggregated immediately after solubilization, with structures measuring 1.1(0.3) nm (Fig. 1A). 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "AFM analysis of different commercial lots of synthetic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "recombinant A1-42 directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514798:recombinant [Organism]
   812   C1947931:Directly [Qualitative Concept]

Phrase: "resuspended to 5mM"

Phrase: "in 100% anhydrous Me2SO"

Phrase: "without HFIP pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "primarily unaggregated immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "solubilization,"

Phrase: "with structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(0.3"

Phrase: ")"

Phrase: "nm (Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.110: However, in some cases small diameter (~2-nm) fibrils were observed (Fig. 1A, inset). 

Phrase: "However,"

Phrase: "in some cases small diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301886:Diameter [Quantitative Concept]

Phrase: "(~2-nm) fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.111: After 24h at room temperature, additional small A fibrils were detected in A1-42 Me2SO solutions, even in preparations that were initially fibril-free. 

Phrase: "After 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "at room temperature, additional small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0700321:Small [Quantitative Concept]

Phrase: "A fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "detected in A1-42 Me2SO solutions,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0037633:Solutions [Substance]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "even in preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0455052:Preparation [Health Care Activity]
   756   C1521827:Preparation [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "initially fibril-free."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
Processing 00000000.tx.112: These small fibrillar structures were stable in Me2SO for several weeks and formed even after HFIP pretreatment (data not shown). 

Phrase: "These small fibrillar structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "stable in Me2SO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205360:Stable [Qualitative Concept]
   790   C1547311:Stable [Intellectual Product]

Phrase: "for several weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "even"

Phrase: "after"

Phrase: "HFIP pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: These results indicate that 100% anhydrous Me2SO alone is not a sufficiently strong solvent to remove all structural history present in lyophilized A or maintain a concentrated unaggregated peptide solution. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that 100% anhydrous Me2SO"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a sufficiently strong solvent to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "all structural history present in lyophilized A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "a concentrated unaggregated peptide solution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1707468:Concentrated Solution [Biomedical or Dental Material]
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.114: Detection of A1-42 Fibrils, Protofibrils, Large Aggregates, and Oligomers after Direct Resuspension in Water-- Resuspension of lyophilized A142 directly in dH2O or aqueous buffer is also used by investigators (44, 45) and recommended by commercial manufacturers (AnaSpec, Bachem, U.S. Peptide, Inc.). 

Phrase: "Detection of A1-42 Fibrils,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "Protofibrils,"

Phrase: "Large Aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "Oligomers after Direct Resuspension"

Phrase: "in Water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "--"

Phrase: "Resuspension of lyophilized A142 directly"

Phrase: "in dH2O"

Phrase: "or"

Phrase: "aqueous buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "is"

Phrase: "also"

Phrase: "used by investigators"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C1273517:Used by [Finding]
           used
   790   C0035173:Investigators [Professional or Occupational Group]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "(44,"

Phrase: "45"

Phrase: ")"

Phrase: "and"

Phrase: "recommended by commercial manufacturers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034866:Recommended [Idea or Concept]
   770   C0680536:commercial [Intellectual Product]
   770   C3272563:Commercial [Intellectual Product]
   737   C0947322:Manufacturer [Intellectual Product]
   737   C1705426:Manufacturer [Population Group]

Phrase: "(AnaSpec,"

Phrase: "Bachem,"

Phrase: "U.S. Peptide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   734   C0041703:U S [Geographic Area]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.115: To determine the extent of structural heterogeneity present in lyophilized stocks of A1-42, peptide was directly resuspended to 5mM in dH2O and characterized by AFM. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the extent of structural heterogeneity present"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "in lyophilized stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710198:Stock [Idea or Concept]

Phrase: "of A1-42,"

Phrase: "peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "resuspended to 5mM"

Phrase: "in dH2O"

Phrase: "and"

Phrase: "characterized by AFM."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   760   C1880022:Characterized [Activity]
   704 E C0729333:Dynamic [Functional Concept]
Processing 00000000.tx.116: Analysis of these solutions revealed a wide size range of peptide aggregates and extended fibrils immediately after resuspension (Fig. 1A). 

Phrase: "Analysis of these solutions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a wide size range of peptide aggregates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0456389:size [Spatial Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "extended fibrils immediately"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0752265:extended fibrils [Cell Component]
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "after"

Phrase: "resuspension"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.117: These structures included large (10-15-nm z-height) and small (2-5-nm z-height) amorphous peptide aggregates and intermediate diameter fibrils (4-6 nm) greater than 1m in length. 

Phrase: "These structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "(10-15-nm z-height"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   804   C0489786:Height [Organism Attribute]
   733 E C0205250:High [Qualitative Concept]
   733 E C1299351:High [Qualitative Concept]
   733 E C1522410:Highest [Qualitative Concept]
   733 E C2700149:HIGH [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "(2-5-nm z-height"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   804   C0489786:Height [Organism Attribute]
   733 E C0205250:High [Qualitative Concept]
   733 E C1299351:High [Qualitative Concept]
   733 E C1522410:Highest [Qualitative Concept]
   733 E C2700149:HIGH [Intellectual Product]

Phrase: ")"

Phrase: "amorphous peptide aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "intermediate diameter fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "(4-6 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "greater than 1m"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "in length."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]
Processing 00000000.tx.118: These structures persisted after 24h at room temperature, in addition to an increase in the number of 2-5-nm globular aggregates. 

Phrase: "These structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "persisted after 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456696:/24h [Temporal Concept]
   790   C1442770:24H [Temporal Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "in addition to an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of 2-5-nm globular aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.119: However, the extent of all the structures observed under these conditions is highly dependent on seeded aggregation and thus dependent on the initial lyophilized peptide. 

Phrase: "However,"

Phrase: "the extent of all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "the structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "observed under these conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441672:Observed [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "highly dependent on seeded aggregation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "thus dependent on the initial lyophilized peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]
Processing 00000000.tx.120: These data indicate that direct resuspension of lyophilized A1-42 in dH2O produces heterogeneous structural populations incompatible with controlled aggregation studies. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that direct resuspension of lyophilized A1-42"

Phrase: "in dH2O"

Phrase: "produces"

Phrase: "heterogeneous structural populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "incompatible with controlled aggregation studies."
Processing 00000000.tx.121: Note that the z-height range for this H2O preparation was maintained at 5nm, resulting in a greater contrast compared with images of HFIP- and Me2SO-solubilized peptide. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the z-height range for this H2O preparation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "maintained at 5nm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "resulting in a greater contrast"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0332294:Resulting in [Functional Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1704243:Greater [Quantitative Concept]
   760   C1979874:Contrast [Qualitative Concept]
   726 E C0549177:Great [Quantitative Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "compared with images of HFIP-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1707455:Compared [Activity]
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "Me2SO-solubilized peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.122: Solubilization of HFIP-treated Peptide in Me2SO Produces a Uniform, Unaggregated Field of A142-- To ensure that the HFIP-treated A1-42 peptide film was fully solubilized, peptide stocks were resuspended to 5mM in Me2SO. 

Phrase: "Solubilization of HFIP-treated Peptide"

Phrase: "in Me2SO"

Phrase: "Produces"

Phrase: "a Uniform,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205375:Uniform [Qualitative Concept]
  1000   C1608508:uniform [Quantitative Concept]

Phrase: "Unaggregated Field of A142"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   770   C1521738:Field [Conceptual Entity]
   770   C2346620:Field [Conceptual Entity]
   770   C2349184:Field [Conceptual Entity]
   770   C3539073:FIELD [Spatial Concept]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the HFIP-treated A1-42 peptide film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0086296:Film [Manufactured Object]
   799   C1561571:film [Biomedical or Dental Material]
   799   C1561572:film [Substance]

Phrase: "was"

Phrase: "fully"

Phrase: "solubilized"

Phrase: ","

Phrase: "peptide stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710198:Stock [Idea or Concept]

Phrase: "were"

Phrase: "resuspended to 5mM"

Phrase: "in Me2SO."
Processing 00000000.tx.123: The resulting solution contained unaggregated structures (Fig. 1B) that measured 1.0(0.3) nm by AFM (Fig. 1B, inset), comparable with the measurements for A1-42 structures measured directly in HFIP or Me2SO (Fig. 1A). 

Phrase: "The resulting solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "unaggregated structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "that"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(0.3"

Phrase: ")"

Phrase: "nm by AFM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0312860:NM [Cell Function]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "inset"

Phrase: ")"

Phrase: ","

Phrase: "comparable with the measurements"

Phrase: "for A1-42 structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "directly in HFIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "Me2SO"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.124: Solubilization of the HFIP-treated peptide directly into dH2O or aggregation buffer does not produce a fully resuspended unaggregated solution. 

Phrase: "Solubilization of the HFIP-treated peptide directly"

Phrase: "into dH2O"

Phrase: "or"

Phrase: "aggregation buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "produce"

Phrase: "a fully"

Phrase: "resuspended"

Phrase: "unaggregated solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.125: The thin film resulting from the HFIP treatment is not easily resuspended directly in dH2O without the use of sonication or other methods. 

Phrase: "The thin film"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1441759:Thin film [Laboratory Procedure]
   861   C0086296:Film [Manufactured Object]
   861   C1561571:film [Biomedical or Dental Material]
   861   C1561572:film [Substance]

Phrase: "resulting from the HFIP treatment"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0678226:resulting [Functional Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "is"

Phrase: "not easily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332219:Easily [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "resuspended"

Phrase: "directly in dH2O"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1947931:Directly [Qualitative Concept]

Phrase: "without the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037680:Sonication [Research Activity]

Phrase: "or"

Phrase: "other methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.126: The peptide film is more soluble in Me2SO facilitating complete resuspension of the HFIP-treated peptide (data not shown). 

Phrase: "The peptide film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086296:Film [Manufactured Object]
   861   C1561571:film [Biomedical or Dental Material]
   861   C1561572:film [Substance]

Phrase: "is"

Phrase: "more soluble in Me2SO facilitating complete resuspension of the HFIP-treated peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1749467:soluble [Cell Component]
   736   C1948047:Soluble [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: Solution Conditions for the Formation of Oligomeric or Fibrillar A1-42 Assemblies-- Once conditions were established that consistently produce unaggregated A preparations, two different aggregation protocols were used with the HFIP-treated Me2SO peptide stocks. 

Phrase: "Solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "Conditions for the Formation of Oligomeric"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0012634:condition [Disease or Syndrome]
   753   C0220781:formation [Biologic Function]
   753   C0348080:Condition [Qualitative Concept]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
   753   C1705253:Condition [Conceptual Entity]

Phrase: "or"

Phrase: "Fibrillar A1-42 Assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1706853:Assembly [Activity]
   779   C1879748:Assembly [Manufactured Object]

Phrase: "-"

Phrase: "-"

Phrase: "Once"

Phrase: "conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that consistently"

Phrase: "produce"

Phrase: "unaggregated"

Phrase: "A preparations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "two different aggregation protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0442711:Protocols [Intellectual Product]
   779 E C1507394:Protocol [Intellectual Product]
   779 E C1522729:Protocol [Intellectual Product]
   779 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "used with the HFIP-treated Me2SO peptide stocks."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C1273517:used [Finding]
   744   C1522326:Treated [Functional Concept]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]
   711   C1710198:Stock [Idea or Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.128: Previous studies demonstrated the formation of small soluble oligomeric assemblies derived from A1-42 either incubated in the presence of apolipoprotein J under physiologic conditions (18) or in cell culture medium where the oligomeric assemblies were referred to as ADDLs (amyloid-derived diffusible ligands) (19). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "the formation of small soluble oligomeric assemblies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "derived from A1-42 either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "incubated in the presence of apolipoprotein J"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0055966:Apolipoprotein J [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C1413514:APOLIPOPROTEIN J [Gene or Genome]
   778   C2609437:Apolipoprotein J [Laboratory Procedure]
   748   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "under physiologic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(18"

Phrase: ")"

Phrase: "or"

Phrase: "in cell culture medium where"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0007585:Cell Culture [Laboratory Procedure]
   840   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   804   C0009458:Medium [Intellectual Product]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C2242979:Culture [Laboratory Procedure]
   804   C3244283:medium [Intellectual Product]

Phrase: "the oligomeric assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "were"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "ADDLs"

Phrase: "(amyloid-derived diffusible ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023688:Ligands [Chemical]

Phrase: ")"

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.129: For the studies presented herein, the cell culture medium method with a 24-h incubation at 4C was used for oligomer formation. 

Phrase: "For the studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "herein,"

Phrase: "the cell culture medium method with a 24-h incubation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "was"

Phrase: "used for oligomer formation."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1273517:used [Finding]
   770   C1522492:Formation [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.130: For the fibril-forming conditions, previous studies have indicated that acidic pH favors fibrillogenesis for A (46, 47) and other amyloid-forming proteins (48-50). 

Phrase: "For the fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "fibrillogenesis for A (46,"

Phrase: "47"

Phrase: ")"

Phrase: "and"

Phrase: "other amyloid-forming proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(48-50"

Phrase: ")."
Processing 00000000.tx.131: The acidic pH method using 10mM HCl with a 24-h incubation at 37C was chosen for fibril formation. 

Phrase: "The acidic pH method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "10mM HCl with a 24-h incubation"

Phrase: "at 37C"

Phrase: "was"

Phrase: "chosen for fibril formation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0220781:formation [Biologic Function]
   770   C0225328:Fibril [Cell Component]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C1707391:Chosen [Activity]
   770   C1948066:Fibril [Physical Object]
Processing 00000000.tx.132: The resulting oligomeric and fibrillar A142 structures were characterized by AFM (Fig. 2A) and Western blot analysis of SDS-PAGE (Fig. 2B). 

Phrase: "The resulting oligomeric"

Phrase: "and"

Phrase: "fibrillar A142 structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "characterized by AFM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   760   C1880022:Characterized [Activity]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "and"

Phrase: "Western blot analysis of SDS-PAGE (Fig. 2B"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.133: View larger version (57K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.134: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.135: Solution conditions for the formation of oligomeric or fibrillar A1-42 assemblies. 

Phrase: "Solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "conditions for the formation of oligomeric"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0012634:condition [Disease or Syndrome]
   753   C0220781:formation [Biologic Function]
   753   C0348080:Condition [Qualitative Concept]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
   753   C1705253:Condition [Conceptual Entity]

Phrase: "or"

Phrase: "fibrillar A1-42 assemblies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1706853:Assembly [Activity]
   779   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.136: A, AFM. 

Phrase: "A,"

Phrase: "AFM."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.137: 5mM HFIP-treated A1-42 in Me2SO was diluted to 100M in ice-cold F-12 culture medium for oligomers and 10mM HCl for fibrils. 

Phrase: "5mM HFIP-treated A1-42 in Me2SO"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0332293:treated [Therapeutic or Preventive Procedure]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "was"

Phrase: "diluted to 100M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "in ice-cold F-12 culture medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   876   C0456913:Cold medium [Finding]
   827   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   799   C0009458:Medium [Intellectual Product]
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C0439536:Medium [Quantitative Concept]
   799   C1705217:Medium [Substance]
   799   C2242979:Culture [Laboratory Procedure]
   799   C3244283:medium [Intellectual Product]

Phrase: "for oligomers"

Phrase: "and"

Phrase: "10mM HCl for fibrils."
Processing 00000000.tx.138: Oligomer and fibril preparations were incubated for 24h at 4and 37C, respectively. 

Phrase: "Oligomer"

Phrase: "and"

Phrase: "fibril preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "at 4and 37C,"

Phrase: "respectively."
Processing 00000000.tx.139: Samples before (0-h) and after incubation (24-h) were mounted for AFM analysis at 10M. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "before"

Phrase: "(0-h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and after incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "(24-h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "mounted for AFM analysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0026018:Microscopy [Laboratory Procedure]
   753   C0441722:Force [Phenomenon or Process]
   753   C0449878:mounted [Finding]
   753   C0563538:Force [Phenomenon or Process]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   719 E C0181909:Mount [Medical Device]

Phrase: "at 10M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]
Processing 00000000.tx.140: Representative 22-m x-y, 10-nm total z-range AFM images are shown. 

Phrase: "Representative 22-m x-y,"

Phrase: "10-nm total z-range AFM images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1704254:Image [Intellectual Product]
   758   C1704922:Image [Entity]
   758   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.141: Inset images, 200200-nm x-y, 2-nm total z-range. 

Phrase: "Inset images,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "200200-nm x-y,"

Phrase: "2-nm total z-range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]
Processing 00000000.tx.142: B, Western analysis of SDS-PAGE. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Western analysis of SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.143: Representative Western blots of A1-42 oligomers and fibrils incubated for 0and 24h, separated by SDS-PAGE on a 12% NuPAGE bis-Tris gel, and probed with the monoclonal antibody 6E10 (recognizing residues 1-17 of A) are shown. 

Phrase: "Representative Western blots of A1-42 oligomers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0949466:Western Blots [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]
   745 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "incubated for 0and 24h,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456696:/24h [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1442770:24H [Temporal Concept]

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "on a 12% NuPAGE bis-Tris gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "probed with the monoclonal antibody 6E10"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "(recognizing residues 1-17 of A)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.144: Oligomeric and fibrillar preparations of A1-42 were prepared as described for A. 

Phrase: "Oligomeric"

Phrase: "and"

Phrase: "fibrillar preparations of A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0455052:Preparation [Health Care Activity]
   726   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described for A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.145: Samples were visualized by enhanced chemiluminescence. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "visualized by enhanced chemiluminescence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]
Processing 00000000.tx.146: The representative figure shows 0-and 24-h oligomers (lanes 1and 2) and fibrils (lanes 3and 4). 

Phrase: "The representative figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "0-"

Phrase: "and"

Phrase: "24-h oligomers"

Phrase: "(lanes 1and 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "(lanes 3and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.147: Immediately after resuspension under both the oligomer- and fibril-forming conditions, the majority of A1-42 remained as unassembled structures measuring ~1.0 nm (Fig. 2A, insets), although a few oligomers measuring between 2and 4nm were also detected (Fig. 2A). 

Phrase: "Immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "resuspension under both"

Phrase: "the oligomer-"

Phrase: "and"

Phrase: "fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the majority of A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "remained as unassembled structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:structures [Spatial Concept]

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "~1.0 nm (Fig. 2A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   897   C0450309:1/2a [Intellectual Product]

Phrase: "insets"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "a few oligomers"

Phrase: "measuring between 2and 4nm"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:measuring [Qualitative Concept]
   770   C0449770:measuring [Quantitative Concept]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "were"

Phrase: "also"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.148: After a 24-h incubation under oligomer-forming conditions, A1-42 assembled into predominantly 2-4-nm oligomeric structures (Fig. 2A). 

Phrase: "After a 24-h incubation"

Phrase: "under oligomer-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "A1-42"

Phrase: "assembled into predominantly 2-4-nm oligomeric structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0312860:NM [Cell Function]
   744   C0678594:structures [Spatial Concept]
   711   C1706853:Assemble [Activity]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.149: No fibril formation was detected under these conditions. 

Phrase: "No fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "detected under these conditions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.150: Within 24h under fibril-forming conditions, A1-42 converted to ~4-nm amyloid fibrils that extended over several microns, some of which had a semi-periodic structure along the fibril axis. 

Phrase: "Within 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "under fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "A1-42"

Phrase: "converted"

Phrase: "to ~4-nm amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0225328:fibrils [Cell Component]
   771 E C1948066:Fibril [Physical Object]

Phrase: "that"

Phrase: "extended over several microns,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439201:microns [Quantitative Concept]
   770   C0439792:extended [Spatial Concept]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "had"

Phrase: "a semi-periodic structure along the fibril axis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.151: As previously reported, AFM measurements may underestimate the diameter of A structures because of sample compression by the AFM probe (25, 51). 

Phrase: "As"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "AFM measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0242485:measurements [Functional Concept]
   756   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "may"

Phrase: "underestimate"

Phrase: "the diameter of A structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1301886:Diameter [Quantitative Concept]

Phrase: "because of sample compression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332459:Compression [Functional Concept]
   861   C0565514:Compression [Therapeutic or Preventive Procedure]
   861   C0728907:Compression [Natural Phenomenon or Process]
   861   C1257972:Compression [Machine Activity,Occupational Activity]

Phrase: "by the AFM probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]
   756   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "(25,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.152: Western blot analysis of SDS-PAGE revealed A1-42 monomer, trimer, and tetramer for unaggregated (0h) samples incubated under both oligomer- and fibril-forming conditions (Fig. 2B, lanes 1and 3, respectively). 

Phrase: "Western blot analysis of SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "A1-42 monomer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "trimer,"

Phrase: "and"

Phrase: "tetramer for unaggregated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0039686:Tetramere [Eukaryote]

Phrase: "(0h"

Phrase: ")"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "incubated under both oligomer-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "fibril-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lanes 1and 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.153: Larger oligomeric assemblies ranging from 30to 60kDa were detected after incubation for 24h under oligomer-forming conditions. 

Phrase: "Larger oligomeric assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1706853:Assembly [Activity]
   793   C1879748:Assembly [Manufactured Object]

Phrase: "ranging from 30to 60kDa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "were"

Phrase: "detected after incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "under oligomer-forming conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.154: Additionally, there was an increase in the trimer and tetramer bands, as well as smearing between tetramer and monomer, possibly indicating interconversion between these assemblies during electrophoresis (Fig. 2B, lane 2). 

Phrase: "Additionally,"

Phrase: "there"

Phrase: "was"

Phrase: "an increase in the trimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "tetramer bands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "as well as"

Phrase: "smearing between tetramer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0444186:smearing [Diagnostic Procedure]
   756 E C1947932:Smear [Activity]

Phrase: "and"

Phrase: "monomer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "indicating"

Phrase: "interconversion between these assemblies"

Phrase: "during electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.155: After 24h, A1-42 samples incubated under fibril-forming conditions contained high molecular weight immunoreactive A that remained in the well, less abundant 30-60-kDa large oligomers, and a smear between tetramer and monomer (Fig. 2B, lane 4). 

Phrase: "After 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "A1-42 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "incubated under fibril-forming conditions"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0205431:Forming [Functional Concept]
   760   C0225328:Fibril [Cell Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1522492:Forming [Functional Concept]
   760   C1948066:Fibril [Physical Object]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "high molecular weight immunoreactive A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1979900:High molecular weight [Qualitative Concept]

Phrase: "that"

Phrase: "remained in the well,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "less abundant 30-60-kDa large oligomers,"

Phrase: "and"

Phrase: "a smear between tetramer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444186:Smear [Diagnostic Procedure]
   770   C1947932:Smear [Activity]

Phrase: "and"

Phrase: "monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.156: The abundant tetramer detected after 24h under oligomer-forming conditions was not present under fibril-forming conditions, although the increase in the trimer band and smearing between trimer and monomer were present in both preparations at 24h. 

Phrase: "The abundant tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039686:Tetramere [Eukaryote]

Phrase: "detected after 24h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442726:Detected [Finding]
   790   C0456696:/24h [Temporal Concept]
   790   C1442770:24H [Temporal Concept]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "under oligomer-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present under fibril-forming conditions,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0150312:Present [Quantitative Concept]
   760   C0205431:Forming [Functional Concept]
   760   C0225328:Fibril [Cell Component]
   760   C0449450:Present [Idea or Concept]
   760   C1522492:Forming [Functional Concept]
   760   C1948066:Fibril [Physical Object]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "although"

Phrase: "the increase in the trimer band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "smearing between trimer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0444186:smearing [Diagnostic Procedure]
   756 E C1947932:Smear [Activity]

Phrase: "and"

Phrase: "monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "present in both preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "at 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.157: Western analysis of SDS-PAGE for A1-42 oligomers and fibrils was variable. 

Phrase: "Western analysis of SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "for A1-42 oligomers"

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "was"

Phrase: "variable."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]
Processing 00000000.tx.158: In our previous report we observed more SDS-stable structures between monomer and tetramer, particularly dimer, in the 24-h fibril preparations than reported herein (24). 

Phrase: "In our previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "more SDS-stable structures between monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "tetramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "particularly dimer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596448:dimer [Chemical Viewed Structurally]

Phrase: "in the 24-h fibril preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0071888:h preparation [Pharmacologic Substance]
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "than"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "herein"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.159: Common trends observed in both studies for oligomeric preparations include detection of an abundant tetramer and trimer. 

Phrase: "Common trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040833:trends [Temporal Concept]
   861   C1521798:Trends [Temporal Concept]

Phrase: "observed in both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "studies for oligomeric preparations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   737   C0455052:Preparation [Health Care Activity]
   737   C1521827:Preparation [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "detection of an abundant tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "trimer."
Processing 00000000.tx.160: Fibril preparations typically include less abundant tetramer and the presence of >60-kDa large aggregates, including A immunoreactive material that remains in the well of the gel. 

Phrase: "Fibril preparations typically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0455052:Preparation [Health Care Activity]
   793   C1521827:Preparation [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "less abundant tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039686:Tetramere [Eukaryote]

Phrase: "and"

Phrase: "the presence of >60-kDa large aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205418:aggregates [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "A immunoreactive material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "that remains in the well of the gel."
Processing 00000000.tx.161: Unaggregated (0h) A1-42 samples typically contain some trimer and tetramer, in addition to monomer. 

Phrase: "Unaggregated"

Phrase: "(0h"

Phrase: ")"

Phrase: "A1-42 samples typically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "some trimer"

Phrase: "and"

Phrase: "tetramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "in addition to monomer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.162: Comparable results are obtained with A monoclonal antibodies 6E10, recognizing A residues 1-16 (Fig. 2B), and 4G8, recognizing A residues 17-24 (data not shown). 

Phrase: "Comparable results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "obtained with A monoclonal antibodies 6E10,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0746619:monoclonal [Finding]
   753   C1301820:Obtained [Functional Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C1706701:Obtain [Activity]

Phrase: "recognizing"

Phrase: "A residues 1-16"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "4G8,"

Phrase: "recognizing"

Phrase: "A residues 17-24"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.163: The NuPAGE gel system used in these studies yields slightly different banding patterns with these two antibodies than Tris/Tricine and Tris/glycine gels where more dimer is detected (data not shown). 

Phrase: "The NuPAGE gel system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "used in these studies"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   802   C0869040:Use studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]

Phrase: "yields"

Phrase: "slightly different banding patterns with these two antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1268872:Antibody band pattern [Physiologic Function]
   744   C0449774:Patterns [Spatial Concept]
   737   C1442158:band pattern [Clinical Attribute]

Phrase: "than Tris/Tricine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0077068:tricine [Organic Chemical]

Phrase: "and"

Phrase: "Tris/glycine gels where more dimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0596448:dimer [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.164: Thus, in contrast to the limited and variable information gained by the gel-dependent detection of SDS-stable A structures, AFM analysis clearly differentiates between oligomeric and fibrillar A1-42 structures that form under the conditions described for these experiments. 

Phrase: "Thus,"

Phrase: "in contrast to the limited"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]

Phrase: "and"

Phrase: "variable information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "gained by the gel-dependent detection of SDS-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1382104:Gel [Substance]
   744   C1511790:Detection [Therapeutic or Preventive Procedure]
   744   C1701901:Dependent [Qualitative Concept]
   744   C3244310:dependent [Functional Concept]
   711   C1517378:Gain [Quantitative Concept]

Phrase: "stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]

Phrase: "A structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "AFM analysis clearly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   717   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "differentiates between oligomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205615:differentiate [Qualitative Concept]

Phrase: "and"

Phrase: "fibrillar A1-42"

Phrase: "structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "that form under the conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "described for these experiments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1552738:described [Idea or Concept]
   737 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.165: A1-42 Assembly Is Dependent on Incubation Time and Peptide Concentration-- Total peptide concentration is known to influence the fibrillogenesis of A (47). 

Phrase: "A1-42 Assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "Is"

Phrase: "Dependent on Incubation Time"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "Peptide Concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "--"

Phrase: "Total peptide concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the fibrillogenesis of A (47"

Phrase: ")."
Processing 00000000.tx.166: To determine how A peptide concentration affects assembly under oligomer- and fibril-forming conditions, A1-42 concentrations ranging from 10to 100M were prepared and analyzed immediately after dilution (0h), after 24h, and after 1week. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "how"

Phrase: "A peptide concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "assembly under oligomer-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1706853:Assembly [Activity]
   790   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "A1-42 concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "ranging from 10to 100M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "(0h"

Phrase: ")"

Phrase: ","

Phrase: "after"

Phrase: "24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "and after 1week."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.167: Immediately after dilution, 2-4-nm A1-42 oligomers formed rapidly under the oligomer-forming conditions at concentrations greater than 25M (Fig. 3A, 0h). 

Phrase: "Immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "2-4-nm A1-42 oligomers"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "rapidly under the oligomer-forming conditions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0205431:Forming [Functional Concept]
   753   C1522492:Forming [Functional Concept]
   753   C1637379:Rapidly [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719 E C0348078:Form [Qualitative Concept]
   719   C0348080:Condition [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "greater than 25M"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "(Fig. 3A,"

Phrase: "0h"

Phrase: ")."
Processing 00000000.tx.168: In general, a concentration-dependent increase in the number of 2-4-nm oligomers was observed between 10and 100M for all three incubation periods (Fig. 3A). 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "a concentration-dependent increase in the number"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "of 2-4-nm oligomers"

Phrase: "was"

Phrase: "observed between 10and 100M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "for all three incubation periods"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C1320226:incubation periods [Finding]
   793   C0439531:/period [Temporal Concept]
   793   C1948053:Period [Temporal Concept]
   743 E C0332182:Periodic [Temporal Concept]
   743 E C1706381:PERIODIC [Intellectual Product]
   721 E C0031084:Periodicities [Temporal Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.169: After 24h, a slight increase in the number of 2-4-nm oligomers, but no fibril formation, was detected at each of the four concentrations (Fig. 3A, 24h). 

Phrase: "After 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "a slight increase in the number of 2-4-nm oligomers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "but"

Phrase: "no fibril formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "detected at each of the four concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0086045:Concentrations [Mental Process]
   748   C0205450:Four [Quantitative Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "(Fig. 3A,"

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.170: After 1week, a concentration-dependent increase in protofibrils (measuring <200 nm) and some short fibrils both straight and curved (measuring <1 m) were observed in the oligomer preparations at 50and 100M, with very few protofibrils in 25M samples, and no protofibrils in the 10M A1-42 solutions (Fig. 3A, 1week). 

Phrase: "After 1week,"

Phrase: "a concentration-dependent increase in protofibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "("

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "<200 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "some short fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "both straight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445291:Straight [Spatial Concept]

Phrase: "and"

Phrase: "curved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curved [Spatial Concept]

Phrase: "("

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "<1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "m)"

Phrase: "were"

Phrase: "observed in the oligomer preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1441672:Observed [Functional Concept]
   726   C0455052:Preparation [Health Care Activity]
   726   C1521827:Preparation [Functional Concept]

Phrase: "at 50and 100M,"

Phrase: "with very few protofibrils"

Phrase: "in 25M samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "no protofibrils in the 10M A1-42 solutions"

Phrase: "(Fig. 3A,"

Phrase: "1week"

Phrase: ")."
Processing 00000000.tx.171: Of interest, no mature fibrils (measuring >1 m) were detected at any of the time points or concentrations despite the detection of protofibrils and short fibrils, particularly abundant at 100M and 1-week incubation time. 

Phrase: "Of interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "no mature fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "("

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ">1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "m)"

Phrase: "were"

Phrase: "detected at any of the time points"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0040223:Time [Temporal Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C3541383:Time [Temporal Concept]
   745   C2348792:Time Point [Temporal Concept]
   714   C1552961:Point [Quantitative Concept]
   714   C2347617:point [Quantitative Concept]

Phrase: "or"

Phrase: "concentrations despite the detection of protofibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "short fibrils,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "particularly abundant at 100M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "1-week incubation time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:Time [Temporal Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.172: These results demonstrate that A1-42 rapidly forms oligomers under these conditions and that only after extended incubation at A142 concentrations25M were significant numbers of protofibrils and slightly longer structures detected. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that A1-42 rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1637379:Rapidly [Qualitative Concept]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "oligomers under these conditions"

Phrase: "and"

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "after"

Phrase: "extended incubation at A142 concentrations25M"

Phrase: "were"

Phrase: "significant numbers of protofibrils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "slightly longer structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.173: View larger version (108K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(108K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.174: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.175: A1-42 assembly is dependent on incubation time and peptide concentration. 

Phrase: "A1-42 assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "is"

Phrase: "dependent on incubation time"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "peptide concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.176: 5mM A1-42 Me2SO stocks were diluted to 10,25,50,or 100M under oligomer- (A) or fibril-forming conditions, (B) as described in the legend for Fig. 

Phrase: "5mM A1-42 Me2SO stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1710198:Stock [Idea or Concept]

Phrase: "were"

Phrase: "diluted to 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "25,"

Phrase: "50,"

Phrase: "or"

Phrase: "100M under oligomer-"

Phrase: "(A)"

Phrase: "or"

Phrase: "fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.177: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.178: Samples were prepared for AFM analysis immediately after dilution (0-h), after 24h, and after 1week of incubation. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared for AFM analysis immediately"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0026018:Microscopy [Laboratory Procedure]
   748   C0205548:Immediately [Temporal Concept]
   748   C0441722:Force [Phenomenon or Process]
   748   C0563538:Force [Phenomenon or Process]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   714   C1521827:Prepare [Functional Concept]

Phrase: "after"

Phrase: "dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "(0-h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "after"

Phrase: "24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "and after 1week of incubation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.179: Representative 22-m x-y, 10-nm total z-range AFM images are shown. 

Phrase: "Representative 22-m x-y,"

Phrase: "10-nm total z-range AFM images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1704254:Image [Intellectual Product]
   758   C1704922:Image [Entity]
   758   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.180: Under fibril-forming conditions, immediately after dilution A1-42 forms 2-4-nm oligomers, in addition to some protofibrils at 50and 100M (Fig. 3B, 0h). 

Phrase: "Under fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "dilution A1-42 forms 2-4-nm oligomers,"

Phrase: "in addition to some protofibrils"

Phrase: "at 50and 100M"

Phrase: "(Fig. 3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "0h"

Phrase: ")."
Processing 00000000.tx.181: After incubation for 24h, no fibril formation could be detected at 10M, and mixed individual 4-nm fibrils, protofibrils, and oligomers were detected at 25M, 4-nm fibrils mixed with some 2-4-nm oligomers were present at 50M, and dense networks of ~4-nm fibrils were present at 100M. 

Phrase: "After incubation"

Phrase: "for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "no fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected at 10M,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C1442446:10M [Temporal Concept]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mixed individual 4-nm fibrils,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0225328:fibrils [Cell Component]
   771 E C1948066:Fibril [Physical Object]

Phrase: "protofibrils,"

Phrase: "and"

Phrase: "oligomers"

Phrase: "were"

Phrase: "detected at 25M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "4-nm fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "mixed with some 2-4-nm oligomers"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0205430:Mixed [Functional Concept]
   748   C0312860:NM [Cell Function]
   748   C3160715:Mixed [Finding]
   714 E C1421951:MIX [Gene or Genome]
   714 E C1720722:Mix [Qualitative Concept]

Phrase: "were"

Phrase: "present at 50M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "dense networks of ~4-nm fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0225328:fibrils [Cell Component]
   766 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "present at 100M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
Processing 00000000.tx.182: After 1week, only oligomeric and protofibrillar structures could be detected at 10M A1-42. 

Phrase: "After 1week,"

Phrase: "only oligomeric"

Phrase: "and"

Phrase: "protofibrillar structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected at 10M A1-42."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442726:Detected [Finding]
   760   C1442446:10M [Temporal Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.183: At 25M, mixed oligomeric, protofibrillar, and fibrillar A1-42 structures were observed, with the fibrils appearing more rigid than at 24h. 

Phrase: "At 25M,"

Phrase: "mixed oligomeric, protofibrillar,"

Phrase: "and"

Phrase: "fibrillar A1-42 structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "with the fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "appearing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "more rigid than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026837:Rigid [Sign or Symptom]
   790   C0231517:Rigid [Individual Behavior]
   790   C1882952:RIGID [Phenomenon or Process]
   718 E C0700109:rigidity [Natural Phenomenon or Process]

Phrase: "at 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.184: At both 50and 100M, dense fields fibrils were present. 

Phrase: "At both 50and 100M,"

Phrase: "dense fields fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.185: These results indicate that A1-42 incubated under fibril-forming conditions results in concentration- and time-dependent fibril formation and that under these conditions, homogeneous fibril populations form within 24h at 100M A1-42 and are stable for at least 1week. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that A1-42"

Phrase: "incubated under fibril-forming conditions"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0205431:Forming [Functional Concept]
   760   C0225328:Fibril [Cell Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1522492:Forming [Functional Concept]
   760   C1948066:Fibril [Physical Object]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "results in concentration-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0086045:Concentration [Mental Process]
   790   C1274040:Result [Functional Concept]
   790   C1446561:Concentration [Quantitative Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   718 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "time-dependent fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "that under these conditions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "homogeneous fibril populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "form within 24h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C0456696:/24h [Temporal Concept]
   790   C1442770:24H [Temporal Concept]
   790   C1522492:Form [Functional Concept]

Phrase: "at 100M A1-42"

Phrase: "and"

Phrase: "are"

Phrase: "stable for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205360:Stable [Qualitative Concept]
   833   C1547311:Stable [Intellectual Product]

Phrase: "at least 1week."
Processing 00000000.tx.186: A1-42 Assembly Is Dependent on Temperature-- Temperature has been shown previously to be an important factor in fibril assembly (52). 

Phrase: "A1-42 Assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "Is"

Phrase: "Dependent on Temperature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]

Phrase: "--"

Phrase: "Temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously to"

Phrase: "be"

Phrase: "an important factor in fibril assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.187: Here we investigated the effects of temperature on oligomer- and fibril-forming conditions. 

Phrase: "Here"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effects of temperature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0871499:effects temperature [Natural Phenomenon or Process]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on oligomer-"

Phrase: "and"

Phrase: "fibril-forming conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.188: Solutions of 100M A1-42 incubated at 4C under the standard oligomer-forming conditions were also incubated at room temperature and 37C. 

Phrase: "Solutions of 100M A1-42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0037633:Solutions [Substance]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "under the standard oligomer-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "37C."
Processing 00000000.tx.189: Solutions of 100M A1-42 incubated at 37C under the standard fibril-forming conditions were also incubated at room temperature and 4C. 

Phrase: "Solutions of 100M A1-42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0037633:Solutions [Substance]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "under the standard fibril-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.190: The resulting structures were characterized by AFM (Fig. 4A) and Western blot analysis of SDS-PAGE (Fig. 4B). 

Phrase: "The resulting structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "characterized by AFM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   760   C1880022:Characterized [Activity]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "Western blot analysis of SDS-PAGE (Fig. 4B"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.191: View larger version (46K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.192: 4.  

Phrase: "4."
Processing 00000000.tx.193: A1-42 assembly is dependent on temperature. 

Phrase: "A1-42 assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "is"

Phrase: "dependent on temperature."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]
Processing 00000000.tx.194: A, AFM. 

Phrase: "A,"

Phrase: "AFM."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.195: A1-42 oligomers and fibrils prepared as described in the legend for Fig. 

Phrase: "A1-42 oligomers"

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.196: 2 were incubated at 4C, room temperature, or 37C for 24h. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "incubated at 4C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "or"

Phrase: "37C for 24h."
Processing 00000000.tx.197: Representative 22-m x-y, 10-nm total z-range AFM images are shown. 

Phrase: "Representative 22-m x-y,"

Phrase: "10-nm total z-range AFM images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1704254:Image [Intellectual Product]
   758   C1704922:Image [Entity]
   758   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.198: B, Western analysis of SDS-PAGE. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Western analysis of SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.199: Representative Western blots of samples prepared as described for A and analyzed as described in the legend for Fig. 

Phrase: "Representative Western blots of samples"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described for A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.200: 2 are shown. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.201: The figure shows oligomers and fibrils at 4C (lanes 1and 4), room temperature (lanes 2and 5), and 37C (lanes 3and 6), respectively. 

Phrase: "The figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "oligomers"

Phrase: "and"

Phrase: "fibrils at 4C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0225328:fibrils [Cell Component]
   756 E C1948066:Fibril [Physical Object]

Phrase: "(lanes 1and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "(lanes 2and 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "37C"

Phrase: "(lanes 3and 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.202: Under oligomer-forming conditions (4C), 100M A1-42 incubated for 24h produced homogeneous solutions of 2-4-nm oligomers comparable with Fig. 

Phrase: "Under oligomer-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "100M A1-42"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "produced"

Phrase: "homogeneous solutions of 2-4-nm oligomers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0037633:Solutions [Substance]
   714 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "comparable with Fig."
Processing 00000000.tx.203: 2A (Fig. 4A, 4C). 

Phrase: "2A"

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.204: At room temperature, the solution remained predominately oligomeric with a low concentration of short protofibrils (Fig. 4A, RT). 

Phrase: "At room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "the solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "remained"

Phrase: "predominately oligomeric with a low concentration of short protofibrils"

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "RT"

Phrase: ")."
Processing 00000000.tx.205: At 37C, the solution contained both oligomers and an increased number of protofibrils (Fig. 4A, 37C). 

Phrase: "At 37C,"

Phrase: "the solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "both oligomers"

Phrase: "and"

Phrase: "an increased number of protofibrils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "37C"

Phrase: ")."
Processing 00000000.tx.206: These results indicate that uniform populations of oligomers form at 4C, and increasing temperature produces limited protofibril formation within 24h at 100M A1-42. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that uniform populations of oligomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "form at 4C,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C0450376:4c [Intellectual Product]
   790   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "increasing temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "produces"

Phrase: "limited protofibril formation within 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "at 100M A1-42."
Processing 00000000.tx.207: However, as with incubation time and peptide concentration, although protofibrils were present, no extended fibrils were observed with the oligomer-forming conditions at any of the temperatures. 

Phrase: "However,"

Phrase: "as with incubation time"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "peptide concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "although"

Phrase: "protofibrils"

Phrase: "were"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "no extended fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0752265:extended fibrils [Cell Component]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "observed with the oligomer-forming conditions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0205431:Forming [Functional Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1522492:Forming [Functional Concept]
   719   C0012634:condition [Disease or Syndrome]
   719 E C0348078:Form [Qualitative Concept]
   719   C0348080:Condition [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "at any"

Phrase: "of the temperatures."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0039476:Temperatures [Quantitative Concept]
   966 E C0005903:temperature [Organism Attribute]
Processing 00000000.tx.208: Under fibril-forming conditions (37C), 100M A1-42 incubated for 24h produced extended ~4-nm fibrils, comparable with Fig. 

Phrase: "Under fibril-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(37C"

Phrase: ")"

Phrase: ","

Phrase: "100M A1-42"

Phrase: "incubated for 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456696:/24h [Temporal Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1442770:24H [Temporal Concept]

Phrase: "produced"

Phrase: "extended ~4-nm fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   902   C0752265:extended fibrils [Cell Component]
   812   C0225328:fibrils [Cell Component]
   779 E C1948066:Fibril [Physical Object]

Phrase: "comparable with Fig."
Processing 00000000.tx.209: 2A (Fig. 4A, 37C). 

Phrase: "2A"

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "37C"

Phrase: ")."
Processing 00000000.tx.210: When the incubation temperature was lowered to room temperature, A1-42 continued to form extended fibrils, although an increase in the oligomeric background was observed (Fig. 4A, RT). 

Phrase: "When"

Phrase: "the incubation temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "was"

Phrase: "lowered to room temperature, A1-42"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   753   C0005903:temperature [Organism Attribute]
   753   C0039476:*Temperature [Quantitative Concept]
   753   C0441994:lowered [Spatial Concept]
   753   C1272755:Lowered [Quantitative Concept]
   753   C1547703:Room [Spatial Concept]
   753   C2003888:Lowered [Activity]
   719 E C1548802:Lower [Body Location or Region]

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "extended fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0752265:extended fibrils [Cell Component]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "although"

Phrase: "an increase in the oligomeric background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "RT"

Phrase: ")."
Processing 00000000.tx.211: Solutions incubated at 4C contained predominately unassembled peptide and 2-4-nm oligomeric structures, in addition to a sparse population of 2-4-nm-diameter fibrils less than 2m in length. 

Phrase: "Solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "predominately unassembled peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "2-4-nm oligomeric structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0678594:structures [Spatial Concept]

Phrase: "in addition to a sparse population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "of 2-4-nm-diameter fibrils less"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0225328:fibrils [Cell Component]
   766 E C1948066:Fibril [Physical Object]

Phrase: "than 2m"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3171718:2M [Quantitative Concept]

Phrase: "in length."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]
Processing 00000000.tx.212: In summary, incubation at 37C produces the most uniform fibril populations, with fibril density decreasing significantly with temperature. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "incubation at 37C"

Phrase: "produces"

Phrase: "the most uniform fibril populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032659:Population [Quantitative Concept]
   812   C1257890:Population [Population Group]

Phrase: "with fibril density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "significantly with temperature."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005903:temperature [Organism Attribute]
   790   C0039476:*Temperature [Quantitative Concept]
Processing 00000000.tx.213: Western blot analysis of SDS-PAGE of A1-42 incubated under oligomer-forming conditions detected SDS-stable tetramer, trimer, and monomer (Fig. 4B, lane 1). 

Phrase: "Western blot analysis of SDS-PAGE of A1-42"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]

Phrase: "incubated under oligomer-forming conditions"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0205431:Forming [Functional Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1522492:Forming [Functional Concept]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "SDS-stable tetramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039686:Tetramere [Eukaryote]

Phrase: "trimer,"

Phrase: "and"

Phrase: "monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.214: When the incubation temperature was raised to room temperature and 37C, there was a decrease in the amount of monomer and an increase in the presence of large oligomers (Fig. 4B, lanes 2and 3). 

Phrase: "When"

Phrase: "the incubation temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "was"

Phrase: "raised to room temperature"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   819   C0015967:Temperature raised [Finding]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0442818:Raised [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "37C,"

Phrase: "there"

Phrase: "was"

Phrase: "a decrease in the amount of monomer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "an increase in the presence of large oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "lanes 2and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.215: Under fibril-forming conditions, the majority of the large fibril assemblies were not SDS-stable as A appeared as monomer, trimer, and tetramer, and decreasing temperature induced an increase in the amount of trimer and tetramer (Fig. 4B, lanes 4-6). 

Phrase: "Under fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the majority of the large fibril assemblies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "not SDS-"

Phrase: "stable as A appeared"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205360:Stable [Qualitative Concept]
   770   C1547311:Stable [Intellectual Product]

Phrase: "as"

Phrase: "monomer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "trimer,"

Phrase: "and"

Phrase: "tetramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "and"

Phrase: "decreasing temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "an increase in the amount of trimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "(Fig. 4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "lanes 4-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.216: A1-42 Assembly Is Dependent on Ionic Strength and pH-- Two primary differences between the oligomer- and fibril-forming conditions are ionic strength and pH. 

Phrase: "A1-42 Assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "Is"

Phrase: "Dependent on Ionic Strength"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "pH-- Two primary differences between the oligomer-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "fibril-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "ionic strength"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0086486:Ionic Strength [Quantitative Concept]
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789   C0022023:Ion [Element, Ion, or Isotope]
   789 E C0442821:Strong [Qualitative Concept]
   789   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]
Processing 00000000.tx.217: For the oligomer-forming conditions, A1-42 is incubated in cell culture medium at physiologic ionic strength and neutral pH. 

Phrase: "For the oligomer-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "A1-42"

Phrase: "is"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in cell culture medium at physiologic ionic strength"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0007585:Cell Culture [Laboratory Procedure]
   770   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   744   C0009458:Medium [Intellectual Product]
   744   C0010453:Culture [Idea or Concept]
   744   C0220814:culture [Functional Concept]
   744   C0430400:Culture [Laboratory Procedure]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C2242979:Culture [Laboratory Procedure]
   744   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "neutral pH."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.218: For fibril-forming conditions, A1-42 is incubated in dilute HCl at low ionic strength and acidic pH. 

Phrase: "For fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "A1-42"

Phrase: "is"

Phrase: "incubated in dilute HCl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1720119:Dilute [Functional Concept]
   770   C1948037:Dilute [Functional Concept]

Phrase: "at low ionic strength"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "acidic pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.219: To determine how the combination of ionic strength and pH influence the assembly of A1-42, 100M A1-42 solutions were incubated at 37C at acidic pH and neutral pH and at both low and physiologic ionic strength. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "how"

Phrase: "the combination of ionic strength"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "influence"

Phrase: "the assembly of A1-42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "100M A1-42 solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0037633:Solutions [Substance]
   779 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and at both low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "physiologic ionic strength."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]
Processing 00000000.tx.220: At acidic pH and low ionic strength (standard fibril-forming conditions), extended ~40-nm fibrils were detected by AFM, comparable with Fig. 

Phrase: "At acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "low ionic strength"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: "(standard fibril-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "extended ~40-nm fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   902   C0752265:extended fibrils [Cell Component]
   812   C0225328:fibrils [Cell Component]
   779 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "detected by AFM,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "comparable with Fig."
Processing 00000000.tx.221: 2A (Fig. 5A). 

Phrase: "2A"

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.222: Adding 150mM NaCl while maintaining the acidic pH resulted in the formation of dense fibrillar aggregates that vary in z-height from 5to greater than 25nm (Fig. 5A). 

Phrase: "Adding 150mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "while"

Phrase: "maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "the acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "resulted in the formation of dense fibrillar aggregates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205418:aggregates [Qualitative Concept]
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0439794:Dense [Qualitative Concept]
   744   C1522492:Formation [Functional Concept]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "that"

Phrase: "vary in z-height"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0489786:Height [Organism Attribute]

Phrase: "from 5to"

Phrase: "greater than 25nm"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.223: Note that the z-height range representation for this image was increased from 10to 25nm because of the size of the fibrillar aggregates. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the z-height range representation for this image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1514861:Representation [Conceptual Entity]
   744   C1882932:Representation [Activity]

Phrase: "was"

Phrase: "increased from 10to 25nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "because of the size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "of the fibrillar aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.224: At neutral pH and low ionic strength, A1-42 solutions remained primarily oligomeric comparable with Fig. 

Phrase: "At neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "low ionic strength,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: "A1-42 solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "remained"

Phrase: "primarily oligomeric comparable with Fig."
Processing 00000000.tx.225: 2A, in addition to several short fibrils (Fig. 5A). 

Phrase: "2A,"

Phrase: "in addition to several short fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.226: When the pH was neutral, and 150mM NaCl was added, A1-42 oligomers coalesced into primarily small oligomeric aggregates with z-height values measuring ~5-8 nm and protofibrils. 

Phrase: "When"

Phrase: "the pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "neutral,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1882074:Neutral [Qualitative Concept]
  1000   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "150mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "A1-42 oligomers"

Phrase: "coalesced into primarily small oligomeric aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205418:aggregates [Qualitative Concept]
   753   C0700321:Small [Quantitative Concept]

Phrase: "with z-height values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "~5-8 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "protofibrils."
Processing 00000000.tx.227: View larger version (51K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(51K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.228: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.229: A1-42 assembly is dependent on ionic strength and pH. 

Phrase: "A1-42 assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "is"

Phrase: "dependent on ionic strength"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]
Processing 00000000.tx.230: A, AFM. 

Phrase: "A,"

Phrase: "AFM."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.231: 5mM A1-42 in Me2SO stocks were diluted to 100M in either 10mM HCl (low ionic strength, acidic pH), 10mM HCl+150mM NaCl (acidic pH, physiologic ionic strength), 10mM Tris, pH 7.4(neutral pH), or 10mM Tris, pH 7.4,+150mM NaCl (neutral pH, physiologic ionic strength). 

Phrase: "5mM A1-42 in Me2SO stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710198:Stock [Idea or Concept]

Phrase: "were"

Phrase: "diluted to 100M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "in either 10mM HCl (low ionic strength,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C0086486:Ionic Strength [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0237897:Strength [Quantitative Concept]
   799   C0808080:Strength [Idea or Concept]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   799   C1705922:Strength [Qualitative Concept]
   727   C0022023:Ion [Element, Ion, or Isotope]
   727 E C0442821:Strong [Qualitative Concept]
   727   C1700702:ION [Functional Concept]

Phrase: "acidic pH), 10mM HCl+150mM NaCl (acidic pH,"

Phrase: "physiologic ionic strength"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "10mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(neutral pH),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "or"

Phrase: "10mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "+150mM NaCl (neutral pH,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1882074:Neutral pH [Qualitative Concept]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]

Phrase: "physiologic ionic strength"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: ")."
Processing 00000000.tx.232: Samples were prepared after a 24-h incubation at 37C. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared after a 24-h incubation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719   C1521827:Prepare [Functional Concept]

Phrase: "at 37C."
Processing 00000000.tx.233: Representative 22-m x-y, 10-nm total z-range AFM images are shown, except for the image of the acidic pH, physiologic ionic strength condition, which is scaled to 22-m x-y, 25-nm total z-range. 

Phrase: "Representative 22-m x-y,"

Phrase: "10-nm total z-range AFM images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1704254:Image [Intellectual Product]
   758   C1704922:Image [Entity]
   758   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "except for the image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "of the acidic pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "physiologic ionic strength condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0012634:condition [Disease or Syndrome]
   812   C0348080:Condition [Qualitative Concept]
   812   C1705253:Condition [Conceptual Entity]
   741 E C0009647:Conditioned [Mental Process]
   741 E C1701901:Conditional [Qualitative Concept]
   741 E C1963686:Conditional [Functional Concept]
   712 E C1519605:Conditionality [Conceptual Entity]

Phrase: "which"

Phrase: "is"

Phrase: "scaled to 22-m x-y,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   719   C0175659:Scale [Medical Device]
   719   C0349674:Scale [Intellectual Product]
   719   C1947916:Scale [Activity]
   719   C3536777:Scale [Manufactured Object]

Phrase: "25-nm total z-range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]
Processing 00000000.tx.234: B, Western analysis of SDS-PAGE. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Western analysis of SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.235: Representative Western blots of samples prepared as described for A and analyzed as described in the legend for Fig. 

Phrase: "Representative Western blots of samples"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described for A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.236: 2 are shown. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.237: The figure shows HCl (lane 1), HCl+NaCl (lane 2), Tris (lane 3), and Tris+NaCl (lane 4). 

Phrase: "The figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "HCl (lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "HCl+NaCl (lane 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1708639:Lane [Spatial Concept]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Tris"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
  1000   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
  1000   C0814229:TRI [Intellectual Product]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Tris+NaCl (lane 4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   812   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   812   C0814229:TRI [Intellectual Product]
   812   C1708639:Lane [Spatial Concept]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.238: Oligomer formation was favored at neutral pH and physiologic ionic strength. 

Phrase: "Oligomer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "favored at neutral pH"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C2825492:Neutral [Phenomenon or Process]
   737   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "physiologic ionic strength."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]
Processing 00000000.tx.239: However, some differences were present between A1-42 assemblies formed in F-12 culture medium (Fig. 2A) and in a buffered salt solution (Fig. 5A). 

Phrase: "However,"

Phrase: "some differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "present between A1-42 assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "formed in F-12 culture medium"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   790   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   790   C0117953:f 12 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C0009458:Medium [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   753   C0205431:Formed [Functional Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439133:(f) [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1553038:[f] [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3244283:medium [Intellectual Product]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "and in a buffered salt solution"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1515981:And [Idea or Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.240: In F-12 culture medium, more evenly dispersed fields of 2-4-nm oligomers were observed by AFM, whereas A1-42 incubated in buffered salt solutions yielded more aggregated clusters of oligomers and protofibrils. 

Phrase: "In F-12 culture medium,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Medium [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C2242979:Culture [Laboratory Procedure]
   812   C3244283:medium [Intellectual Product]

Phrase: "more evenly dispersed fields of 2-4-nm oligomers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   708   C1521738:Field [Conceptual Entity]
   708   C2346620:Field [Conceptual Entity]
   708   C2349184:Field [Conceptual Entity]
   708   C3539073:FIELD [Spatial Concept]

Phrase: "were"

Phrase: "observed by AFM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   760   C1441672:Observed [Functional Concept]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "whereas"

Phrase: "A1-42"

Phrase: "incubated in buffered salt solutions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0036140:Salt [Chemical Viewed Structurally]
   760   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0037633:Solutions [Substance]
   760   C0206136:Salt [Food,Inorganic Chemical]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "yielded"

Phrase: "more aggregated clusters of oligomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]

Phrase: "and"

Phrase: "protofibrils."
Processing 00000000.tx.241: This may result from the differences in the inorganic salts or the presence of trace metals and/or amino acids in F-12 culture medium, initially selected based on oligomer-forming conditions reported in the literature (19). 

Phrase: "This"

Phrase: "may"

Phrase: "result from the differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in the inorganic salts"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0036140:Salts [Chemical Viewed Structurally]
   827 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827 E C0206136:Salt [Food,Inorganic Chemical]
   777 E C1537053:salty [Qualitative Concept]
   755 E C0678584:saltiness [Qualitative Concept]

Phrase: "or"

Phrase: "the presence of trace metals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "amino acids in F-12 culture medium,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "based on oligomer-forming conditions"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0205431:Forming [Functional Concept]
   760   C1522492:Forming [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "reported in the literature"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023866:Literature [Intellectual Product]
   770   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.242: In an effort to simplify the oligomer-forming solution, several solutions of comparable pH and ionic strength were screened, including Dulbecco's modified Eagle's medium, artificial cerebral spinal fluid, and buffered salt solutions containing trace metals and N,N-dimethylglycine in place of individual amino acids. 

Phrase: "In an effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "simplify"

Phrase: "the oligomer-forming solution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "several solutions of comparable pH"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0037633:Solutions [Substance]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "ionic strength"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0086486:Ionic Strength [Quantitative Concept]
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789   C0022023:Ion [Element, Ion, or Isotope]
   789 E C0442821:Strong [Qualitative Concept]
   789   C1700702:ION [Functional Concept]

Phrase: "were"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Dulbecco's modified Eagle's medium,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "artificial cerebral spinal fluid,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0007806:Cerebral Spinal Fluid [Body Substance]
           Spinal fluid
   812   C0005889:FLUID [Body Substance]
   812   C0302908:fluid [Substance]
   812   C0444611:Fluid [Qualitative Concept]
   812   C0521329:Spinal [Spatial Concept]
   812   C1704353:Fluid [Substance]
   812   C2004457:Artificial [Qualitative Concept]

Phrase: "and"

Phrase: "buffered salt solutions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0036140:Salt [Chemical Viewed Structurally]
   827   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0037633:Solutions [Substance]
   827   C0206136:Salt [Food,Inorganic Chemical]
   793 E C0525069:Solution [Biomedical or Dental Material]
   755 E C1537053:salty [Qualitative Concept]
   727 E C0678584:saltiness [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "trace metals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0723796:trace metals [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0025552:Metals [Inorganic Chemical]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "and"

Phrase: "N,N-dimethylglycine in place of individual amino acids."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C3499933:N,N-dimethylglycine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0058265:dimethylglycine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.243: Although A1-42 formed oligomeric assemblies in each of these solutions as determined by AFM (data not shown), globular structures were present in solution controls in the absence of A, confounding the detection of A oligomers prepared in these solutions. 

Phrase: "Although"

Phrase: "A1-42 formed oligomeric assemblies in each of these solutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1706853:Assembly [Activity]
   706   C1879748:Assembly [Manufactured Object]

Phrase: "as"

Phrase: "determined by AFM"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "globular structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "present in solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "controls in the absence of A,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0243148:control [Qualitative Concept]
   753   C0332197:absence [Quantitative Concept]
   753   C1550141:Control [Substance]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "confounding"

Phrase: "the detection of A oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "prepared in these solutions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0037633:Solutions [Substance]
   737 E C0525069:Solution [Biomedical or Dental Material]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.244: Ultimately, the most consistent preparations with the lowest background levels for AFM were obtained using F-12 cell culture medium. 

Phrase: "Ultimately,"

Phrase: "the most consistent preparations with the lowest background levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0455052:Preparation [Health Care Activity]
   708   C1521827:Preparation [Functional Concept]

Phrase: "for AFM"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "F-12 cell culture medium."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   840   C0007585:Cell Culture [Laboratory Procedure]
   840   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   804   C0007634:Cell [Cell]
   804   C0009458:Medium [Intellectual Product]
   804   C0010453:Culture [Idea or Concept]
   804   C0220814:culture [Functional Concept]
   804   C0430400:Culture [Laboratory Procedure]
   804   C0439536:Medium [Quantitative Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1705217:Medium [Substance]
   804   C1948049:Cell [Spatial Concept]
   804   C2242979:Culture [Laboratory Procedure]
   804   C3244283:medium [Intellectual Product]
Processing 00000000.tx.245: Western blot analysis of SDS-PAGE revealed that samples prepared at acidic pH and low ionic strength contained A1-42 tetramer, trimer, and monomer (Fig. 5B, lane 1). 

Phrase: "Western blot analysis of SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "prepared at acidic pH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001128:Acidic [Chemical]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   737   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "low ionic strength"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "A1-42 tetramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039686:Tetramere [Eukaryote]

Phrase: "trimer,"

Phrase: "and"

Phrase: "monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "(Fig. 5B,"

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.246: The addition of 150mM NaCl at acidic pH corresponded to a slight decrease in trimer and a slight increase in large oligomers (Fig. 5B, lane 2). 

Phrase: "The addition of 150mM NaCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "at acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "corresponded to a slight decrease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C2937276:Slight [Qualitative Concept]
   760   C2945599:Slight [Qualitative Concept]

Phrase: "in trimer"

Phrase: "and"

Phrase: "a slight increase in large oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 5B,"

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.247: When A1-42 was incubated at neutral pH and low ionic strength, a prominent smear of large oligomers was detected, in addition to A tetramer, trimer, and monomer. 

Phrase: "When"

Phrase: "A1-42"

Phrase: "was"

Phrase: "incubated at neutral pH"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "low ionic strength,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: "a prominent smear of large oligomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444186:Smear [Diagnostic Procedure]
   753   C1947932:Smear [Activity]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "in addition to A tetramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "trimer,"

Phrase: "and"

Phrase: "monomer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.248: The addition of 150mM NaCl at neutral pH resulted in a decrease in the large oligomers (Fig. 5B, lane 4) relative to the same sample incubated without additional NaCl. 

Phrase: "The addition of 150mM NaCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "at neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "resulted in a decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in the large oligomers"

Phrase: "(Fig. 5B,"

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "relative to the same sample"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "incubated without additional NaCl."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1524062:Additional [Functional Concept]
   770   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.249: The relative similarity between acidic pH samples analyzed by Western blot indicates that most of the dramatic conformational differences detected by AFM cannot be detected by Western analysis of SDS-PAGE. 

Phrase: "The relative similarity between acidic pH samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similarity [Qualitative Concept]

Phrase: "analyzed by Western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "indicates"

Phrase: "that most of the dramatic conformational differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "detected by AFM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "detected by Western analysis of SDS-PAGE."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0442726:Detected [Finding]
   748   C0936012:Analysis [Research Activity]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1524024:analysis [Functional Concept]
   748   C1704732:Page [Intellectual Product]
   748   C1705493:Western [Spatial Concept]
Processing 00000000.tx.250: Solubility of A1-42 Assemblies-- Sedimentation analysis has been used previously (53, 54) to characterize the aggregation state of A under a variety of conditions. 

Phrase: "Solubility of A1-42 Assemblies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037628:Solubility [Qualitative Concept]

Phrase: "--"

Phrase: "Sedimentation analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously"

Phrase: "(53,"

Phrase: "54"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the aggregation state of A under a variety of conditions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1301808:State [Geographic Area]
   739   C1442792:State [Functional Concept]
   739   C3148680:State [Geographic Area]
Processing 00000000.tx.251: In the present study, the solubilities of unaggregated A142, oligomers, and fibrils (Fig. 2) and the fibrillar aggregates (Fig. 5A, acidic pH and physiologic ionic strength) were estimated after centrifugation for 30min at 16,000and 100,000g. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the solubilities of unaggregated A142,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037628:Solubilities [Qualitative Concept]

Phrase: "oligomers,"

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "the fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "physiologic ionic strength"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "estimated after centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0750572:Estimated [Quantitative Concept]

Phrase: "for 30min"

Phrase: "at 16,"

Phrase: "000and 100,"

Phrase: "000g."
Processing 00000000.tx.252: The soluble A1-42 structures remaining in the supernatants were characterized by AFM. 

Phrase: "The soluble A1-42 structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:structures [Spatial Concept]

Phrase: "remaining in the supernatants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1527428:Remaining [Qualitative Concept]
   737   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "characterized by AFM."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   760   C1880022:Characterized [Activity]
   704 E C0729333:Dynamic [Functional Concept]
Processing 00000000.tx.253: Unaggregated A1-42 total and supernatant fractions (Fig. 6) contained structures that measured 1.0(0.3) nm (Fig. 6, insets) and very few oligomeric assemblies. 

Phrase: "Unaggregated A1-42 total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "supernatant fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "that"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(0.3"

Phrase: ")"

Phrase: "nm (Fig. 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0312860:NM [Cell Function]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: "insets"

Phrase: ")"

Phrase: "and"

Phrase: "very few oligomeric assemblies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1706853:Assembly [Activity]
   779   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.254: The total oligomeric and fibrillar A1-42, as well as the 16,000and 100,000g supernatants (Fig. 6), were comparable in size and morphology to the assemblies described for Fig. 

Phrase: "The total oligomeric"

Phrase: "and"

Phrase: "fibrillar A1-42,"

Phrase: "as well as"

Phrase: "the 16,"

Phrase: "000and 100,"

Phrase: "000g supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "comparable in size"

Phrase: "and"

Phrase: "morphology to the assemblies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332437:Morphology [Qualitative Concept]
   770   C0543482:morphology [Spatial Concept]
   770   C0700329:Morphology, NOS [Finding]
   770   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "described for Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.255: 2A. 

Phrase: "2A."
Processing 00000000.tx.256: A decrease in the number of fibrils was observed in the 100,000g supernatant fraction, indicating that these fibrils may eventually sediment with prolonged ultracentrifugation. 

Phrase: "A decrease in the number of fibrils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed in the 100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "000g supernatant fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "these fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "may"

Phrase: "eventually sediment with prolonged ultracentrifugation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1550099:Sediment [Body Substance]
Processing 00000000.tx.257: In contrast, fibrillar aggregates could not be detected by AFM in either 16,000or 100,000g supernatants. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "detected by AFM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "in either 16,"

Phrase: "000or 100,"

Phrase: "000g supernatants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.258: No unassembled or oligomeric structures were detected in the fibrillar aggregate 100,000g supernatant fraction at high resolution by AFM (Fig. 6, inset). 

Phrase: "No unassembled"

Phrase: "or"

Phrase: "oligomeric structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "detected in the fibrillar aggregate 100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205418:Aggregate [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "000g supernatant fraction at high resolution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "by AFM"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "inset"

Phrase: ")."
Processing 00000000.tx.259: View larger version (134K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(134K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.260: 6.  

Phrase: "6."
Processing 00000000.tx.261: AFM analysis of the solubility of A1-42 assemblies. 

Phrase: "AFM analysis of the solubility of A1-42 assemblies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]
Processing 00000000.tx.262: Oligomeric and fibrillar A1-42 samples were prepared as described in the legend for Fig. 

Phrase: "Oligomeric"

Phrase: "and"

Phrase: "fibrillar A1-42 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.263: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.264: Unaggregated solutions of A1-42 were prepared by dilution of 5mM A1-42 Me2SO stock solution to 10M in ice-cold dH2O. 

Phrase: "Unaggregated solutions of A1-42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0037633:Solutions [Substance]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "prepared by dilution of 5mM A1-42 Me2SO stock solution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0037633:Solution [Substance]
   739   C0079240:Dilution [Laboratory Procedure]
   739   C0525069:Solution [Biomedical or Dental Material]
   739   C1710198:Stock [Idea or Concept]
   739   C1948037:Dilution [Functional Concept]
   706   C1521827:Prepare [Functional Concept]

Phrase: "to 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "in ice-cold dH2O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0456963:Ice cold [Qualitative Concept]
Processing 00000000.tx.265: Fibrillar aggregates of A1-42 were prepared by incubation in 10mM HCl+150mM NaCl for 24h at 37C as described in the legend for Fig. 

Phrase: "Fibrillar aggregates of A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "prepared by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "in 10mM HCl+150mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "at 37C"

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.266: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.267: 100M samples were diluted 1:10 and either not centrifuged (total) or centrifuged for 30min at 16,000or 100,000g. 

Phrase: "100M samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10"

Phrase: "and"

Phrase: "either"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "centrifuged for 30min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 16,"

Phrase: "000or 100,"

Phrase: "000g."
Processing 00000000.tx.268: Similar results were obtained if the preparations were diluted before or after centrifugation. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "if"

Phrase: "the preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "diluted before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1720119:Dilute [Functional Concept]
   799   C1948037:Dilute [Functional Concept]

Phrase: "or after centrifugation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0007703:Centrifugation [Laboratory Procedure]
Processing 00000000.tx.269: Diluting the samples prior to centrifugation facilitated supernatant and pellet recovery. 

Phrase: "Diluting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "the samples prior to centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "facilitated"

Phrase: "supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet recovery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237820:Recovery [Activity]
   861   C1555688:recovery [Idea or Concept]
   861   C2004454:Recovery [Organism Function]
Processing 00000000.tx.270: Total and supernatant fractions were prepared for AFM analysis. 

Phrase: "Total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "supernatant fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "prepared for AFM analysis."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0026018:Microscopy [Laboratory Procedure]
   753   C0441722:Force [Phenomenon or Process]
   753   C0563538:Force [Phenomenon or Process]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   719   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.271: Representative 22-m x-y, 10-nm total z-range AFM images are shown. 

Phrase: "Representative 22-m x-y,"

Phrase: "10-nm total z-range AFM images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1704254:Image [Intellectual Product]
   758   C1704922:Image [Entity]
   758   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.272: Inset images, 200200-nm x-y, 2-nm total z-range. 

Phrase: "Inset images,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "200200-nm x-y,"

Phrase: "2-nm total z-range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]
Processing 00000000.tx.273: Approximately 90% of the total A peptide remained in the supernatants when unaggregated, oligomeric, and fibrillar preparations were centrifuged at 16,000g for 30min (Table II). 

Phrase: "Approximately 90% of the total"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0332232:Approximately [Qualitative Concept]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "A peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "remained in the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1550101:Supernatant [Body Substance]

Phrase: "when"

Phrase: "unaggregated, oligomeric,"

Phrase: "and"

Phrase: "fibrillar preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "centrifuged at 16,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 30min"

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.274: Fibrillar aggregates were more insoluble yielding ~23% recovery from the 16,000g supernatants. 

Phrase: "Fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "more insoluble yielding ~23% recovery from the 16,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0237820:Recovery [Activity]
   744   C1555688:recovery [Idea or Concept]
   744   C2004454:Recovery [Organism Function]

Phrase: "000g supernatants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.275: Unaggregated and oligomeric preparations remained in the supernatant at 100,000g, whereas the fibrillar conformations began to sediment with ~51% remaining in the supernatant. 

Phrase: "Unaggregated"

Phrase: "and"

Phrase: "oligomeric preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "remained in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550101:Supernatant [Body Substance]

Phrase: "at 100,"

Phrase: "000g,"

Phrase: "whereas"

Phrase: "the fibrillar conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "began to sediment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1550099:Sediment [Body Substance]
   756   C0439659:Begin [Temporal Concept]

Phrase: "with ~51% remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "in the supernatant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.276: Fibrillar aggregates completely sedimented at 100,000g. 

Phrase: "Fibrillar aggregates completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "sedimented at 100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1550099:Sediment [Body Substance]

Phrase: "000g."
Processing 00000000.tx.277: These percent-recovery results (Table II) agree with the presence of unaggregated, oligomeric, and fibrillar assemblies detected by AFM in supernatant fractions (Fig. 6). 

Phrase: "These percent-recovery results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "(Table II"

Phrase: ")"

Phrase: "agree with the presence of unaggregated, oligomeric,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C3641827:Agree [Intellectual Product]

Phrase: "and"

Phrase: "fibrillar assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "detected by AFM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "in supernatant fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.278: In addition, the absence of fibrillar aggregates in 16,000and 100,000g supernatants (Fig. 6) coincides with low percent-recovery data (Table II). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the absence of fibrillar aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in 16,"

Phrase: "000and 100,"

Phrase: "000g supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "coincides with low percent-recovery data"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205251:low [Qualitative Concept]
   753   C0237820:Recovery [Activity]
   753   C0439165:Percent [Quantitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1511726:Data [Idea or Concept]
   753   C1550472:low [Idea or Concept]
   753   C1555688:recovery [Idea or Concept]
   753   C2004454:Recovery [Organism Function]
   753   C3245479:data [Medical Device]

Phrase: "(Table II"

Phrase: ")."
Processing 00000000.tx.279: Taken together, these data indicate that unaggregated, oligomeric, and to some extent fibrillar, preparations of A1-42 are soluble and that fibrillar aggregates formed at physiologic ionic strength and acidic pH are insoluble.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that unaggregated, oligomeric,"

Phrase: "and to some extent fibrillar, preparations of A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439792:Extent [Spatial Concept]
   742   C1515981:And [Idea or Concept]
   708   C0455052:Preparation [Health Care Activity]
   708   C1521827:Preparation [Functional Concept]

Phrase: "are"

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "that fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "formed at physiologic ionic strength"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0086486:Ionic Strength [Quantitative Concept]
   760   C0205431:Formed [Functional Concept]
   760   C0205463:Physiologic [Functional Concept]
   760   C0237897:Strength [Quantitative Concept]
   760   C0808080:Strength [Idea or Concept]
   760   C1705922:Strength [Qualitative Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "are"

Phrase: "insoluble."
Processing 00000000.tx.280: View this table: [in this window] [in a new window]  Table II Quantitation of the solubility of A1-42 assemblies 100 M unaggregated, oligomeric, fibrillar, and fibrillar aggregates of A1-42 were prepared as described in the legend for Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table II Quantitation of the solubility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantitation [Quantitative Concept]

Phrase: "of A1-42 assemblies 100 M unaggregated, oligomeric, fibrillar,"

Phrase: "and"

Phrase: "fibrillar aggregates of A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.281: 6A. 

Phrase: "6A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]
Processing 00000000.tx.282: Samples diluted 1:10 were either not centrifuged (total) or centrifuged for 30minutes at 16,000g or 100,000g. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10"

Phrase: "were"

Phrase: "either"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "centrifuged for 30minutes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 16,"

Phrase: "000g"

Phrase: "or"

Phrase: "100,"

Phrase: "000g."
Processing 00000000.tx.283: Total, supernatant, and pellet fractions were extracted in 70% formic acid and quantitated by dot blot analysis. 

Phrase: "Total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "supernatant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "extracted in 70% formic acid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0885348:formic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "quantitated by dot blot analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0013064:dot blot [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0872145:DOT [Therapeutic or Preventive Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.284: Values represent means (S.E.M) of the percent recovery of the total (uncentrifuged) in the supernatant and pellet fractions. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "("

Phrase: "S."

Phrase: "E.M) of the percent recovery of the total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]

Phrase: "(uncentrifuged"

Phrase: ")"

Phrase: "in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellet fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.285: Control samples were prepared in an identical manner using the same tubes and solutions in the absence of centrifugation. 

Phrase: "Control samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared in an identical manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205280:Identical [Qualitative Concept]
   726   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]

Phrase: "and"

Phrase: "solutions in the absence of centrifugation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0037633:Solutions [Substance]
   719 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.286: Values from these control samples were used to determine non-sedimenting background and were subtracted from test samples. 

Phrase: "Values from these control samples"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "non-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Non [Functional Concept]

Phrase: "sedimenting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550099:Sediment [Body Substance]

Phrase: "background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "and"

Phrase: "were"

Phrase: "subtracted from test samples."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   737   C0370003:Sample [Substance]
   737   C1719767:Subtract [Intellectual Product]
   737   C2347026:Sample [Conceptual Entity]
   737   C2348589:Subtract [Phenomenon or Process]
Processing 00000000.tx.287: A1-40 Requires Longer Incubation Times to Form Oligomers and Fibrils Comparable with A1-42 Oligomers and Fibrils-- A1-40 is the predominant species of A produced from the variable C-terminal cleavage of APP. 

Phrase: "A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "Requires"

Phrase: "Longer Incubation Times to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "Form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "Oligomers"

Phrase: "and"

Phrase: "Fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "Comparable with A1-42 Oligomers"

Phrase: "and"

Phrase: "Fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "--"

Phrase: "A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "is"

Phrase: "the predominant species of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705920:Species [Conceptual Entity]

Phrase: "produced from the variable C-terminal cleavage of APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1707271:C-Terminal [Amino Acid Sequence]
   742   C0010813:cleavage [Cell Function]
   742   C0205088:Terminal [Temporal Concept]
   742   C0439828:Variable [Qualitative Concept]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C3538722:APP [Laboratory Procedure]
Processing 00000000.tx.288: The oligomer- and fibril-forming conditions defined for A1-42 were applied to A1-40. 

Phrase: "The oligomer-"

Phrase: "and"

Phrase: "fibril-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "defined for A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]

Phrase: "were"

Phrase: "applied to A1-40."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C0439509:/40 [Temporal Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.289: AFM characterization of A1-40 immediately upon dilution reveals a fairly homogeneous field of unaggregated peptide structures (Fig. 7A). 

Phrase: "AFM characterization of A1-40 immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "upon dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a fairly homogeneous field of unaggregated peptide structures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   744   C1521738:Field [Conceptual Entity]
   744   C2346620:Field [Conceptual Entity]
   744   C2349184:Field [Conceptual Entity]
   744   C3539073:FIELD [Spatial Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.290: High resolution scans detect dense fields peptide measuring 1.0(0.3) nm (Fig. 7A, insets for 0h). 

Phrase: "High resolution scans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0034606:Scan [Diagnostic Procedure]
   827   C0441633:Scan [Diagnostic Procedure]
   827   C2826292:SCAN [Finding]
   734   C1719039:High resolution [Laboratory Procedure]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "dense fields peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(0.3"

Phrase: ")"

Phrase: "nm (Fig. 7A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "insets for 0h"

Phrase: ")."
Processing 00000000.tx.291: No significant changes in A1-40 assembly state could be detected under the A1-42 oligomer- or fibril-forming conditions by AFM after 24h (Fig. 7A), although some short, ~4-nm-diameter A1-40 fibrils and 2-4-nm oligomers were detected under fibril-forming conditions. 

Phrase: "No significant changes in A1-40 assembly state"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   767   C0443172:State changes [Quantitative Concept]
           changes
   750   C0442739:No change [Finding]
   750   C1548568:No change [Intellectual Product]
   744   C0392747:changes [Functional Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected under the A1-42 oligomer-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "fibril-forming conditions by AFM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0012634:condition [Disease or Syndrome]
   714   C0348080:Condition [Qualitative Concept]
   714   C1705253:Condition [Conceptual Entity]

Phrase: "after 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "some short, ~4-nm-diameter A1-40 fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0225328:fibrils [Cell Component]
   762 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "2-4-nm oligomers"

Phrase: "were"

Phrase: "detected under fibril-forming conditions."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0205431:Forming [Functional Concept]
   760   C0225328:Fibril [Cell Component]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1522492:Forming [Functional Concept]
   760   C1948066:Fibril [Physical Object]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.292: Both A1-40 solutions were allowed to incubate for 6weeks. 

Phrase: "Both A1-40 solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "incubate for 6weeks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:incubate [Laboratory Procedure]
Processing 00000000.tx.293: At this time point, ~4-nm assemblies comparable in size to 24-h A1-42 oligomers in Fig. 

Phrase: "At this time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "~4-nm assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1706853:Assembly [Activity]
   793   C1879748:Assembly [Manufactured Object]

Phrase: "comparable in size"

Phrase: "to 24-h A1-42 oligomers"

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.294: 2A were detected under oligomer-forming conditions (Fig. 7A). 

Phrase: "2A"

Phrase: "were"

Phrase: "detected under oligomer-forming conditions"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0205431:Forming [Functional Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1522492:Forming [Functional Concept]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.295: At 6-weeks, solutions of A1-40 incubated under fibril-forming conditions contained several 2-6-nm oligomeric assemblies and ~4-6-nm-diameter fibrils (Fig. 7A), slightly larger than 24-h A1-42 fibrils (~4 nm) in Fig. 

Phrase: "At 6-weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "solutions of A1-40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0037633:Solutions [Substance]
   737 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "incubated under fibril-forming conditions"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0205431:Forming [Functional Concept]
   760   C0225328:Fibril [Cell Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1522492:Forming [Functional Concept]
   760   C1948066:Fibril [Physical Object]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "several 2-6-nm oligomeric assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1706853:Assembly [Activity]
   766   C1879748:Assembly [Manufactured Object]

Phrase: "and ~"

Phrase: "4-6-nm-diameter fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0225328:fibrils [Cell Component]
   771 E C1948066:Fibril [Physical Object]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "slightly larger than 24-h A1-42 fibrils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0443228:larger [Quantitative Concept]
   744   C0549177:Larger [Quantitative Concept]
   744   C1704243:Larger [Quantitative Concept]

Phrase: "(~4 nm) in Fig."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]
Processing 00000000.tx.296: 2A. 

Phrase: "2A."
Processing 00000000.tx.297: View larger version (56K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(56K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.298: 7.  

Phrase: "7."
Processing 00000000.tx.299: A1-40 requires longer incubation times to form oligomers and fibrils comparable with A1-42 oligomers and fibrils. 

Phrase: "A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "requires"

Phrase: "longer incubation times to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0040223:times [Temporal Concept]
   812   C1632851:Times [Quantitative Concept]
   779 E C3541383:Time [Temporal Concept]
   741 E C0442043:Temporal [Spatial Concept]
   741 E C2362314:Temporal [Temporal Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "oligomers"

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "comparable with A1-42 oligomers"

Phrase: "and"

Phrase: "fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.300: A, AFM. 

Phrase: "A,"

Phrase: "AFM."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.301: Oligomeric and fibrillar A1-40 samples prepared as described in the legend for Fig. 

Phrase: "Oligomeric"

Phrase: "and"

Phrase: "fibrillar A1-40 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.302: 2 were mounted for AFM analysis immediately after dilution (0-h), 24h, and 6weeks. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "mounted for AFM analysis immediately"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0026018:Microscopy [Laboratory Procedure]
   748   C0205548:Immediately [Temporal Concept]
   748   C0441722:Force [Phenomenon or Process]
   748   C0449878:mounted [Finding]
   748   C0563538:Force [Phenomenon or Process]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   714 E C0181909:Mount [Medical Device]

Phrase: "after"

Phrase: "dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "(0-h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "and"

Phrase: "6weeks."
Processing 00000000.tx.303: Representative 22-m x-y, 10-nm total z-range AFM images are shown. 

Phrase: "Representative 22-m x-y,"

Phrase: "10-nm total z-range AFM images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1704254:Image [Intellectual Product]
   758   C1704922:Image [Entity]
   758   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.304: Inset images, 200200-nm x-y, 2-nm total z-range. 

Phrase: "Inset images,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "200200-nm x-y,"

Phrase: "2-nm total z-range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514721:Range [Quantitative Concept]
   804   C2348147:Range [Quantitative Concept]
   804   C3542016:Range [Intellectual Product]
Processing 00000000.tx.305: B, Western analysis of SDS-PAGE. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Western analysis of SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.306: Representative Western blots of A1-40 samples prepared as described in A were analyzed as described in the legend for Fig. 

Phrase: "Representative Western blots of A1-40 samples"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0949466:Western Blots [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]
   745 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in the legend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   770   C2729544:Legend [Pharmacologic Substance]

Phrase: "for Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.307: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.308: Oligomers and fibrils were sampled at 0h (lanes 1and 3), 24h (lanes 2and 4), and 6weeks (lanes 5and 6), respectively. 

Phrase: "Oligomers"

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "sampled at 0h"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0441621:sampled [Diagnostic Procedure]
   790   C0870078:sampled [Idea or Concept]
   756 E C0370003:Sample [Substance]
   756 E C2347026:Sample [Conceptual Entity]

Phrase: "(lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "(lanes 2and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "6weeks"

Phrase: "(lanes 5and 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.309: Western blot analysis of SDS-PAGE for A1-40 incubated under oligomer (Fig. 7B, lanes 1and 2)- and fibril (Fig. 7B, lanes 3and 4)-forming conditions revealed A tetramer and monomer in both preparations at 0(Fig. 

Phrase: "Western blot analysis of SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "for A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "incubated under oligomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Fig. 7B,"

Phrase: "lanes 1and 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "-"

Phrase: "and"

Phrase: "fibril"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0225328:Fibril [Cell Component]
  1000   C1948066:Fibril [Physical Object]

Phrase: "(Fig. 7B,"

Phrase: "lanes 3and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")-"

Phrase: "forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "A tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "and"

Phrase: "monomer in both preparations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "at 0"

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.310: 7B, lanes 1and 3)- and 24(Fig. 

Phrase: "7B,"

Phrase: "lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "-"

Phrase: "and"

Phrase: "24"

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.311: 7B, lanes 2and 4)-h time points. 

Phrase: "7B,"

Phrase: "lanes 2and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")-"

Phrase: "h time points."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.312: Faint bands of larger oligomers between 30and 60kDa are present in both 24-h samples, and a faint smear centered at ~60 kDa can be detected in the 24-h sample incubated under fibril-forming conditions. 

Phrase: "Faint bands of larger oligomers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "between 30and 60kDa"

Phrase: "are"

Phrase: "present in both 24-h samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "a faint smear"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0444186:Smear [Diagnostic Procedure]
   861   C1947932:Smear [Activity]

Phrase: "centered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:centered [Spatial Concept]

Phrase: "at ~60 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "detected in the 24-h sample"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0370003:Sample [Substance]
   753   C0441932:H+ [Classification]
   753   C0442726:Detected [Finding]
   753   C0564385:/h [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "incubated under fibril-forming conditions."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0205431:Forming [Functional Concept]
   760   C0225328:Fibril [Cell Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1522492:Forming [Functional Concept]
   760   C1948066:Fibril [Physical Object]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.313: Western blot analysis of long-aged A1-40 under oligomer-forming conditions (Fig. 7B, lane 5) reveals monomer and a smear around ~60 kDa. 

Phrase: "Western blot analysis of long-aged A1-40"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "under oligomer-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(Fig. 7B,"

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "a smear around ~60 kDa."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444186:Smear [Diagnostic Procedure]
   760   C1947932:Smear [Activity]
Processing 00000000.tx.314: Long-aged A1-40 solutions incubated under fibril-forming conditions (Fig. 7B, lane 6) contain a faint monomer band, a smear around ~60 kDa, and large aggregates >60 kDa extending up to the well of the gel.  

Phrase: "Long-aged A1-40 solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0037633:Solutions [Substance]
   771 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "incubated under fibril-forming conditions"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0205431:Forming [Functional Concept]
   760   C0225328:Fibril [Cell Component]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1522492:Forming [Functional Concept]
   760   C1948066:Fibril [Physical Object]
   726   C0012634:condition [Disease or Syndrome]
   726 E C0348078:Form [Qualitative Concept]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "(Fig. 7B,"

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a faint monomer band,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "a smear around ~60 kDa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444186:Smear [Diagnostic Procedure]
   760   C1947932:Smear [Activity]

Phrase: "and"

Phrase: "large aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: ">60 kDa extending up to the well of the gel."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0439792:Extending [Spatial Concept]
   706 E C0231448:Extend [Functional Concept]
Processing 00000000.tx.315: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The biological roles that A plays in normal humans or in those that suffer from AD remain unclear. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The biological roles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "A"

Phrase: "plays in normal humans"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0032214:Play [Daily or Recreational Activity]
   770   C0086418:Humans [Human]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0600138:Plays [Finding]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "or in those"

Phrase: "that"

Phrase: "suffer from AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0683278:suffer [Mental or Behavioral Dysfunction]

Phrase: "remain"

Phrase: "unclear."
Processing 00000000.tx.316: Definitive genetic studies, as well as a large number of in vitro and in vivo experiments, provide compelling evidence that A1-42 is a direct causal agent for AD. 

Phrase: "Definitive genetic studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C2827447:Genetic Study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "as well as"

Phrase: "a large number of in vitro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "in vivo experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "compelling evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that A1-42"

Phrase: "is"

Phrase: "a direct causal agent for AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0450442:Agent [Chemical Viewed Functionally]
   753   C1254351:Agent [Pharmacologic Substance]
   753   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.317: What remains unclear is the relevant conformational assembly(s) of A142 associated with the disease pathology. 

Phrase: "What"

Phrase: "remains"

Phrase: "unclear"

Phrase: "is"

Phrase: "the relevant conformational assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "("

Phrase: "s) of A142"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2603362:S' [Clinical Attribute]

Phrase: "associated with the disease pathology."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0243083:associated disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.318: Early studies provided evidence that A had to assemble into a fibrillar conformation to induce significant levels of neurotoxicity in vitro (55-57) or A-induced tau phosphorylation (58). 

Phrase: "Early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "provided evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "A"

Phrase: "had to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0062074:HAD [Therapeutic or Preventive Procedure]
   833   C1415458:HAD [Gene or Genome]
   833   C3539897:Had [Qualitative Concept]

Phrase: "assemble into a fibrillar conformation to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026377:Conformation [Spatial Concept]
   753   C1706853:Assemble [Activity]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "significant levels of neurotoxicity"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   783   C0814896:levels significance [Research Activity]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(55-57"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "A-induced tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.319: Recently, a number of studies have uncovered both in vitro and in vivo biological activities associated with soluble oligomeric and protofibrillar conformations of A, challenging the idea that fibrillar amyloid is the causative pathogenic agent in AD. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "uncovered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439845:Uncovered [Functional Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo biological activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0005532:Biological [Biomedical Occupation or Discipline]
   812   C0205460:biological [Qualitative Concept]
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "associated with soluble oligomeric"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "protofibrillar conformations of A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0026377:Conformation [Spatial Concept]

Phrase: "challenging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0798503:Challenge [Clinical Attribute]
   966   C0805586:Challenge [Health Care Activity]
   966   C3274764:Challenge [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that fibrillar amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the causative pathogenic agent in AD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0449411:Causative agent [Finding]
   753   C0450442:Agent [Chemical Viewed Functionally]
   753   C1254351:Agent [Pharmacologic Substance]
   753   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.320: The first studies that characterized soluble oligomeric A (18), a dimer-containing A1-42 fraction (15), ADDLs (amyloid-derived diffusible ligands) (19), and protofibrils (51, 59) introduced the concept that amyloid fibrils are not the only biologically relevant A conformation. 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that characterized soluble oligomeric A (18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1749467:soluble [Cell Component]
   804   C1880022:Characterized [Activity]
   804   C1948047:Soluble [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a dimer-containing A1-42 fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1264633:Fraction [Quantitative Concept]
   804   C1554103:Fraction [Idea or Concept]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "ADDLs"

Phrase: "(amyloid-derived diffusible ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0023688:Ligands [Chemical]

Phrase: ")"

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "protofibrils"

Phrase: "(51,"

Phrase: "59"

Phrase: ")"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "the concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "that amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the only biologically relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347946:Relevant [Qualitative Concept]

Phrase: "A conformation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.321: In the present study, A1-42 pretreated in HFIP and solubilized in Me2SO produced uniform peptide solutions that were free from the structural history present in commercially available lyophilized stocks, laying the critical foundation for controlled aggregation studies. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "A1-42"

Phrase: "pretreated in HFIP"

Phrase: "and"

Phrase: "solubilized in Me2SO"

Phrase: "produced"

Phrase: "uniform peptide solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "that"

Phrase: "were"

Phrase: "free from the structural history present"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]

Phrase: "in commercially available lyophilized stocks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710198:Stock [Idea or Concept]

Phrase: "laying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1622979:LAYING [Organism Function]

Phrase: "the critical foundation for controlled aggregation studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0016617:Foundation [Organization]
Processing 00000000.tx.322: From this structurally and chemically identical starting material, conformationally distinct populations of oligomeric and fibrillar A were produced by controlling the incubation time, concentration, temperature, pH, ionic strength, and A species. 

Phrase: "From this structurally"

Phrase: "and"

Phrase: "chemically identical starting material,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Material [Substance]

Phrase: "conformationally distinct populations of oligomeric"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "fibrillar A"

Phrase: "were"

Phrase: "produced by controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0332298:controlling [Functional Concept]
   790   C2587213:Controlling [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]

Phrase: "the incubation time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "ionic strength,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0086486:Ionic Strength [Quantitative Concept]
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789   C0022023:Ion [Element, Ion, or Isotope]
   789 E C0442821:Strong [Qualitative Concept]
   789   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "A species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.323: Incubation time had a moderate effect on A142 conformation in that the majority of the structures that formed within 24h remained for up to 1week. 

Phrase: "Incubation time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "had"

Phrase: "a moderate effect on A142 conformation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in"

Phrase: "that"

Phrase: "the majority of the structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "that"

Phrase: "formed within 24h"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0205431:Formed [Functional Concept]
   790   C0456696:/24h [Temporal Concept]
   790   C1442770:24H [Temporal Concept]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]
   756 E C1522492:Form [Functional Concept]

Phrase: "remained for"

Phrase: "up to 1week."
Processing 00000000.tx.324: Concentration also had a moderate effect on conformation, particularly fibril formation, as the critical concentration for fibrillogenesis under these conditions appears to be between 10and 50M, whereas oligomer formation can proceed at much lower concentrations (Fig. 3). 

Phrase: "Concentration also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "had"

Phrase: "a moderate effect on conformation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "particularly fibril formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "the critical concentration for fibrillogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C2348011:Critical Concentration [Quantitative Concept]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "under these conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be between 10and 50M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2987476:Be [Conceptual Entity]

Phrase: "whereas"

Phrase: "oligomer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "can"

Phrase: "proceed at much lower concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.325: Temperature also appeared to influence the rate of fibril formation to a greater extent than oligomer formation. 

Phrase: "Temperature also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the rate of fibril formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "to a greater extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1555603:Great extent [Qualitative Concept]
   861   C0439792:Extent [Spatial Concept]

Phrase: "than oligomer formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.326: Oligomer and protofibril formation was favored at neutral pH, and fibril formation was favored at acidic pH. 

Phrase: "Oligomer"

Phrase: "and"

Phrase: "protofibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "favored at neutral pH,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C2825492:Neutral [Phenomenon or Process]
   737   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "favored at acidic pH."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001128:Acidic [Chemical]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   737   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.327: Ionic strength had a significant effect on conformation, particularly the coalescence of soluble fibrillar A1-42 into compact insoluble fibril aggregates at 150mM NaCl. 

Phrase: "Ionic strength"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0086486:Ionic Strength [Quantitative Concept]
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789   C0022023:Ion [Element, Ion, or Isotope]
   789 E C0442821:Strong [Qualitative Concept]
   789   C1700702:ION [Functional Concept]

Phrase: "had"

Phrase: "a significant effect on conformation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "particularly"

Phrase: "the coalescence of soluble fibrillar A1-42"

Phrase: "into compact insoluble fibril"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0225328:Fibril [Cell Component]
   827   C1948066:Fibril [Physical Object]

Phrase: "aggregates at 150mM NaCl."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0205418:Aggregate [Qualitative Concept]
   770   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.328: When these oligomer- and fibril-forming conditions for A1-42 were applied to A1-40, significantly longer periods of time were required for oligomeric and fibrillar structures to form that resembled those formed by A1-42 within 24h. 

Phrase: "When"

Phrase: "these oligomer-"

Phrase: "and"

Phrase: "fibril-forming conditions for A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "were"

Phrase: "applied to A1-40,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185125:Applied [Health Care Activity]
   770   C0439509:/40 [Temporal Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "significantly longer periods of time"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   807   C0425943:Length of periods [Finding]
           period length
   797   C0439582:Time periods [Temporal Concept]
   770 E C0585019:Temporal periods [Temporal Concept]
   726   C0439531:/period [Temporal Concept]
   726   C1948053:Period [Temporal Concept]

Phrase: "were"

Phrase: "required for oligomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "fibrillar structures to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "resembled"

Phrase: "those"

Phrase: "formed by A1-42"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0205431:Formed [Functional Concept]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "within 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.329: Taken together, these results define specific conditions for reproducibly controlling the formation of unaggregated, oligomeric, fibrillar, and fibrillar aggregate conformations of A1-42. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "define"

Phrase: "specific conditions for reproducibly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the formation of unaggregated, oligomeric, fibrillar,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "fibrillar aggregate conformations of A1-42."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.330: In vitro biological activity studies have demonstrated that oligomeric (17-19, 21) and protofibrillar (20, 60) conformations of A are neurotoxic and impair electrophysiologic activity. 

Phrase: "In vitro biological activity studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   894   C0681828:in vitro study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   787   C2347179:Active Study [Functional Concept]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that oligomeric"

Phrase: "(17-19,"

Phrase: "21"

Phrase: ")"

Phrase: "and"

Phrase: "protofibrillar"

Phrase: "(20,"

Phrase: "60"

Phrase: ")"

Phrase: "conformations of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0026377:Conformation [Spatial Concept]

Phrase: "are"

Phrase: "neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "impair"

Phrase: "electrophysiologic activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.331: Although experiments using a single conformation of A can be informative, comparative experiments using multiple conformations of A derived from a single starting material will further our understanding of how structure affects function. 

Phrase: "Although"

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a single conformation of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026377:Conformation [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "informative, comparative experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "multiple conformations of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0026377:Conformation [Spatial Concept]

Phrase: "derived from a single starting material"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0520510:Material [Substance]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]
   719   C0439659:Start [Temporal Concept]

Phrase: "will"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "our understanding of how structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.332: Using this approach, we demonstrated recently (24) a significant difference in neurotoxicity among unaggregated, oligomeric, and fibrillar A1-42. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(24"

Phrase: ")"

Phrase: "a significant difference in neurotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "among unaggregated, oligomeric,"

Phrase: "and"

Phrase: "fibrillar A1-42."
Processing 00000000.tx.333: Oligomers inhibited neuronal viability 10-fold more than fibrils and ~40-fold more than unaggregated peptide, with oligomer-induced toxicity significant at 10nM. 

Phrase: "Oligomers"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "neuronal viability 10-fold more than fibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443348:viability [Qualitative Concept]

Phrase: "and ~"

Phrase: "40-fold more than unaggregated peptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C0332462:Fold [Spatial Concept]
   753   C0439509:/40 [Temporal Concept]
   753   C1880834:FOLD [Phenomenon or Process]

Phrase: "with oligomer-induced toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "significant at 10nM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237881:significant [Quantitative Concept]
   790   C0750502:Significant [Idea or Concept]
   790   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.334: In addition, we were able to differentiate by structure and neurotoxic activity wild-type A1-42 from isoforms containing known familial mutations (24). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "differentiate by structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205615:differentiate [Qualitative Concept]
   790   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "neurotoxic activity wild-type A1-42 from isoforms"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0205177:Activity [Functional Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0445392:Wild [Intellectual Product]
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   744   C1547052:*Type [Quantitative Concept]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "known familial mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.335: An in vitro comparative analysis using these preparations also demonstrated a significant increase in glial activation by A1-42 oligomers compared with fibrils, as measured by morphological changes and increased expression of inflammatory markers including nitric oxide, inducible nitric-oxide synthase, and interlukin-1.2 The variability in A activity reported in the literature is likely because of the structural heterogeneity present in commercial preparations that are chemically identical. 

Phrase: "An in vitro comparative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0683941:comparative analysis [Research Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these preparations also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "demonstrated"

Phrase: "a significant increase in glial activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "by A1-42 oligomers"

Phrase: "compared with fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0225328:fibrils [Cell Component]
   790   C1707455:Compared [Activity]
   756 E C1948066:Fibril [Physical Object]

Phrase: "as"

Phrase: "measured by morphological changes"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C0543482:morphological [Spatial Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   766   C1260954:Morphologic change [Anatomical Abnormality]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "increased expression of inflammatory markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "nitric oxide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "inducible nitric-oxide synthase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
  1000   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   861   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0030015:oxide [Inorganic Chemical]
   812   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "interlukin-1.2"

Phrase: "The variability in A activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827666:Variability [Conceptual Entity]

Phrase: "reported in the literature"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023866:Literature [Intellectual Product]
   770   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "is"

Phrase: "likely because of the structural heterogeneity present"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0019409:Heterogeneity [Qualitative Concept]
   748   C0150312:Present [Quantitative Concept]
   748   C0332148:Likely [Qualitative Concept]
   748   C0449450:Present [Idea or Concept]
   748   C0678594:Structural [Spatial Concept]
   748   C0750492:Likely [Idea or Concept]

Phrase: "in commercial preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "chemically identical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205280:Identical [Qualitative Concept]
Processing 00000000.tx.336: Commercial sources of synthetic A suggest resuspension in either H2O or Me2SO, and these solubilization procedures are reported throughout the literature. 

Phrase: "Commercial sources of synthetic A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1516719:Commercial Sources [Classification]
   760   C0449416:sources [Finding]
   726 E C1705919:Source [Idea or Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "resuspension in either H2O"

Phrase: "or"

Phrase: "Me2SO,"

Phrase: "and"

Phrase: "these solubilization procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "are"

Phrase: "reported throughout the literature."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0023866:Literature [Intellectual Product]
   770   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.337: In this study, AFM analysis of lyophilized A stocks directly resuspended in H2O detected a wide variety of structures including oligomers, fibrils, and globular aggregates. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "AFM analysis of lyophilized"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "A stocks directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710198:Stock [Idea or Concept]

Phrase: "resuspended in H2O"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a wide variety of structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "oligomers,"

Phrase: "fibrils,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "globular aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.338: These structures could seed further aggregation, strongly influencing the formation and biological activity of the resulting solutions. 

Phrase: "These structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "could"

Phrase: "seed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036563:Seed [Plant]
  1000   C1705192:Seed [Laboratory Procedure]
  1000   C1882540:{Seed} [Quantitative Concept]
  1000   C2346495:Seed [Conceptual Entity]

Phrase: "further aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: "strongly"

Phrase: "influencing"

Phrase: "the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "biological activity of the resulting solutions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0005532:Biological [Biomedical Occupation or Discipline]
   753   C0205177:Activity [Functional Concept]
   753   C0205460:biological [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.339: Seed-free preparations of A have been described using the polar solvent Me2SO, in conjunction with bath sonication and/or filtration (61, 62). 

Phrase: "Seed-free preparations of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0455052:Preparation [Health Care Activity]
   726   C1521827:Preparation [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polar solvent Me2SO,"

Phrase: "in conjunction with bath sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037680:Sonication [Research Activity]

Phrase: "and/or"

Phrase: "filtration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016107:filtration [Laboratory Procedure]

Phrase: "(61,"

Phrase: "62"

Phrase: ")."
Processing 00000000.tx.340: Surprisingly, in this study AFM analysis of A solutions in Me2SO that appeared initially uniform and unaggregated revealed fibril formation over time. 

Phrase: "Surprisingly,"

Phrase: "in this study AFM analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   717   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "of A solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "in Me2SO"

Phrase: "that"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "initially uniform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205375:Uniform [Qualitative Concept]
   861   C1608508:uniform [Quantitative Concept]

Phrase: "and"

Phrase: "unaggregated revealed fibril formation over time."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.341: Previous studies characterizing the formation of A protofibrils (59) and oligomers (63) have emphasized the importance of removing preexisting seeds from A stocks by size-exclusion chromatography. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "characterizing"

Phrase: "the formation of A protofibrils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(59"

Phrase: ")"

Phrase: "and"

Phrase: "oligomers"

Phrase: "(63"

Phrase: ")"

Phrase: "have"

Phrase: "emphasized"

Phrase: "the importance of removing preexisting seeds"

Phrase: "from A stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710198:Stock [Idea or Concept]

Phrase: "by size-exclusion chromatography."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
  1000   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0456389:size [Spatial Concept]
   827   C0680251:EXCLUSION [Functional Concept]
   827   C2828389:Exclusion [Activity]
   727 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.342: Although this approach appears to be successful, it is not always practical for the routine preparation of the large number of small peptide aliquots frequently required for biological assays or screening. 

Phrase: "Although"

Phrase: "this approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "successful,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272703:Successful [Qualitative Concept]
   928 E C0597535:Success [Social Behavior]

Phrase: "it"

Phrase: "is"

Phrase: "not always practical for the routine preparation of the large number"

Phrase: "of small peptide aliquots frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1510844:Aliquot [Quantitative Concept]

Phrase: "required for biological assays"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0005507:Assays, Biological [Laboratory Procedure]
           Assay
   770   C0005532:Biological [Biomedical Occupation or Discipline]
   770   C0205460:biological [Qualitative Concept]
   770   C1514873:Required [Functional Concept]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "or"

Phrase: "screening."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]
Processing 00000000.tx.343: Centrifugation is another method commonly used to separate soluble A from insoluble fibrillar amyloid in both extracted tissue (64, 65) and in vitro aggregation preparations (66, 67). 

Phrase: "Centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "is"

Phrase: "another method commonly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "soluble A from insoluble fibrillar amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in both extracted tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(64,"

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "in vitro aggregation preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "(66,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.344: In this study, the fibrillar aggregates formed at acidic pH and physiologic ionic strength were insoluble and sedimented upon centrifugation at both 16,000and 100,000g (see Fig. 6 and Table II). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "formed at acidic pH"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0001128:Acidic [Chemical]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0205431:Formed [Functional Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "physiologic ionic strength"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: "were"

Phrase: "insoluble"

Phrase: "and"

Phrase: "sedimented upon centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1550099:Sediment [Body Substance]

Phrase: "at both 16,"

Phrase: "000and 100,"

Phrase: "000g"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table II"

Phrase: ")."
Processing 00000000.tx.345: However, fibrillar preparations of A1-42 remained in the supernatant at 16,000g and only partially sedimented at 100,000g (see Fig. 6 and Table II). 

Phrase: "However,"

Phrase: "fibrillar preparations of A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0455052:Preparation [Health Care Activity]
   726   C1521827:Preparation [Functional Concept]

Phrase: "remained in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550101:Supernatant [Body Substance]

Phrase: "at 16,"

Phrase: "000g"

Phrase: "and"

Phrase: "only partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "sedimented at 100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1550099:Sediment [Body Substance]

Phrase: "000g"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table II"

Phrase: ")."
Processing 00000000.tx.346: Although these results confirm the solubility of unaggregated and oligomeric A1-42 preparations, and the insolubility of fibrillar aggregates, the importance of differentiating between preparations defined as "soluble" versus those that are truly "fibril-free" is emphasized by the solubility of fibril preparations. 

Phrase: "Although"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the solubility of unaggregated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0037628:Solubility [Qualitative Concept]

Phrase: "and"

Phrase: "oligomeric A1-42 preparations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "the insolubility of fibrillar aggregates,"

Phrase: "the importance of"

Phrase: "differentiating between preparations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205615:differentiating [Qualitative Concept]
   756   C0455052:Preparation [Health Care Activity]
   756   C1521827:Preparation [Functional Concept]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "as """

Phrase: "soluble"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "versus"

Phrase: "those that"

Phrase: "are"

Phrase: "truly ""fibril-free"""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: "is"

Phrase: "emphasized by the solubility of fibril preparations."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0037628:Solubility [Qualitative Concept]
   748   C0225328:Fibril [Cell Component]
   748   C1948066:Fibril [Physical Object]
   714   C0455052:Preparation [Health Care Activity]
   714   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.347: The A structural conformations that formed under the conditions used in this study were readily discriminated by AFM, whereas Western blot analysis of SDS-PAGE provided only limited information. 

Phrase: "The"

Phrase: "A structural conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0026377:Conformation [Spatial Concept]

Phrase: "that"

Phrase: "formed under the conditions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205431:Formed [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737 E C0348078:Form [Qualitative Concept]
   737   C0348080:Condition [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "readily"

Phrase: "discriminated by AFM,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   726   C0205235:Discriminate [Qualitative Concept]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "whereas"

Phrase: "Western blot analysis of SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "only limited information."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1533716:Information [Idea or Concept]
   755 E C3242430:informational [Idea or Concept]
Processing 00000000.tx.348: In light of the structural differences detected by AFM, it is clear that some of the A1-42 and A1-40 assemblies that form under the oligomer- and fibril-forming conditions used in this study dissociate during SDS-PAGE. 

Phrase: "In light of the structural differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "detected by AFM,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "some of the A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205392:Some [Quantitative Concept]
   760   C3540770:Some [Intellectual Product]

Phrase: "and"

Phrase: "A1-40 assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1706853:Assembly [Activity]
   793   C1879748:Assembly [Manufactured Object]

Phrase: "that"

Phrase: "form under the oligomer-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "fibril-forming conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "dissociate during SDS-PAGE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.349: In particular, the distinct structural morphologies in A1-42 resulting from changes in pH and ionic strength detected by AFM (Fig. 5A) could not be differentiated clearly by Western blot analysis of SDS-PAGE (Fig. 5B). 

Phrase: "In particular,"

Phrase: "the distinct structural morphologies in A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C0332437:Morphology [Qualitative Concept]
   714   C0543482:morphology [Spatial Concept]
   714   C0700329:Morphology, NOS [Finding]
   714   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "resulting from changes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C1705241:Change [Quantitative Concept]
   756 E C2825142:Result [Finding]

Phrase: "in pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "ionic strength"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0086486:Ionic Strength [Quantitative Concept]
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789   C0022023:Ion [Element, Ion, or Isotope]
   789 E C0442821:Strong [Qualitative Concept]
   789   C1700702:ION [Functional Concept]

Phrase: "detected by AFM"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "differentiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]

Phrase: "clearly by Western blot analysis of SDS-PAGE (Fig. 5B"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   760   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0349966:Fig [Food]
   739   C0936012:Analysis [Research Activity]
   739   C1337208:FIG [Food]
   739   C1524024:analysis [Functional Concept]
   739   C1704732:Page [Intellectual Product]
   739   C1705493:Western [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.350: In addition, the electrophoretic process and the combination buffer, glycerol, and detergent present in SDS sample buffer may actually induce the formation of SDS-stable oligomers as reported previously (68). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the electrophoretic process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "the combination buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "detergent present in SDS sample buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "may"

Phrase: "actually"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the formation of SDS-stable oligomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.351: This may account for the SDS-stable oligomers, trimers, and tetramers detected in preparations of A1-40 and A1-42 that appeared unaggregated by AFM (see Figs. 2, 6, and 7). 

Phrase: "This"

Phrase: "may"

Phrase: "account for the SDS-stable oligomers,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205360:Stable [Qualitative Concept]
   753   C1547311:Stable [Intellectual Product]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "trimers,"

Phrase: "and"

Phrase: "tetramers"

Phrase: "detected in preparations of A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439509:/40 [Temporal Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719   C0455052:Preparation [Health Care Activity]
   719   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "A1-42"

Phrase: "that appeared unaggregated by AFM"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Figs. 2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "6,"

Phrase: "and"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.352: In addition, when distinct A1-40 oligomers and fibrils were detected by AFM, no SDS-stable oligomeric bands were present. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "when"

Phrase: "distinct A1-40 oligomers"

Phrase: "and"

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "detected by AFM,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "no SDS-stable oligomeric bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0175723:Bands [Medical Device]
   779 E C0439645:Band [Spatial Concept]
   779 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.353: Despite these limitations, some general trends were observed between Western blot analysis of SDS-PAGE of A1-42 preparations incubated under oligomer- and fibril-forming conditions. 

Phrase: "Despite these limitations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:limitations [Functional Concept]

Phrase: "some general trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040833:trends [Temporal Concept]
   861   C1521798:Trends [Temporal Concept]

Phrase: "were"

Phrase: "observed between Western blot analysis of SDS-PAGE of A1-42 preparations"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   753   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1441672:Observed [Functional Concept]
   736   C1524024:analysis [Functional Concept]
   736   C1704732:Page [Intellectual Product]
   736   C1705493:Western [Spatial Concept]
   703   C0455052:Preparation [Health Care Activity]
   703   C1521827:Preparation [Functional Concept]

Phrase: "incubated under oligomer-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "fibril-forming conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.354: Oligomers produced slightly more SDS-stable tetramer and large oligomer bands than fibrils, and both conditions showed more SDS-stable trimer and tetramer than unaggregated peptide. 

Phrase: "Oligomers"

Phrase: "produced"

Phrase: "slightly more SDS-stable tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0039686:Tetramere [Eukaryote]

Phrase: "and"

Phrase: "large oligomer bands than fibrils,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "both conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "more SDS-stable trimer"

Phrase: "and"

Phrase: "tetramer than unaggregated peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0039686:Tetramere [Eukaryote]
Processing 00000000.tx.355: Under fibril-forming conditions, the amount of SDS-stable trimer and tetramer appears to vary and may be in equilibrium with unstable assemblies that break down to monomer, the primary conformation observed in fibril preparations in our previous study (24). 

Phrase: "Under fibril-forming conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the amount of SDS-stable trimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "vary"

Phrase: "and"

Phrase: "may"

Phrase: "be in equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014653:Equilibrium [Organism Function]
   790   C1547026:Equilibrium [Quantitative Concept]
   790   C2987476:Be [Conceptual Entity]

Phrase: "with unstable assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "that break down to monomer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0443161:break down [Qualitative Concept]
   760   C1881704:BREAK [Phenomenon or Process]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "the primary conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "observed in fibril preparations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0225328:Fibril [Cell Component]
   770   C1441672:Observed [Functional Concept]
   770   C1948066:Fibril [Physical Object]
   737   C0455052:Preparation [Health Care Activity]
   737   C1521827:Preparation [Functional Concept]

Phrase: "in our previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.356: An indication of this molecular rearrangement between monomer and tetramer was indicated by the pronounced boundary and smear between these bands (Fig. 2B, lanes 2and 4). 

Phrase: "An indication of this molecular rearrangement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392360:indication [Idea or Concept]
   753   C3146298:Indication [Functional Concept]

Phrase: "between monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "was"

Phrase: "indicated by the pronounced boundary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "smear between these bands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444186:Smear [Diagnostic Procedure]
   770   C1947932:Smear [Activity]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lanes 2and 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.357: These intermediates appear unstable during SDS-PAGE and form under both oligomer- and fibril-forming conditions. 

Phrase: "These intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0205103:Intermediate [Spatial Concept]
   966   C1550465:intermediate [Idea or Concept]
   966   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "unstable during SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443343:Unstable [Finding]
   770   C1883468:UNSTABLE [Phenomenon or Process]

Phrase: "and"

Phrase: "form under both oligomer-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "fibril-forming conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.358: Interestingly, unaggregated preparations (Fig. 2B, lanes 1and 3) that did contain some trimer and tetramer did not contain a smear between tetramer and monomer. 

Phrase: "Interestingly,"

Phrase: "unaggregated preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "lanes 1and 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "that"

Phrase: "did"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "some trimer"

Phrase: "and"

Phrase: "tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039686:Tetramere [Eukaryote]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a smear between tetramer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444186:Smear [Diagnostic Procedure]
   770   C1947932:Smear [Activity]

Phrase: "and"

Phrase: "monomer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.359: A more accurate representation of the molecular stoichiometry of the different assemblies as they exist in solution may require covalent cross-linking. 

Phrase: "A more accurate representation of the molecular stoichiometry of the different assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1514861:Representation [Conceptual Entity]
   736   C1882932:Representation [Activity]

Phrase: "as"

Phrase: "they"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "in solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "may"

Phrase: "require"

Phrase: "covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]
Processing 00000000.tx.360: This strategy was used recently (69) to demonstrate the complexity and dynamic nature of the prenucleation phases of A140 assembly and specifically detected oligomeric intermediates that were not SDS-stable. 

Phrase: "This strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the complexity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0439855:Complex [Qualitative Concept]
   928   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "dynamic nature of the prenucleation phases of A140 assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0349590:Nature [Idea or Concept]
   742   C1262865:Nature [Functional Concept]

Phrase: "and"

Phrase: "specifically"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "oligomeric intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "that"

Phrase: "were"

Phrase: "not SDS-"

Phrase: "stable."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]
Processing 00000000.tx.361: Further evidence that SDS-PAGE alone cannot detect A140 monomer-oligomer distribution as it exists in solution comes from studies using analytical ultracentrifugation (63) and mass spectrometry (70). 

Phrase: "Further evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "cannot"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "A140 monomer-oligomer distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0520511:distribution [Idea or Concept]
   812   C1704711:Distribution [Functional Concept]

Phrase: "as"

Phrase: "it"

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "in solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "comes from studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0947630:studies [Laboratory Procedure]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "analytical ultracentrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596085:analytical ultracentrifugation [Laboratory Procedure]
   861   C0041609:Ultracentrifugation [Laboratory Procedure]
   861   C0936012:Analytical [Research Activity]

Phrase: "(63"

Phrase: ")"

Phrase: "and"

Phrase: "mass spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "(70"

Phrase: ")."
Processing 00000000.tx.362: These studies, like the covalent cross-linking study, revealed a more complex, dynamic equilibrium between monomer and oligomer. 

Phrase: "These studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "like the covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a more complex, dynamic equilibrium between monomer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0014653:Equilibrium [Organism Function]
   748   C1547026:Equilibrium [Quantitative Concept]

Phrase: "and"

Phrase: "oligomer."
Processing 00000000.tx.363: Thus, it does not appear possible to equate an aggregate conformation of A1-40 or 1-42 as visualized by AFM to a particular molecular weight band from Western blot analysis of SDS-PAGE. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "equate"

Phrase: "an aggregate conformation of A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026377:Conformation [Spatial Concept]

Phrase: "or"

Phrase: "1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "as"

Phrase: "visualized by AFM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0234621:Visualized [Functional Concept]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "to a particular molecular weight band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]

Phrase: "from Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "of SDS-PAGE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]
Processing 00000000.tx.364: In general, ionic interactions are influenced by pH. 

Phrase: "In general, ionic interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "influenced by pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0020283:[pH] [Quantitative Concept]
   790   C0450407:ph+ [Finding]
   790   C0450408:ph++ [Finding]
   790   C0450409:ph+++ [Finding]
Processing 00000000.tx.365: In this study, solution pH significantly effected both oligomer and fibril assembly. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "solution pH significantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "effected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1280500:Effect [Qualitative Concept]
   966   C2348382:Effect [Qualitative Concept]

Phrase: "both oligomer"

Phrase: "and"

Phrase: "fibril assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.366: Acidic pH has been shown previously (36, 71, 72) to favor fibril formation, possibly resulting from a partial denaturation state similar to that observed with other amyloid-forming proteins (73). 

Phrase: "Acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "(36,"

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "72"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "fibril formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "resulting from a partial denaturation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0301642:Denaturation [Molecular Function]
   760   C0678226:resulting [Functional Concept]
   760   C0728938:Partial [Quantitative Concept]
   760   C1550516:partial [Idea or Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed with other amyloid-forming proteins"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   783   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205431:Forming [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1441672:Observed [Functional Concept]
   753   C1522492:Forming [Functional Concept]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]

Phrase: "(73"

Phrase: ")."
Processing 00000000.tx.367: This may be the result of protonation of the C-terminal carboxyl, N-terminal Asp1, Glu23-Asp24, His13-His14, or other Asp, Glu, or His residues. 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "the result of protonation of the C-terminal carboxyl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]

Phrase: "N-terminal Asp1,"

Phrase: "Glu23-Asp24,"

Phrase: "His13-His14,"

Phrase: "or"

Phrase: "other Asp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206293:Asp [Reptile]
  1000   C3541260:ASP [Gene or Genome]

Phrase: "Glu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061472:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0220839:Glu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "His residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.368: These charged amino acids may be involved in the stabilization of the local secondary structure that facilitates fibrillogenesis. 

Phrase: "These charged amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the stabilization of the local secondary structure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0162807:Secondary Structure [Spatial Concept]
   742   C0027627:secondary [Neoplastic Process]
   742   C0175668:Secondary [Temporal Concept]
   742   C0205276:Local [Spatial Concept]
   742   C0205436:Secondary [Quantitative Concept]
   742   C0678594:Structure [Spatial Concept]
   742   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
   742   C1314939:Involved [Functional Concept]

Phrase: "that"

Phrase: "facilitates"

Phrase: "fibrillogenesis."
Processing 00000000.tx.369: Studies of modified A1-40, in which Asp or His residues were replaced by Asn and Gln, demonstrated that a strong relationship exists between the protonation state at these positions and -helical content (74). 

Phrase: "Studies of modified A1-40,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "in which Asp"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206293:Asp [Reptile]
  1000   C3541260:ASP [Gene or Genome]

Phrase: "or"

Phrase: "His residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "replaced by Asn"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1299987:Replaced by [Functional Concept]
           replaced
   790   C0003995:Asn [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0559956:Replaced [Functional Concept]
   756 E C1554078:Replace [Idea or Concept]

Phrase: "and"

Phrase: "Gln,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "a strong relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439849:Relationship [Qualitative Concept]
   861   C1705630:Relationship [Idea or Concept]
   861   C1706279:Relationship [Idea or Concept]
   861   C3540605:Relationship [Intellectual Product]

Phrase: "exists between the protonation state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0178812:Protonation [Phenomenon or Process]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C2987476:Exist [Conceptual Entity]
   760   C3148680:State [Geographic Area]

Phrase: "at these positions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:positions [Spatial Concept]
   916 E C0240795:POSITIONAL [Finding]

Phrase: "and -"

Phrase: "helical content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "(74"

Phrase: ")."
Processing 00000000.tx.370: Fibrillogenesis is thought to proceed through an -helical intermediate, and stabilization of local helical structure can accelerate this process (40). 

Phrase: "Fibrillogenesis"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "proceed through an -helical intermediate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205103:Intermediate [Spatial Concept]
   760   C1550465:intermediate [Idea or Concept]
   760   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "stabilization of local helical structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.371: This may account for the very rapid conversion of unassembled A1-42 to extended fibrils within 24h of incubation at acidic pH as observed in this study. 

Phrase: "This"

Phrase: "may"

Phrase: "account for the very rapid conversion of unassembled A1-42"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0439831:Rapid [Qualitative Concept]
   739   C0439836:Conversion [Functional Concept]
   739   C0442824:Very [Qualitative Concept]
   739   C1551359:account [Idea or Concept]
   739   C2741673:Account # [Clinical Attribute]
   739   C2981730:Account [Classification]

Phrase: "to extended fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0752265:extended fibrils [Cell Component]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "within 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "of incubation"

Phrase: "at acidic pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "as"

Phrase: "observed in this study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1441672:Observed [Functional Concept]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.372: In addition to ionic interactions influenced by solution pH, hydrophobic interactions also appear to have a significant effect, particularly on fibril formation. 

Phrase: "In addition to ionic interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "influenced by solution pH,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0020283:[pH] [Quantitative Concept]
   770   C0037633:Solution [Substance]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "hydrophobic interactions also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0678607:Hydrophobic Interactions [Molecular Function]
   793   C1704675:Interaction [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a significant effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "particularly on fibril formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0220781:formation [Biologic Function]
   770   C0225328:Fibril [Cell Component]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C1948066:Fibril [Physical Object]
Processing 00000000.tx.373: At low ionic strength, A1-42 fibrils form but remain as individual extended structures for at least a week (Fig. 3B) and are resistant to sedimentation (see Fig. 6 and Table II). 

Phrase: "At low ionic strength,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0086486:Ionic Strength [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C0237897:Strength [Quantitative Concept]
   827   C0808080:Strength [Idea or Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   827   C1705922:Strength [Qualitative Concept]
   755   C0022023:Ion [Element, Ion, or Isotope]
   755 E C0442821:Strong [Qualitative Concept]
   755   C1700702:ION [Functional Concept]

Phrase: "A1-42 fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "but"

Phrase: "remain as individual extended structures"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0027361:Individual [Population Group]
   760   C0231448:Extended [Functional Concept]
   760   C0231449:Extended [Spatial Concept]
   760   C0237401:Individual [Human]
   760   C0439792:extended [Spatial Concept]
   760   C0678594:structures [Spatial Concept]

Phrase: "for"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "a week"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332174:/week [Temporal Concept]
  1000   C0439230:week [Temporal Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "resistant to sedimentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "Table II"

Phrase: ")."
Processing 00000000.tx.374: However, the salt-dependent coalescence of A142 fibrils into supramolecular fibril aggregates (see Fig. 5A and Fig. 6) argues that exposed hydrophobic patches present on the surface of A1-42 fibrils can drive the formation of dense, insoluble fibrillar aggregates. 

Phrase: "However,"

Phrase: "the salt-dependent coalescence of A142 fibrils"

Phrase: "into supramolecular fibril aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "and"

Phrase: "Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "argues"

Phrase: "that exposed hydrophobic patches"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
   827   C0994894:Patches [Medical Device]
   793 E C0332461:Patch [Finding]
   793 E C0445403:Patch [Biomedical or Dental Material]
   793 E C0991556:Patch [Medical Device]
   793 E C1305400:Patch [Medical Device]
   793 E C1533128:Patch [Biomedical or Dental Material]
   793 E C1706366:{Patch} [Quantitative Concept]
   793 E C1707974:Patch [Biomedical or Dental Material]
   743 E C0205413:Patchy [Qualitative Concept]

Phrase: "present on the surface of A1-42 fibrils"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0150312:Present [Quantitative Concept]
   744   C0205148:Surface [Spatial Concept]
   744   C0225328:fibrils [Cell Component]
   744   C0449450:Present [Idea or Concept]
   711 E C1948066:Fibril [Physical Object]

Phrase: "can"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the formation of dense, insoluble fibrillar aggregates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
Processing 00000000.tx.375: Alternatively, this process may be the result of polar interactions screened by the increased ionic strength, although it is more likely that the fibrillar aggregates resulted from non-polar surface interactions. 

Phrase: "Alternatively,"

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "may"

Phrase: "be"

Phrase: "the result of polar interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "screened by the increased ionic strength,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0086486:Ionic Strength [Quantitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0237897:Strength [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0808080:Strength [Idea or Concept]
   753   C1705922:Strength [Qualitative Concept]
   719   C0220908:screen [Health Care Activity]
   719   C1305399:screen [Functional Concept]
   719   C1705053:Screen [Medical Device]

Phrase: "although"

Phrase: "it"

Phrase: "is"

Phrase: "more likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the fibrillar aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "resulted from non-polar surface interactions."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205148:Surface [Spatial Concept]
   753   C0813983:polar [Quantitative Concept]
   753   C1518422:Non [Functional Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C1704675:Interaction [Functional Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.376: Interestingly, the presence or absence of 150mM NaCl did not have as significant of an effect on the coalescence of primarily oligomeric assemblies formed at neutral pH (Fig. 5A), indicating that these oligomeric assemblies may have already sequestered non-polar surfaces by adopting a favorable conformation. 

Phrase: "Interestingly,"

Phrase: "the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 150mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have as significant of an effect"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0237881:significant [Quantitative Concept]
   753   C0750502:Significant [Idea or Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C1546944:Significant [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   753   C3154893:Have [Idea or Concept]
   753   C3539897:Have [Qualitative Concept]

Phrase: "on the coalescence"

Phrase: "of primarily oligomeric assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1706853:Assembly [Activity]
   793   C1879748:Assembly [Manufactured Object]

Phrase: "formed at neutral pH (Fig. 5A"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   753   C0020283:[pH] [Quantitative Concept]
   753   C0205431:Formed [Functional Concept]
   753   C0349966:Fig [Food]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]
   753   C1337208:FIG [Food]
   753   C1553637:5a [Medical Device]
   753   C2825492:Neutral [Phenomenon or Process]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "these oligomeric assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "may"

Phrase: "have"

Phrase: "already"

Phrase: "sequestered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:Sequestered [Functional Concept]

Phrase: "non-polar surfaces by adopting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205148:Surface [Spatial Concept]

Phrase: "a favorable conformation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.377: Further evidence supporting the role of hydrophobic interactions comes from the dramatic differences between A1-42 and A1-40 conformations that were observed by AFM under the A1-42 fibril- and oligomer-forming conditions. 

Phrase: "Further evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the role of hydrophobic interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "comes from the dramatic differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "between A1-42"

Phrase: "and"

Phrase: "A1-40 conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0026377:Conformation [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "observed by AFM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0563538:Force [Phenomenon or Process]
   760   C1441672:Observed [Functional Concept]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "under the A1-42 fibril-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0225328:Fibril [Cell Component]
   827   C1948066:Fibril [Physical Object]

Phrase: "and"

Phrase: "oligomer-forming conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.378: The additional hydrophobic Ile-Ala residues found at the C termini of A1-42 were necessary for the fibril and oligomer formation within 24h as detected by AFM, as well as the different patterns of SDS-stable assemblies detected by Western blot analysis of SDS-PAGE. 

Phrase: "The additional hydrophobic Ile-Ala residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]

Phrase: "found at the C termini of A1-42"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0150312:Found [Quantitative Concept]
   711 E C0243095:Find [Finding]

Phrase: "were"

Phrase: "necessary for the fibril"

Phrase: "and"

Phrase: "oligomer formation within 24h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "detected by AFM,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0441722:Force [Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0563538:Force [Phenomenon or Process]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   704 E C0729333:Dynamic [Functional Concept]

Phrase: "as well as"

Phrase: "the different patterns of SDS-stable assemblies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]

Phrase: "detected by Western blot analysis of SDS-PAGE."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0442726:Detected [Finding]
   744   C0936012:Analysis [Research Activity]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1524024:analysis [Functional Concept]
   744   C1704732:Page [Intellectual Product]
   744   C1705493:Western [Spatial Concept]
Processing 00000000.tx.379: Therefore, these hydrophobic residues in A1-42 appear to play an important role in vitro in the formation of stable oligomers fibrils. 

Phrase: "Therefore,"

Phrase: "these hydrophobic residues in A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "in vitro in the formation of stable oligomers fibrils."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.380: These findings provide evidence that hydrophobic forces play an important role in both differentiating A1-40 and A1-42 species and in the formation of oligomeric and fibrillar aggregates of A1-42. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that hydrophobic forces"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0441722:forces [Phenomenon or Process]
   827 E C0563538:Force [Phenomenon or Process]
   789 E C0729333:Dynamic [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in both differentiating A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "A1-42 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "and in the formation of oligomeric"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1515981:And [Idea or Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "fibrillar aggregates of A1-42."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.381: Polarity changes induced by protein oxidation may influence both ionic and hydrophobic interactions. 

Phrase: "Polarity changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "induced by protein oxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1159301:protein oxidation [Molecular Function]
   770   C0030011:Oxidation [Molecular Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205263:Induced [Functional Concept]

Phrase: "may"

Phrase: "influence"

Phrase: "both ionic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0022023:Ion [Element, Ion, or Isotope]
   928   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "hydrophobic interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0678607:Hydrophobic Interactions [Molecular Function]
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.382: In particular, oxidation of A at methionine 35alters the polarity at that position and may influence hydrophobic or ionic interactions necessary for fibril formation (28). 

Phrase: "In particular, oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "of A at methionine 35alters"

Phrase: "the polarity at"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0596963:Polarity [Quantitative Concept]
   718 E C0813983:polar [Quantitative Concept]

Phrase: "that position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0733755:Position [Spatial Concept]
   928 E C0240795:POSITIONAL [Finding]

Phrase: "and"

Phrase: "may"

Phrase: "influence"

Phrase: "hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "or"

Phrase: "ionic interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "necessary for fibril formation"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.383: In this recent study, AFM analysis differentiated A1-42 solutions containing mixed short fibrils from A1-42Met35ox solutions containing only small, non-fibrillar aggregates. 

Phrase: "In this recent study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "AFM analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   756   C0242849:Microscopy, Atomic Force [Laboratory Procedure]

Phrase: "differentiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]

Phrase: "A1-42 solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037633:Solutions [Substance]
   793 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "mixed short fibrils from A1-42Met35ox solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0225328:fibrils [Cell Component]
   714 E C1948066:Fibril [Physical Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "only small, non-fibrillar aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.384: These results further emphasize how the distribution of oligomeric and fibrillar A1-42 assemblies is affected by factors that influence molecular interactions. 

Phrase: "These results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "emphasize"

Phrase: "how"

Phrase: "the distribution of oligomeric"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "fibrillar A1-42 assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1706853:Assembly [Activity]
   779   C1879748:Assembly [Manufactured Object]

Phrase: "is"

Phrase: "affected by factors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
   756   C1521761:Factor [Functional Concept]
   756   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "influence"

Phrase: "molecular interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1167622:Molecular Interaction [Molecular Function]
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.385: The physical presence of amyloid plaques in vivo demonstrates that at some point, favorable conditions exist for their formation. 

Phrase: "The physical presence of amyloid plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1553521:physical presence [Idea or Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "demonstrates"

Phrase: "that at some point,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "favorable conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "exist for their formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.386: However, in vitro fibril formation occurs in solution conditions and at A concentrations that are decidedly non-physiologic. 

Phrase: "However,"

Phrase: "in vitro fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "in solution conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and at A concentrations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0086045:Concentrations [Mental Process]
   770   C1515981:And [Idea or Concept]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "decidedly non-physiologic."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0205463:Physiologic [Functional Concept]
   827   C1518422:Non [Functional Concept]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]
Processing 00000000.tx.387: The trends observed in this study suggest that at lower concentrations and under physiologic solution conditions A1-42 adopts a favorable, stable oligomeric conformation. 

Phrase: "The trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "observed in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1441672:Observed [Functional Concept]
   770   C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that at lower concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086045:Concentrations [Mental Process]
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "and under physiologic solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037633:Solution [Substance]
   770   C0205463:Physiologic [Functional Concept]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C1515981:And [Idea or Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "A1-42"

Phrase: "adopts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a favorable, stable oligomeric conformation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.388: At higher peptide concentrations and elevated temperature under oligomer-forming conditions, soluble oligomeric, protofibrillar, and short fibrillar conformations coexist, indicating that these structures may be in a conformational equilibrium. 

Phrase: "At higher peptide concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "elevated temperature under oligomer-forming conditions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015967:elevated temperature [Finding]
   753   C0005903:temperature [Organism Attribute]
   753   C0039476:*Temperature [Quantitative Concept]

Phrase: "soluble oligomeric, protofibrillar,"

Phrase: "and"

Phrase: "short fibrillar conformations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0026377:Conformation [Spatial Concept]

Phrase: "coexist"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "these structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "may"

Phrase: "be in a conformational equilibrium."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]
Processing 00000000.tx.389: However, it is unlikely that these soluble assemblies represent on-pathway fibril intermediates under the oligomer-forming conditions used in this study. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "these soluble assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "on-pathway fibril"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0225328:Fibril [Cell Component]
   827   C1948066:Fibril [Physical Object]

Phrase: "intermediates under the oligomer-forming conditions"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0205103:Intermediate [Spatial Concept]
   753   C0205431:Forming [Functional Concept]
   753   C1522492:Forming [Functional Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]
   719   C0012634:condition [Disease or Syndrome]
   719 E C0348078:Form [Qualitative Concept]
   719   C0348080:Condition [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.390: If this were the case, then increasing the peptide concentration, increasing temperature, or extending the incubation time would result in the rapid conversion of oligomeric, protofibrillar, and short fibrillar conformations to mature fibrillar conformations >1 m in length. 

Phrase: "If"

Phrase: "this"

Phrase: "were"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the peptide concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "or"

Phrase: "extending"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439792:Extending [Spatial Concept]
   966 E C0231448:Extend [Functional Concept]

Phrase: "the incubation time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "would"

Phrase: "result in the rapid conversion of oligomeric, protofibrillar,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0439831:Rapid [Qualitative Concept]
   744   C0439836:Conversion [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "and"

Phrase: "short fibrillar conformations to mature fibrillar conformations"

Phrase: ">1 m in length."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.391: This result was not observed (see Fig. 3A and Fig. 4A). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3A"

Phrase: "and"

Phrase: "Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.392: In vitro studies characterizing A protofibrils as metastable fibril precursors demonstrated that in the absence of fibrillar seeds, the conversion of protofibrils to mature amyloid fibrils is a slow process (26). 

Phrase: "In vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "characterizing"

Phrase: "A protofibrils as metastable fibril precursors"

Phrase: "demonstrated"

Phrase: "that in the absence of fibrillar seeds,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0036563:Seed [Plant]
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1705192:Seed [Laboratory Procedure]
   748   C1882540:{Seed} [Quantitative Concept]
   748   C2346495:Seed [Conceptual Entity]

Phrase: "the conversion of protofibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439836:Conversion [Functional Concept]

Phrase: "to mature amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "is"

Phrase: "a slow process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.393: Additionally, the authors noted a disappearance of protofibrils that preceded the appearance of mature fibrils (26, 51), and in vitro dialysis experiments using radiolabeled A indicate that protofibrils are in equilibrium with low molecular weight A (60). 

Phrase: "Additionally,"

Phrase: "the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "a disappearance of protofibrils"

Phrase: "that"

Phrase: "preceded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:preceded [Temporal Concept]

Phrase: "the appearance of mature fibrils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]

Phrase: "(26,"

Phrase: "51"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "in vitro dialysis experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "A"

Phrase: "indicate"

Phrase: "that protofibrils"

Phrase: "are in equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014653:Equilibrium [Organism Function]
   790   C1547026:Equilibrium [Quantitative Concept]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with low molecular weight A (60"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   853   C0041667:Low weight [Finding]
   840   C0026385:Molecular Weight [Quantitative Concept]
   804   C0005910:weight [Organism Attribute]
   804   C0043100:Weight [Quantitative Concept]
   804   C0205251:low [Qualitative Concept]
   804   C1299352:Low [Qualitative Concept]
   804   C1305866:weight [Diagnostic Procedure]
   804   C1521991:Molecular [Qualitative Concept]
   804   C1550472:low [Idea or Concept]
   804   C1705104:Weight [Idea or Concept]
   733 E C0567416:Molecule [Substance]

Phrase: ")."
Processing 00000000.tx.394: Whether in vivo oligomeric and protofibrillar forms of A1-42 represent stable end point assemblies that dissociate to monomer before proceeding to form mature fibrils via a nucleation-dependent polymerization mechanism remains to be determined. 

Phrase: "Whether"

Phrase: "in vivo oligomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "protofibrillar forms of A1-42"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "stable end point assemblies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   830   C1707720:Terminal Assembly [Manufactured Object]
   779   C1706853:Assembly [Activity]
   779   C1879748:Assembly [Manufactured Object]

Phrase: "that"

Phrase: "dissociate to monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "before proceeding to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "mature fibrils via a nucleation-dependent polymerization mechanism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0225328:fibrils [Cell Component]
   711 E C1948066:Fibril [Physical Object]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.395: Amyloid deposits that form in vivo may result from microenvironments where nucleation-dependent polymerization can proceed and are only indirectly responsible for neurodegeneration and cognitive impairment in AD. 

Phrase: "Amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "that form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "may"

Phrase: "result from microenvironments where nucleation-dependent polymerization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0314672:Polymerisation [Phenomenon or Process]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C2825142:Result [Finding]
   748   C3244310:dependent [Functional Concept]

Phrase: "can"

Phrase: "proceed"

Phrase: "and"

Phrase: "are"

Phrase: "only indirectly responsible for neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "cognitive impairment in AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   770   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.396: However, a second and potentially more biologically significant soluble pool of oligomeric and/or protofibrillar A favored by A1-42 may play a more direct and deleterious role in AD pathology. 

Phrase: "However,"

Phrase: "a second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "potentially more biologically significant soluble pool of oligomeric"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0337051:Pool [Geographic Area]
   744   C1509144:pool [Clinical Attribute]
   744   C2349200:Pool [Functional Concept]

Phrase: "and/or"

Phrase: "protofibrillar A"

Phrase: "favored by A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "deleterious role in AD pathology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.397: These remaining mechanistic questions can be addressed by additional kinetic studies. 

Phrase: "These remaining mechanistic questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1522634:Question [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "addressed by additional kinetic studies."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0022702:kinetic [Natural Phenomenon or Process]
   760   C0947630:studies [Laboratory Procedure]
   760   C1524062:Additional [Functional Concept]
   726   C0376649:Address [Intellectual Product]
   726 E C0557651:Study [Manufactured Object]
   726   C1442065:Address [Spatial Concept]
   726 E C2603343:Study [Research Activity]
   704 E C0026597:Motion [Natural Phenomenon or Process]
   704 E C0687704:Motions [Functional Concept]
Processing 00000000.tx.398: Evidence in the literature continues to build supporting a central causative role for A in the neuropathology of AD. 

Phrase: "Evidence in the literature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "continues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "build"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707059:Build [Conceptual Entity]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a central causative role for A in the neuropathology of AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.399: With increased significance comes an increased need for a better understanding of how A structure affects function. 

Phrase: "With increased significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "comes"

Phrase: "an increased need for a better understanding of how"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0027552:Need [Qualitative Concept]
   742   C0686904:need [Functional Concept]

Phrase: "A structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.400: The in vitro experiments reported in this study provide unique insights into the conditions that control the complex process of A assembly by utilizing a single, homogenous starting material to produce multiple, distinct conformational species by varying the incubation conditions. 

Phrase: "The in vitro experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "reported in this study"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   802   C1317750:Study report [Intellectual Product]
   802   C1831145:Study report [Clinical Attribute]
   770   C0557651:Study [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2603343:Study [Research Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "unique insights into the conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:insights [Mental Process]

Phrase: "that"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the complex process of A assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1522240:Process [Phenomenon or Process]

Phrase: "by utilizing"

Phrase: "a single, homogenous starting material to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Material [Substance]

Phrase: "produce"

Phrase: "multiple, distinct conformational species by varying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705920:Species [Conceptual Entity]

Phrase: "the incubation conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.401: Understanding the assembly and biological activity of both oligomeric and fibrillar forms of A is important both mechanistically and because it influences whether therapeutic strategies in AD are best aimed at eliminating oligomeric assemblies of A or plaque deposition. 

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "biological activity of both oligomeric"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205177:Activity [Functional Concept]
   760   C0205460:biological [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "fibrillar forms of A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "important"

Phrase: "both mechanistically"

Phrase: "and"

Phrase: "because"

Phrase: "it"

Phrase: "influences"

Phrase: "whether"

Phrase: "therapeutic strategies in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679199:strategies [Mental Process]

Phrase: "are"

Phrase: "best"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "aimed at eliminating oligomeric assemblies of A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   714   C1706853:Assembly [Activity]
   714   C1879748:Assembly [Manufactured Object]
   714   C1947946:Aim [Idea or Concept]
   714   C2948600:Aim [Pharmacologic Substance]
   714   C3540471:AIM [Gene or Genome]
   714   C3540472:AIM [Functional Concept]

Phrase: "or"

Phrase: "plaque deposition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.402: Furthermore, therapeutic approaches solely focused on fibril destabilization may have the undesirable side effect of increasing a soluble pool of neurotoxic A oligomers and protofibrils. 

Phrase: "Furthermore,"

Phrase: "therapeutic approaches solely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "focused on fibril destabilization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205234:Focused [Spatial Concept]
   770   C0225328:Fibril [Cell Component]
   770   C1285542:focused [Functional Concept]
   770   C1948066:Fibril [Physical Object]

Phrase: "may"

Phrase: "have"

Phrase: "the undesirable side effect of increasing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0879626:Side Effect [Pathologic Function]
   753   C0441987:Side [Spatial Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   737   C0595938:EFFECT INCREASED [Pathologic Function]

Phrase: "a soluble pool of neurotoxic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0337051:Pool [Geographic Area]
   760   C1509144:pool [Clinical Attribute]
   760   C2349200:Pool [Functional Concept]

Phrase: "A oligomers"

Phrase: "and"

Phrase: "protofibrils."
Processing 00000000.tx.403: Experiments that take into account A conformational differences will yield more consistent and interpretable results, providing the biological infrastructure for developing successful therapeutics for the treatment of AD.  

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "that"

Phrase: "take into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515187:Take [Health Care Activity]

Phrase: "account"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1551359:account [Idea or Concept]
  1000   C2741673:Account # [Clinical Attribute]
  1000   C2981730:Account [Classification]

Phrase: "A conformational differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "will"

Phrase: "yield"

Phrase: "more consistent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0332290:Consistent [Idea or Concept]
   789 E C0332529:Consistencies [Qualitative Concept]
   789 E C1547017:Consistency [Quantitative Concept]

Phrase: "and"

Phrase: "interpretable results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "the biological infrastructure for developing successful therapeutics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514880:Infrastructure [Classification]
   748   C1998546:Infrastructure [Classification]

Phrase: "for the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of AD."
Processing 00000000.tx.404: ACKNOWLEDGEMENTS We are grateful to Andrew Murphy for help with the CD experiments and Arlene Manelli, Tom Brodowski, and Jillian Hibler for the Western blot experiments and solubility studies. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Andrew Murphy"

Phrase: "for"

Phrase: "help with the CD experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0018896:Help [Social Behavior]
   760   C0681814:Experiments [Research Activity]
   760   C1552861:help [Idea or Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "Arlene Manelli,"

Phrase: "Tom Brodowski,"

Phrase: "and"

Phrase: "Jillian Hibler for the Western blot experiments"

Phrase: "and"

Phrase: "solubility studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
Processing 00000000.tx.405: We thankfully acknowledge the use of instruments in the Keck Biophysics Facility at Northwestern University.  

Phrase: "We thankfully"

Phrase: "acknowledge"

Phrase: "the use of instruments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "in the Keck Biophysics Facility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1547538:Facility [Idea or Concept]

Phrase: "at Northwestern University."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C1709274:Northwestern [Spatial Concept]
Processing 00000000.tx.406: FOOTNOTES * This work was supported in part by National Institute of Health Grants AG19121 (to M.J.L.D.), AG13496 (to G.A.K.), and AG15501 (to G.A.K.), Alzheimer's Association Grant IIRG-01-3073 (to M.J.L.D.), and the Charles Walgreen, Jr. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "of Health Grants AG19121"

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "J."

Phrase: "L.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "AG13496"

Phrase: "("

Phrase: "to G.A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "AG15501"

Phrase: "("

Phrase: "to G.A.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Alzheimer's Association Grant IIRG-01-3073"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0004083:Association [Mental Process]
   799   C0018173:Grant [Quantitative Concept]
   799   C0439849:Association [Qualitative Concept]
   799   C0596306:Association [Phenomenon or Process]
   799   C0699792:association [Social Behavior]
   799   C1548284:Grant [Idea or Concept]

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "J."

Phrase: "L.D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0475219:L/d [Quantitative Concept]
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Charles Walgreen,"

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.407: Fund (to M.J. L.D.).

Phrase: "Fund"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016820:Fund [Quantitative Concept]

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "J. L.D."

Phrase: ")."
Processing 00000000.tx.408: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.409: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.410: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.411: Present address: Acumen Pharmaceuticals, Inc., Glenview, IL. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Acumen Pharmaceuticals,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   861   C1254351:Pharmaceuticals [Pharmacologic Substance]
   827 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Glenview,"

Phrase: "IL."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]
Processing 00000000.tx.412: To whom correspondence should be addressed: ENH Research Inst., 1801Maple Ave., Suite 6240,Evanston, IL 60201.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "ENH Research Inst.,"

Phrase: "1801Maple Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Suite 6240,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553446:Suite [Intellectual Product]

Phrase: "Evanston,"

Phrase: "IL 60201.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.413: 847-467-5975; 

Phrase: "847-467-5975"

Phrase: ";"
Processing 00000000.tx.414: Fax: 847-467-7781; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "847-467-7781"

Phrase: ";"
Processing 00000000.tx.415: E-mail: m-ladu@Northwestern.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "m-"

Phrase: "ladu@Northwestern.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.416: Published, JBC Papers in Press, December 23,2002,DOI 10.1074/jbc.M210207200 2 M.J. 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "December 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M210207200 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2348291:DOI [Classification]

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.417: LaDu and L.J.Van Eldik, unpublished observations.  

Phrase: "LaDu"

Phrase: "and"

Phrase: "L.J.Van Eldik,"

Phrase: "unpublished observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.418: ABBREVIATIONS The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.419: A, amyloid-; 

Phrase: "A,"

Phrase: "amyloid-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.420: AFM, atomic force microscopy; 

Phrase: "AFM,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: "atomic force microscopy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0242849:Microscopy, Atomic Force [Laboratory Procedure]
           Force Microscopy
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0441722:Force [Phenomenon or Process]
   827   C0563538:Force [Phenomenon or Process]
   771 E C0729333:Dynamic [Functional Concept]
   755 E C0205288:Microscopic [Qualitative Concept]
   755   C0567415:Atom [Element, Ion, or Isotope]
   755   C1706222:Atom [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.421: HFIP, 1,1,1,3,3,3-hexafluoro-2-propanol; 

Phrase: "HFIP,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3-hexafluoro-2-propanol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0062622:hexafluoro-2-propanol [Organic Chemical]
   812   C0001964:Propanol [Organic Chemical,Pharmacologic Substance]
   812   C0175804:Propanol [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.422: bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol; 

Phrase: "bis-Tris,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0053809:Bis-Tris [Organic Chemical]
   861   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   861   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   861   C0556985:BIS [Temporal Concept]
   861   C0814229:TRI [Intellectual Product]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[bis(2-hydroxyethyl"

Phrase: ")"

Phrase: "amino"

Phrase: "]-2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(hydroxymethyl"

Phrase: ")"

Phrase: "propane-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033434:Propane [Organic Chemical]

Phrase: "3-diol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017945:diol [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.423: MES, 4-morpholineethanesulfonic acid; 

Phrase: "MES,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265215:MES [Congenital Abnormality]
  1000   C1417092:MES [Gene or Genome]

Phrase: "4-morpholineethanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.424: dH2O, distilled H2O; 

Phrase: "dH2O,"

Phrase: "distilled H2O"

Phrase: ";"
Processing 00000000.tx.425: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.  

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]
Processing 00000000.tx.426: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.427: Goate, A., Chartier-Harlon, M. 

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlon,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.428: C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Roote, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rossor, M., Owen, M., and Hardy, J. 

Phrase: "C., Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mant,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Roote,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Williamson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "Owen,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.429: (1991) Nature 349, 704-706[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Nature 349,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "704-706"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.430: Citron, M., Oltersdorf, T., Haas, C., McConlogue, L., Hung, A. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1828470:HAA [Cell Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.431: Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.432: J. 

Phrase: "J."
Processing 00000000.tx.433: (1992) Nature 360, 672-674[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.434: Cai, X.-D., Golde, T. 

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.435: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.436: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.437: (1993) Science 259, 514-516[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 259,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "514-516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.438: Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Westaway,"

Phrase: "D."

Phrase: ","

Phrase: "Xia,"

Phrase: "W.,"

Phrase: "Carlson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "A.,"

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perry,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Strome,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rommens,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.439: George Hyslop, P., and Selkoe, D. 

Phrase: "George Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.440: J. 

Phrase: "J."
Processing 00000000.tx.441: (1997) Nature Med. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature Med."
Processing 00000000.tx.442: 3, 67-72[Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "67-72"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.443: Selkoe, D. 

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.444: J., and Podlisny, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.445: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.446: (2002) Annu. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.447: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.448: Genomics Hum. 

Phrase: "Genomics Hum."
Processing 00000000.tx.449: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.450: 3, 67-99 6. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "67-99 6."
Processing 00000000.tx.451: Cummings, B. 

Phrase: "Cummings,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.452: J., and Cotman, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.453: W. 

Phrase: "W."
Processing 00000000.tx.454: (1995) Lancet 346, 1524-1528[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Lancet 346,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "1524-1528"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.455: Naslund, J., Haroutunian, V., Mohs, R., Davis, K. 

Phrase: "Naslund,"

Phrase: "J.,"

Phrase: "Haroutunian,"

Phrase: "V.,"

Phrase: "Mohs,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.456: L., Davies, P., Greengard, P., and Buxbaum, J. 

Phrase: "L., Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.457: D. 

Phrase: "D."
Processing 00000000.tx.458: (2000) JAMA 283, 1571-1577[Abstract/Free FullText] 8. 

Phrase: "(2000"

Phrase: ")"

Phrase: "JAMA 283,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: "1571-1577"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.459: Irizarry, M. 

Phrase: "Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.460: C., Soriano, F., McNamara, M., Page, K. 

Phrase: "C., Soriano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "McNamara,"

Phrase: "M."

Phrase: ","

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.461: J., Schenk, D., Games, D., and Hyman, B. 

Phrase: "J.,"

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.462: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.463: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.464: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.465: 17, 7053-7059[Abstract/Free FullText] 9. 

Phrase: "17,"

Phrase: "7053-7059"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.466: Chui, D. 

Phrase: "Chui,"

Phrase: "D."
Processing 00000000.tx.467: H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., Takahashi, K., Gallyas, F., and Tabira, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ozawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "S."

Phrase: ","

Phrase: "Checler,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ueda,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Araki,"

Phrase: "W.,"

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gallyas,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Tabira,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.468: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.469: Med. 

Phrase: "Med."
Processing 00000000.tx.470: 5, 560-564[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "560-564"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.471: Klein, W. 

Phrase: "Klein,"

Phrase: "W."
Processing 00000000.tx.472: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.473: (2002) Neurobiol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.474: Aging 23, 231-235[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "231-235"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.475: Walsh, D. 

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.476: M., Tseng, B. 

Phrase: "M."

Phrase: ","

Phrase: "Tseng,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.477: P., Rydel, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rydel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.478: E., Podlisny, M. 

Phrase: "E.,"

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.479: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.480: J. 

Phrase: "J."
Processing 00000000.tx.481: (2000) Biochemistry 39, 10831-10839[CrossRef][Medline] [OrderarticleviaInfotrieve] 12. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochemistry 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10831-10839"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 12."
Processing 00000000.tx.482: Hsia, A. 

Phrase: "Hsia,"

Phrase: "A."
Processing 00000000.tx.483: Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. 

Phrase: "Y.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.-Q., Tatsuno,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Malenka,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1069595:Malenka [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: C., Nicoll, R. 

Phrase: "C., Nicoll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: A., and Mucke, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.486: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.487: Natl. 

Phrase: "Natl."
Processing 00000000.tx.488: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.489: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.490: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.491: 96, 3228-3233[Abstract/Free FullText] 13. 

Phrase: "96,"

Phrase: "3228-3233"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.492: Nilsberth, C., Westlind-Danielsson, A., Eckman, C. 

Phrase: "Nilsberth,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Westlind-Danielsson,"

Phrase: "A.,"

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.493: B., Condron, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.494: M., Azelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "Azelman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Forsell,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Stenh,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Luthman,"

Phrase: "J.,"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.495: B., Younkin, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.496: G., Naslund, J., and Lannfelt, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Naslund,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Lannfelt,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.497: (2001) Nat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.498: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.499: 4, 887-893[CrossRef][Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "4,"

Phrase: "887-893"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.500: Kuo, Y. 

Phrase: "Kuo,"

Phrase: "Y."
Processing 00000000.tx.501: M., Emmerling, M. 

Phrase: "M."

Phrase: ","

Phrase: "Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.502: R., Vigo-Pelfrey, C., Kasunic, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kasunic,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.503: C., Kirkpatrick, J. 

Phrase: "C., Kirkpatrick,"

Phrase: "J."
Processing 00000000.tx.504: B., Murdoch, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Murdoch,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.505: H., Ball, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.506: J., and Roher, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.507: E. 

Phrase: "E."
Processing 00000000.tx.508: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.509: Biol. 

Phrase: "Biol."
Processing 00000000.tx.510: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.511: 271, 4077-4081[Abstract/Free FullText] 15. 

Phrase: "271,"

Phrase: "4077-4081"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.512: Roher, A. 

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.513: E., Chaney, M. 

Phrase: "E.,"

Phrase: "Chaney,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.514: O., Kuo, Y. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kuo,"

Phrase: "Y."
Processing 00000000.tx.515: M., Webster, S. 

Phrase: "M."

Phrase: ","

Phrase: "Webster,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.516: D., Stine, W. 

Phrase: "D."

Phrase: ","

Phrase: "Stine,"

Phrase: "W."
Processing 00000000.tx.517: B., Haverkamp, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Haverkamp,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.518: J., Woods, A. 

Phrase: "J.,"

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "A."
Processing 00000000.tx.519: S., Cotter, R. 

Phrase: "S."

Phrase: ","

Phrase: "Cotter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.520: J., Tuohy, J. 

Phrase: "J.,"

Phrase: "Tuohy,"

Phrase: "J."
Processing 00000000.tx.521: M., Krafft, G. 

Phrase: "M."

Phrase: ","

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.522: A., Bonnell, B. 

Phrase: "A.,"

Phrase: "Bonnell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.523: S., and Emmerling, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.524: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.525: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.526: Biol. 

Phrase: "Biol."
Processing 00000000.tx.527: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.528: 271, 20631-20635[Abstract/Free FullText] 16. 

Phrase: "271,"

Phrase: "20631-20635"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.529: Podlisny, M. 

Phrase: "Podlisny,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.530: B., Walsh, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.531: M., Amarante, P., Ostaszewski, B. 

Phrase: "M."

Phrase: ","

Phrase: "Amarante,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ostaszewski,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.532: L., Stimson, E. 

Phrase: "L., Stimson,"

Phrase: "E."
Processing 00000000.tx.533: R., Maggio, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Maggio,"

Phrase: "J."
Processing 00000000.tx.534: E., Teplow, D. 

Phrase: "E.,"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.535: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.536: J. 

Phrase: "J."
Processing 00000000.tx.537: (1998) Biochemistry 37, 3602-3611[CrossRef][Medline] [OrderarticleviaInfotrieve] 17. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry 37,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "3602-3611"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 17."
Processing 00000000.tx.538: Walsh, D. 

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.539: M., Klyubin, I., Fadeeva, J. 

Phrase: "M."

Phrase: ","

Phrase: "Klyubin,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fadeeva,"

Phrase: "J."
Processing 00000000.tx.540: V., Cullen, W. 

Phrase: "V., Cullen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1051267:Cullen [Plant]

Phrase: "W."
Processing 00000000.tx.541: K., Anwyl, R., Wolfe, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Anwyl,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.542: S., Rowan, M. 

Phrase: "S."

Phrase: ","

Phrase: "Rowan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330667:Rowan [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: J., and Selkoe, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.544: J. 

Phrase: "J."
Processing 00000000.tx.545: (2002) Nature 416, 535-539[CrossRef][Medline] [OrderarticleviaInfotrieve] 18. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nature 416,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "535-539"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 18."
Processing 00000000.tx.546: Oda, T., Wals, P., Osterburg, H. 

Phrase: "Oda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057642:ODA [Organic Chemical,Pharmacologic Substance]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wals,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Osterburg,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.547: H., Johnson, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Johnson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.548: A., Pasinetti, G. 

Phrase: "A.,"

Phrase: "Pasinetti,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.549: M., Morgan, T. 

Phrase: "M."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.550: E., Rozovsky, I., Stine, W. 

Phrase: "E.,"

Phrase: "Rozovsky,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Stine,"

Phrase: "W."
Processing 00000000.tx.551: B., Snyder, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Snyder,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.552: W., Holzman, T. 

Phrase: "W., Holzman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.553: F., Krafft, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.554: A., and Finch, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C."
Processing 00000000.tx.555: E. 

Phrase: "E."
Processing 00000000.tx.556: (1995) Exp. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.557: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.558: 136, 22-31[CrossRef][Medline] [OrderarticleviaInfotrieve] 19. 

Phrase: "136,"

Phrase: "22-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 19."
Processing 00000000.tx.559: Lambert, M. 

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.560: P., Barlow, A. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Barlow,"

Phrase: "A."
Processing 00000000.tx.561: K., Chromy, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chromy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.562: A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. 

Phrase: "A.,"

Phrase: "Edwards,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Freed,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0332296:free [Functional Concept]
   966   C1880497:Free [Qualitative Concept]
   966   C1996904:Free [Qualitative Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Liosatos,"

Phrase: "M."

Phrase: ","

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.563: E., Rozovsky, I., Trommer, B., Viola, K. 

Phrase: "E.,"

Phrase: "Rozovsky,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Trommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Viola,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330463:Viola [Plant]
  1000   C2673181:Viola [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.564: L., Wals, P., Zhang, C., Finch, C. 

Phrase: "L., Wals,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "C."
Processing 00000000.tx.565: E., Krafft, G. 

Phrase: "E.,"

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.566: A., and Klein, W. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Klein,"

Phrase: "W."
Processing 00000000.tx.567: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.568: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.569: Natl. 

Phrase: "Natl."
Processing 00000000.tx.570: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.571: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.572: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.573: 95, 6448-6453[Abstract/Free FullText] 20. 

Phrase: "95,"

Phrase: "6448-6453"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.574: Hartley, D. 

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."
Processing 00000000.tx.575: M., Walsh, D. 

Phrase: "M."

Phrase: ","

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.576: M., Ye, C. 

Phrase: "M."

Phrase: ","

Phrase: "Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043402:YE [Geographic Area]

Phrase: "C."
Processing 00000000.tx.577: P., Diehl, T., Vasquez, S., Vassilev, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Diehl,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Vasquez,"

Phrase: "S."

Phrase: ","

Phrase: "Vassilev,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.578: M., Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.579: B., and Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.580: J. 

Phrase: "J."
Processing 00000000.tx.581: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.582: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.583: 19, 8876-8884[Abstract/Free FullText] 21. 

Phrase: "19,"

Phrase: "8876-8884"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.584: Wang, H. 

Phrase: "Wang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.585: W., Pasternak, J. 

Phrase: "W., Pasternak,"

Phrase: "J."
Processing 00000000.tx.586: F., Kuo, H., Ristic, H., Lambert, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kuo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ristic,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.587: P., Chromy, B., Viola, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chromy,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Viola,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0330463:Viola [Plant]
  1000   C2673181:Viola [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.588: L., Klein, W. 

Phrase: "L., Klein,"

Phrase: "W."
Processing 00000000.tx.589: L., Stine, W. 

Phrase: "L., Stine,"

Phrase: "W."
Processing 00000000.tx.590: B., Krafft, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.591: A., and Trommer, B. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Trommer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.592: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.593: (2002) Brain Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.594: 924, 133-140[CrossRef][Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "924,"

Phrase: "133-140"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.595: Hardy, J., and Selkoe, D. 

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.596: J. 

Phrase: "J."
Processing 00000000.tx.597: (2002) Science 297, 353-356[Abstract/Free FullText] 23. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Science 297,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "353-356"

Phrase: "[Abstract/Free FullText"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.598: Kirkitadze, M. 

Phrase: "Kirkitadze,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.599: D., Bitan, G., and Teplow, D. 

Phrase: "D."

Phrase: ","

Phrase: "Bitan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.600: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.601: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.602: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.603: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.604: 69, 567-577[CrossRef][Medline] [OrderarticleviaInfotrieve] 24. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "567-577"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 24."
Processing 00000000.tx.605: Dahlgren, K. 

Phrase: "Dahlgren,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.606: N., Manelli, A. 

Phrase: "N., Manelli,"

Phrase: "A."
Processing 00000000.tx.607: M., Stine, W. 

Phrase: "M."

Phrase: ","

Phrase: "Stine,"

Phrase: "W."
Processing 00000000.tx.608: B., Jr., Baker, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.609: K., Krafft, G. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.610: A., and LaDu, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "LaDu,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.611: J. 

Phrase: "J."
Processing 00000000.tx.612: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.613: Biol. 

Phrase: "Biol."
Processing 00000000.tx.614: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.615: 277, 32046-32053[Abstract/Free FullText] 25. 

Phrase: "277,"

Phrase: "32046-32053"

Phrase: "[Abstract/Free FullText"

Phrase: "] 25."
Processing 00000000.tx.616: Stine, W. 

Phrase: "Stine,"

Phrase: "W."
Processing 00000000.tx.617: B., Jr., Snyder, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Snyder,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.618: W., Ladror, U. 

Phrase: "W., Ladror,"

Phrase: "U."
Processing 00000000.tx.619: S., Wade, W. 

Phrase: "S."

Phrase: ","

Phrase: "Wade"

Phrase: ","

Phrase: "W."
Processing 00000000.tx.620: S., Miller, M. 

Phrase: "S."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.621: F., Perun, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Perun,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.622: J., Holzman, T. 

Phrase: "J.,"

Phrase: "Holzman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.623: F., and Krafft, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.624: A. 

Phrase: "A."
Processing 00000000.tx.625: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.626: Protein Chem. 

Phrase: "Protein Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.627: 15, 193-203[Medline] [OrderarticleviaInfotrieve] 26. 

Phrase: "15,"

Phrase: "193-203"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 26."
Processing 00000000.tx.628: Harper, J. 

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.629: D., Lieber, C. 

Phrase: "D."

Phrase: ","

Phrase: "Lieber,"

Phrase: "C."
Processing 00000000.tx.630: M., and Lansbury, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.631: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.632: (1997) Chem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.633: Biol. 

Phrase: "Biol."
Processing 00000000.tx.634: 4, 951-959[Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "4,"

Phrase: "951-959"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.635: Goldsbury, C., Kistler, J., Aebi, U., Arvinte, T., and Cooper, G. 

Phrase: "Goldsbury,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kistler,"

Phrase: "J.,"

Phrase: "Aebi,"

Phrase: "U.,"

Phrase: "Arvinte,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.636: J. 

Phrase: "J."
Processing 00000000.tx.637: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.638: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.639: Biol. 

Phrase: "Biol."
Processing 00000000.tx.640: 285, 33-39[CrossRef][Medline] [OrderarticleviaInfotrieve] 28. 

Phrase: "285,"

Phrase: "33-39"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 28."
Processing 00000000.tx.641: Hou, L., Kang, I., Marchant, R. 

Phrase: "Hou,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kang,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Marchant,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.642: E., and Zagorski, M. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Zagorski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.643: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.644: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.645: Biol. 

Phrase: "Biol."
Processing 00000000.tx.646: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.647: 26, 26 29. 

Phrase: "26,"

Phrase: "26 29."
Processing 00000000.tx.648: Conway, K. 

Phrase: "Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.649: A., Lee, S. 

Phrase: "A.,"

Phrase: "Lee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.650: J., Rochet, J. 

Phrase: "J.,"

Phrase: "Rochet,"

Phrase: "J."
Processing 00000000.tx.651: C., Ding, T. 

Phrase: "C., Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419419:DING [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.652: T., Williamson, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Williamson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.653: E., and Lansbury, P. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.654: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.655: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.656: Natl. 

Phrase: "Natl."
Processing 00000000.tx.657: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.658: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.659: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.660: 97, 571-576[Abstract/Free FullText] 30. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "571-576"

Phrase: "[Abstract/Free FullText"

Phrase: "] 30."
Processing 00000000.tx.661: Serio, T. 

Phrase: "Serio,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.662: R., Cashikar, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cashikar,"

Phrase: "A."
Processing 00000000.tx.663: G., Kowal, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kowal,"

Phrase: "A."
Processing 00000000.tx.664: S., Sawicki, G. 

Phrase: "S."

Phrase: ","

Phrase: "Sawicki,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.665: J., Moslehi, J. 

Phrase: "J.,"

Phrase: "Moslehi,"

Phrase: "J."
Processing 00000000.tx.666: J., Serpell, L., Arnsdorf, M. 

Phrase: "J.,"

Phrase: "Serpell,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Arnsdorf,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.667: F., and Lindquist, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lindquist,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.668: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.669: (2000) Science 289, 1317-1321[Abstract/Free FullText] 31. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 289,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1317-1321"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.670: DePace, A. 

Phrase: "DePace,"

Phrase: "A."
Processing 00000000.tx.671: H., and Weissman, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Weissman,"

Phrase: "J."
Processing 00000000.tx.672: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.673: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.674: Struct. 

Phrase: "Struct."
Processing 00000000.tx.675: Biol. 

Phrase: "Biol."
Processing 00000000.tx.676: 9, 389-396[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "9,"

Phrase: "389-396"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.677: Walsh, D. 

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.678: M., Hartley, D. 

Phrase: "M."

Phrase: ","

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."
Processing 00000000.tx.679: M., Condron, M. 

Phrase: "M."

Phrase: ","

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.680: M., Selkoe, D. 

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.681: J., and Teplow, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.682: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.683: (2001) Biochem. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.684: J. 

Phrase: "J."
Processing 00000000.tx.685: 355, 869-877[Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "355,"

Phrase: "869-877"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.686: Howlett, D. 

Phrase: "Howlett,"

Phrase: "D."
Processing 00000000.tx.687: R., Jennings, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jennings,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.688: H., Lee, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "D."
Processing 00000000.tx.689: C., Clark, M. 

Phrase: "C., Clark,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.690: S., Brown, F., Wetzel, R., Wood, S. 

Phrase: "S."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wetzel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.691: J., Camilleri, P., and Roberts, G. 

Phrase: "J.,"

Phrase: "Camilleri,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.692: W. 

Phrase: "W."
Processing 00000000.tx.693: (1995) Neurodegeneration 4, 23-32[CrossRef][Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neurodegeneration 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "23-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.694: Soto, C., Castano, E. 

Phrase: "Soto,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Castano,"

Phrase: "E."
Processing 00000000.tx.695: M., Kumar, R. 

Phrase: "M."

Phrase: ","

Phrase: "Kumar,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.696: A., Beavis, R. 

Phrase: "A.,"

Phrase: "Beavis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.697: C., and Frangione, B. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.698: (1995) Neurosci. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.699: Lett. 

Phrase: "Lett."
Processing 00000000.tx.700: 200, 105-108[CrossRef][Medline] [OrderarticleviaInfotrieve] 35. 

Phrase: "200,"

Phrase: "105-108"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 35."
Processing 00000000.tx.701: Barrow, C. 

Phrase: "Barrow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551802:Barrow [Population Group]

Phrase: "C."
Processing 00000000.tx.702: J., and Zagorski, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Zagorski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.703: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.704: (1991) Science 253, 179-182[Medline] [OrderarticleviaInfotrieve] 36. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Science 253,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "179-182"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 36."
Processing 00000000.tx.705: Barrow, C. 

Phrase: "Barrow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551802:Barrow [Population Group]

Phrase: "C."
Processing 00000000.tx.706: J., Yasuda, A., Kenny, P. 

Phrase: "J.,"

Phrase: "Yasuda,"

Phrase: "A.,"

Phrase: "Kenny,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.707: T., and Zagorski, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Zagorski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.708: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.709: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.710: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.711: Biol. 

Phrase: "Biol."
Processing 00000000.tx.712: 225, 1075-1093[Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "225,"

Phrase: "1075-1093"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.713: Wood, S. 

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.714: J., Maleeff, B., Hart, T., and Wetzel, R. 

Phrase: "J.,"

Phrase: "Maleeff,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hart,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Wetzel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.715: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.716: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.717: Biol. 

Phrase: "Biol."
Processing 00000000.tx.718: 256, 870-877[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "256,"

Phrase: "870-877"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.719: Tomski, S. 

Phrase: "Tomski,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.720: J., and Murphy, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Murphy,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.721: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.722: (1992) Arch. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.723: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.724: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.725: 294, 630-638[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "294,"

Phrase: "630-638"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.726: Yang, D. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D."
Processing 00000000.tx.727: S., Yip, C. 

Phrase: "S."

Phrase: ","

Phrase: "Yip,"

Phrase: "C."
Processing 00000000.tx.728: M., Huang, T. 

Phrase: "M."

Phrase: ","

Phrase: "Huang,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.729: H., Chakrabartty, A., and Fraser, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chakrabartty,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.730: E. 

Phrase: "E."
Processing 00000000.tx.731: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.732: Biol. 

Phrase: "Biol."
Processing 00000000.tx.733: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.734: 274, 32970-32974[Abstract/Free FullText] 40. 

Phrase: "274,"

Phrase: "32970-32974"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.735: Fezoui, Y., and Teplow, D. 

Phrase: "Fezoui,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.736: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.737: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.738: Biol. 

Phrase: "Biol."
Processing 00000000.tx.739: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.740: 30, 30 41. 

Phrase: "30,"

Phrase: "30 41."
Processing 00000000.tx.741: Shen, C. 

Phrase: "Shen,"

Phrase: "C."
Processing 00000000.tx.742: L., and Murphy, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Murphy,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.743: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.744: (1995) Biophys. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.745: J. 

Phrase: "J."
Processing 00000000.tx.746: 69, 640-651[Abstract] 42. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "640-651"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 42."
Processing 00000000.tx.747: Snyder, S. 

Phrase: "Snyder,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.748: W., Ladror, U. 

Phrase: "W., Ladror,"

Phrase: "U."
Processing 00000000.tx.749: S., Wade, W. 

Phrase: "S."

Phrase: ","

Phrase: "Wade"

Phrase: ","

Phrase: "W."
Processing 00000000.tx.750: S., Wang, G. 

Phrase: "S."

Phrase: ","

Phrase: "Wang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.751: T., Barrett, L. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Barrett,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.752: W., Matayoshi, E. 

Phrase: "W., Matayoshi,"

Phrase: "E."
Processing 00000000.tx.753: D., Huffaker, H. 

Phrase: "D."

Phrase: ","

Phrase: "Huffaker,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.754: J., Krafft, G. 

Phrase: "J.,"

Phrase: "Krafft,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.755: A., and Holzman, T. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Holzman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.756: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.757: (1994) Biophys. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.758: J. 

Phrase: "J."
Processing 00000000.tx.759: 67, 1216-1228[Abstract] 43. 

Phrase: "67,"

Phrase: "1216-1228"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 43."
Processing 00000000.tx.760: Holzman, T. 

Phrase: "Holzman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.761: F., and Snyder, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Snyder,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.762: W. 

Phrase: "W."
Processing 00000000.tx.763: (1994) in Modern Analytical Ultracentrifugation: Acquisition and Interpretation of Data for Biological and Synthetic Polymer Systems (Schuster, T. M. , and Laue, T. M., eds) , pp. 

Phrase: "(1994"

Phrase: ")"

Phrase: "in Modern Analytical Ultracentrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596085:analytical ultracentrifugation [Laboratory Procedure]
   827   C0041609:Ultracentrifugation [Laboratory Procedure]
   827   C0936012:Analytical [Research Activity]

Phrase: ":"

Phrase: "Acquisition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706701:Acquisition [Activity]

Phrase: "and"

Phrase: "Interpretation of Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0459471:Interpretation [Intellectual Product]
   790   C3173575:Interpretation [Clinical Attribute]

Phrase: "for Biological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005532:Biological [Biomedical Occupation or Discipline]
  1000   C0205460:biological [Qualitative Concept]

Phrase: "and"

Phrase: "Synthetic Polymer Systems"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]
   734   C0440257:Synthetic polymer [Biomedical or Dental Material,Organic Chemical]

Phrase: "(Schuster,"

Phrase: "T. M. ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Laue,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.764: 298-314, Birkhuser, Boston, MA 44. 

Phrase: "298-314,"

Phrase: "Birkhuser,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 44."
Processing 00000000.tx.765: Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., and Seubert, P. 

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dunn,"

Phrase: "W.,"

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Grajeda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "J.,"

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Liao,"

Phrase: "Z.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mutter,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Soriano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shopp,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vasquez,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Vandevert,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "S."

Phrase: ","

Phrase: "Wogulis,"

Phrase: "M."

Phrase: ","

Phrase: "Yednock,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Seubert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.766: (1999) Nature 400, 173-177[CrossRef][Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 400,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "173-177"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.767: Gotz, J., Chen, F., van Dorpe, J., and Nitsch, R. 

Phrase: "Gotz,"

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "van Dorpe,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.768: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.769: (2001) Science 293, 1491-1495[Abstract/Free FullText] 46. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1491-1495"

Phrase: "[Abstract/Free FullText"

Phrase: "] 46."
Processing 00000000.tx.770: Fraser, P. 

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.771: E., Nguyen, J. 

Phrase: "E.,"

Phrase: "Nguyen,"

Phrase: "J."
Processing 00000000.tx.772: T., Surewicz, W. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Surewicz,"

Phrase: "W."
Processing 00000000.tx.773: K., and Kirschner, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kirschner,"

Phrase: "D."
Processing 00000000.tx.774: A. 

Phrase: "A."
Processing 00000000.tx.775: (1991) Biophys. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.776: J. 

Phrase: "J."
Processing 00000000.tx.777: 60, 1190-1201[Abstract] 47. 

Phrase: "60,"

Phrase: "1190-1201"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 47."
Processing 00000000.tx.778: Lomakin, A., Chung, D., Benedek, G., Kirschner, D., and Teplow, D. 

Phrase: "Lomakin,"

Phrase: "A.,"

Phrase: "Chung,"

Phrase: "D."

Phrase: ","

Phrase: "Benedek,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kirschner,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.779: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.780: Natl. 

Phrase: "Natl."
Processing 00000000.tx.781: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.782: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.783: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.784: 93, 1125-1129[Abstract/Free FullText] 48. 

Phrase: "93,"

Phrase: "1125-1129"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.785: Whittingham, J. 

Phrase: "Whittingham,"

Phrase: "J."
Processing 00000000.tx.786: L., Scott, D. 

Phrase: "L., Scott,"

Phrase: "D."
Processing 00000000.tx.787: J., Chance, K., Wilson, A., Finch, J., Brange, J., and Guy Dodson, G. 

Phrase: "J.,"

Phrase: "Chance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237506:Chance [Qualitative Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wilson,"

Phrase: "A.,"

Phrase: "Finch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326915:Finch [Bird]

Phrase: "J.,"

Phrase: "Brange,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Guy Dodson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.788: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.789: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.790: Biol. 

Phrase: "Biol."
Processing 00000000.tx.791: 318, 479-490[CrossRef][Medline] [OrderarticleviaInfotrieve] 49. 

Phrase: "318,"

Phrase: "479-490"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 49."
Processing 00000000.tx.792: Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. 

Phrase: "Bucciantini,"

Phrase: "M."

Phrase: ","

Phrase: "Giannoni,"

Phrase: "E.,"

Phrase: "Chiti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Baroni,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Formigli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Zurdo,"

Phrase: "J.,"

Phrase: "Taddei,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ramponi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dobson,"

Phrase: "C."
Processing 00000000.tx.793: M., and Stefani, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Stefani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.794: (2002) Nature 416, 507-511[CrossRef][Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nature 416,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "507-511"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.795: Chiti, F., Bucciantini, M., Capanni, C., Taddei, N., Dobson, C. 

Phrase: "Chiti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bucciantini,"

Phrase: "M."

Phrase: ","

Phrase: "Capanni,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Taddei,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Dobson,"

Phrase: "C."
Processing 00000000.tx.796: M., and Stefani, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Stefani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.797: (2001) Protein Sci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.798: 10, 2541-2547[Abstract/Free FullText] 51. 

Phrase: "10,"

Phrase: "2541-2547"

Phrase: "[Abstract/Free FullText"

Phrase: "] 51."
Processing 00000000.tx.799: Harper, J. 

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.800: D., Wong, S. 

Phrase: "D."

Phrase: ","

Phrase: "Wong,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.801: S., Lieber, C. 

Phrase: "S."

Phrase: ","

Phrase: "Lieber,"

Phrase: "C."
Processing 00000000.tx.802: M., and Lansbury, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.803: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.804: (1997) Chem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.805: Biol. 

Phrase: "Biol."
Processing 00000000.tx.806: 4, 119-125[Medline] [OrderarticleviaInfotrieve] 52. 

Phrase: "4,"

Phrase: "119-125"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 52."
Processing 00000000.tx.807: Kusumoto, Y., Lomakin, A., Teplow, D. 

Phrase: "Kusumoto,"

Phrase: "Y.,"

Phrase: "Lomakin,"

Phrase: "A.,"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.808: B., and Benedek, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Benedek,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.809: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.810: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.811: Natl. 

Phrase: "Natl."
Processing 00000000.tx.812: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.813: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.814: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.815: 95, 12277-12282[Abstract/Free FullText] 53. 

Phrase: "95,"

Phrase: "12277-12282"

Phrase: "[Abstract/Free FullText"

Phrase: "] 53."
Processing 00000000.tx.816: Pike, C. 

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.817: J., Overman, M. 

Phrase: "J.,"

Phrase: "Overman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.818: J., and Cotman, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.819: W. 

Phrase: "W."
Processing 00000000.tx.820: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.821: Biol. 

Phrase: "Biol."
Processing 00000000.tx.822: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.823: 270, 23895-23898[Abstract/Free FullText] 54. 

Phrase: "270,"

Phrase: "23895-23898"

Phrase: "[Abstract/Free FullText"

Phrase: "] 54."
Processing 00000000.tx.824: Atwood, C. 

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.825: S., Moir, R. 

Phrase: "S."

Phrase: ","

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.826: D., Huang, X., Scarpa, R. 

Phrase: "D."

Phrase: ","

Phrase: "Huang,"

Phrase: "X.,"

Phrase: "Scarpa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.827: C., Bacarra, N. 

Phrase: "C., Bacarra,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.828: M., Romano, D. 

Phrase: "M."

Phrase: ","

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.829: M., Hartshorn, M. 

Phrase: "M."

Phrase: ","

Phrase: "Hartshorn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.830: A., Tanzi, R. 

Phrase: "A.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.831: E., and Bush, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.832: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.833: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.834: Biol. 

Phrase: "Biol."
Processing 00000000.tx.835: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.836: 273, 12817-12826[Abstract/Free FullText] 55. 

Phrase: "273,"

Phrase: "12817-12826"

Phrase: "[Abstract/Free FullText"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.837: Pike, C. 

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.838: J., Walencewicz, A. 

Phrase: "J.,"

Phrase: "Walencewicz,"

Phrase: "A."
Processing 00000000.tx.839: J., Glabe, C. 

Phrase: "J.,"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.840: G., and Cotman, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.841: W. 

Phrase: "W."
Processing 00000000.tx.842: (1991) Brain Res. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.843: 563 (1-2), 311-314[CrossRef][Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "563"

Phrase: "(1-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "311-314"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.844: Pike, C. 

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.845: J., Burdick, D., Walencewicz, A. 

Phrase: "J.,"

Phrase: "Burdick,"

Phrase: "D."

Phrase: ","

Phrase: "Walencewicz,"

Phrase: "A."
Processing 00000000.tx.846: J., Glabe, C. 

Phrase: "J.,"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.847: G., and Cotman, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.848: W. 

Phrase: "W."
Processing 00000000.tx.849: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.850: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.851: 13, 1676-1687[Abstract] 57. 

Phrase: "13,"

Phrase: "1676-1687"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 57."
Processing 00000000.tx.852: Lorenzo, A., and Yankner, B. 

Phrase: "Lorenzo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875453:LORENZO'S [Lipid,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.853: A. 

Phrase: "A."
Processing 00000000.tx.854: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.855: Natl. 

Phrase: "Natl."
Processing 00000000.tx.856: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.857: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.858: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.859: 91, 12243-12247[Abstract/Free FullText] 58. 

Phrase: "91,"

Phrase: "12243-12247"

Phrase: "[Abstract/Free FullText"

Phrase: "] 58."
Processing 00000000.tx.860: Busciglio, J., Lorenzo, A., Yeh, J., and Yankner, B. 

Phrase: "Busciglio,"

Phrase: "J.,"

Phrase: "Lorenzo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875453:LORENZO'S [Lipid,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Yeh,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.861: A. 

Phrase: "A."
Processing 00000000.tx.862: (1995) Neuron 14, 879-888[Medline] [OrderarticleviaInfotrieve] 59. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neuron 14,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "879-888"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 59."
Processing 00000000.tx.863: Walsh, D. 

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.864: M., Lomakin, A., Benedek, G. 

Phrase: "M."

Phrase: ","

Phrase: "Lomakin,"

Phrase: "A.,"

Phrase: "Benedek,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.865: B., Condron, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.866: M., and Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.867: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.868: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.869: Biol. 

Phrase: "Biol."
Processing 00000000.tx.870: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.871: 272, 22364-22372[Abstract/Free FullText] 60. 

Phrase: "272,"

Phrase: "22364-22372"

Phrase: "[Abstract/Free FullText"

Phrase: "] 60."
Processing 00000000.tx.872: Walsh, D. 

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.873: M., Hartley, D. 

Phrase: "M."

Phrase: ","

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "D."
Processing 00000000.tx.874: M., Kusumoto, Y., Fezoui, Y., Condron, M. 

Phrase: "M."

Phrase: ","

Phrase: "Kusumoto,"

Phrase: "Y.,"

Phrase: "Fezoui,"

Phrase: "Y.,"

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.875: M., Lomakin, A., Benedek, G. 

Phrase: "M."

Phrase: ","

Phrase: "Lomakin,"

Phrase: "A.,"

Phrase: "Benedek,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.876: B., Selkoe, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.877: J., and Teplow, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.878: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.879: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.880: Biol. 

Phrase: "Biol."
Processing 00000000.tx.881: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.882: 274, 25945-25952[Abstract/Free FullText] 61. 

Phrase: "274,"

Phrase: "25945-25952"

Phrase: "[Abstract/Free FullText"

Phrase: "] 61."
Processing 00000000.tx.883: Harper, J. 

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.884: D., Wong, S. 

Phrase: "D."

Phrase: ","

Phrase: "Wong,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.885: S., Lieber, C. 

Phrase: "S."

Phrase: ","

Phrase: "Lieber,"

Phrase: "C."
Processing 00000000.tx.886: M., and Lansbury, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.887: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.888: (1999) Biochemistry 38, 8972-8980[CrossRef][Medline] [OrderarticleviaInfotrieve] 62. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochemistry 38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "8972-8980"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 62."
Processing 00000000.tx.889: Kowalewski, T., and Holtzman, D. 

Phrase: "Kowalewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.890: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.891: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.892: Natl. 

Phrase: "Natl."
Processing 00000000.tx.893: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.894: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.895: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.896: 96, 3688-3693[Abstract/Free FullText] 63. 

Phrase: "96,"

Phrase: "3688-3693"

Phrase: "[Abstract/Free FullText"

Phrase: "] 63."
Processing 00000000.tx.897: Huang, T. 

Phrase: "Huang,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.898: H., Yang, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D."
Processing 00000000.tx.899: S., Plaskos, N. 

Phrase: "S."

Phrase: ","

Phrase: "Plaskos,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.900: P., Go, S., Yip, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "S."

Phrase: ","

Phrase: "Yip,"

Phrase: "C."
Processing 00000000.tx.901: M., Fraser, P. 

Phrase: "M."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.902: E., and Chakrabartty, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Chakrabartty,"

Phrase: "A."
Processing 00000000.tx.903: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.904: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.905: Biol. 

Phrase: "Biol."
Processing 00000000.tx.906: 297, 73-87[CrossRef][Medline] [OrderarticleviaInfotrieve] 64. 

Phrase: "297,"

Phrase: "73-87"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 64."
Processing 00000000.tx.907: Wang, J., Dickson, D. 

Phrase: "Wang,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.908: W., Trojanowski, J. 

Phrase: "W., Trojanowski,"

Phrase: "J."
Processing 00000000.tx.909: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.910: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.911: (1999) Exp. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.912: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.913: 158, 328-337[CrossRef][Medline] [OrderarticleviaInfotrieve] 65. 

Phrase: "158,"

Phrase: "328-337"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.914: Lue, L. 

Phrase: "Lue,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.915: F., Kuo, Y. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kuo,"

Phrase: "Y."
Processing 00000000.tx.916: M., Roher, A. 

Phrase: "M."

Phrase: ","

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.917: E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. 

Phrase: "E.,"

Phrase: "Brachova,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Shen,"

Phrase: "Y.,"

Phrase: "Sue"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331781:Beach [Geographic Area]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kurth,"

Phrase: "J."
Processing 00000000.tx.918: H., Rydel, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rydel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.919: E., and Rogers, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "J."
Processing 00000000.tx.920: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.921: J.Pathol. 

Phrase: "J.Pathol."
Processing 00000000.tx.922: 155, 853-862[Abstract/Free FullText] 66. 

Phrase: "155,"

Phrase: "853-862"

Phrase: "[Abstract/Free FullText"

Phrase: "] 66."
Processing 00000000.tx.923: Solomon, B., Koppel, R., Frankel, D., and Hanan-Aharon, E. 

Phrase: "Solomon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551833:Solomon [Population Group]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Koppel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frankel,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Hanan-Aharon,"

Phrase: "E."
Processing 00000000.tx.924: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.925: Natl. 

Phrase: "Natl."
Processing 00000000.tx.926: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.927: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.928: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.929: 94, 4109-4112[Abstract/Free FullText] 67. 

Phrase: "94,"

Phrase: "4109-4112"

Phrase: "[Abstract/Free FullText"

Phrase: "] 67."
Processing 00000000.tx.930: Chung, H., Brazil, M. 

Phrase: "Chung,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Brazil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006137:Brazil [Geographic Area]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.931: I., Soe, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Soe,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.932: T., and Maxfield, F. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Maxfield,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.933: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.934: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.935: Biol. 

Phrase: "Biol."
Processing 00000000.tx.936: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.937: 274, 32301-32308[Abstract/Free FullText] 68. 

Phrase: "274,"

Phrase: "32301-32308"

Phrase: "[Abstract/Free FullText"

Phrase: "] 68."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]
Processing 00000000.tx.938: Levine, H., III (1995) Neurobiol. 

Phrase: "Levine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "(1995"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.939: Aging 16, 755-764[CrossRef][Medline] [OrderarticleviaInfotrieve] 69. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "16,"

Phrase: "755-764"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]
Processing 00000000.tx.940: Bitan, G., Lomakin, A., and Teplow, D. 

Phrase: "Bitan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lomakin,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.941: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.942: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.943: Biol. 

Phrase: "Biol."
Processing 00000000.tx.944: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.945: 276, 35176-35184[Abstract/Free FullText] 70. 

Phrase: "276,"

Phrase: "35176-35184"

Phrase: "[Abstract/Free FullText"

Phrase: "] 70."
Processing 00000000.tx.946: Palmblad, M., Westlind-Danielsson, A., and Bergquist, J. 

Phrase: "Palmblad,"

Phrase: "M."

Phrase: ","

Phrase: "Westlind-Danielsson,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Bergquist,"

Phrase: "J."
Processing 00000000.tx.947: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.948: Biol. 

Phrase: "Biol."
Processing 00000000.tx.949: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.950: 277, 19506-19510[Abstract/Free FullText] 71. 

Phrase: "277,"

Phrase: "19506-19510"

Phrase: "[Abstract/Free FullText"

Phrase: "] 71."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]
Processing 00000000.tx.951: Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. 

Phrase: "Burdick,"

Phrase: "D."

Phrase: ","

Phrase: "Soreghan,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kwon,"

Phrase: "M."

Phrase: ","

Phrase: "Kosmoski,"

Phrase: "J.,"

Phrase: "Knauer,"

Phrase: "M."

Phrase: ","

Phrase: "Henschen,"

Phrase: "A.,"

Phrase: "Yates,"

Phrase: "J.,"

Phrase: "Cotman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.952: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.953: Biol. 

Phrase: "Biol."
Processing 00000000.tx.954: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.955: 267, 546-554[Abstract/Free FullText] 72. 

Phrase: "267,"

Phrase: "546-554"

Phrase: "[Abstract/Free FullText"

Phrase: "] 72."
Processing 00000000.tx.956: Shen, C. 

Phrase: "Shen,"

Phrase: "C."
Processing 00000000.tx.957: L., Fitzgerald, M. 

Phrase: "L., Fitzgerald,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.958: C., and Murphy, R. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Murphy,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.959: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.960: (1994) Biophys. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.961: J. 

Phrase: "J."
Processing 00000000.tx.962: 67, 1238-1246[Abstract] 73. 

Phrase: "67,"

Phrase: "1238-1246"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 73."
Processing 00000000.tx.963: Kayed, R., Bernhagen, J., Greenfield, N., Sweimeh, K., Brunner, H., Voelter, W., and Kapurniotu, A. 

Phrase: "Kayed,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bernhagen,"

Phrase: "J.,"

Phrase: "Greenfield,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Sweimeh,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Brunner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Voelter,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Kapurniotu,"

Phrase: "A."
Processing 00000000.tx.964: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.965: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.966: Biol. 

Phrase: "Biol."
Processing 00000000.tx.967: 287, 781-796[CrossRef][Medline] [OrderarticleviaInfotrieve] 74. 

Phrase: "287,"

Phrase: "781-796"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 74."
Processing 00000000.tx.968: Kirkitadze, M. 

Phrase: "Kirkitadze,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.969: D., Condron, M. 

Phrase: "D."

Phrase: ","

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.970: M., and Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.971: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.972: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.973: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.974: Biol. 

Phrase: "Biol."
Processing 00000000.tx.975: 312, 1103-1119[CrossRef][Medline] [OrderarticleviaInfotrieve] Copyright  2003 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "312,"

Phrase: "1103-1119"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2003 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

